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I2L, Nek2C, ‘splicing’ alternativo, mobilidade dos espermatozóides. 
 
resumo 
 
 
A infertilidade masculina tem vindo a assumir proporções preocupantes
na nossa sociedade. Há inúmeros factores que contribuem para esta
condição, incluindo problemas associados à motilidade dos
espermatozóides. As bases moleculares da motilidade dos
espermatozóides ainda não foi completamente desvendada, contudo a
incubação de espermatozóides imaturos imóveis com inibidores de 
proteínas fosfatases induz a sua motilidade. A fosforilação de proteínas
é, então, fundamental na regulação da motilidade dos espermatozóides.
A fosforilação de proteínas é um dos principais mecanismos
reguladores de cascatas de transdução de sinais em organismos
eucariotas. Os mecanismos dinâmicos e reversíveis de
fosforilação/desfosforilação são catalizados pelas proteínas cinases e
pelas proteínas fosfatases, respectivamente. A PP1, uma fosfatase
específica para serina/treonina, está envolvida no controlo da 
motilidade dos espermatozóides, e noutras funções nos testículos. Nas
células somáticas, a PP1 está envolvida em diversos mecanismos, que
incluem o controlo do ciclo celular, a contracção muscular, a expressão
de genes, a actividade neuronal e o metabolismo do glicogénio. A
especificidade da função da PP1 depende das proteínas reguladoras
que interagem com a sua subunidade catalítica, direccionando-a para 
um dado substrato ou para uma determinada localização subcelular, 
e/ou modificando a sua actividade em relação ao substratos.
Actualmente conhecem-se mais de cinquenta subunidades reguladoras 
da PP1, não relacionadas bioquimicamente. 
A diversidade da PP1 também se deve à expressão de várias
isoformas: existem três genes que codificam a PP1 no genoma 
humano, denominados PP1α, PP1β e PP1γ. Maior complexidade 
advem ainda do ‘splicing’ alternativo que é conhecido para a PP1α e 
PP1γ. O gene da PP1γ origina uma variante ubíqua, a PP1γ1, e uma 
variante enriquecida em testículo, a PP1γ2, que é também a isoforma 
da PP1 mais abundante em espermatozóides, e que pode ser alvo de
uma terapêutica para a infertilidade masculina ou contracepção.
Rastreios de uma biblioteca de cDNA de testículo humano utilizando o
sistema dois-híbrido de levedura foram realizados usando como iscos a
PP1γ1 ou a PP1γ2. Várias novas proteínas que se ligam à PP1 foram
identificadas e as respectivas interacções validadas usando uma
diversidade de métodos, quer in vivo quer in vitro (utilizando PP1γ1 e 
PP1γ2 recombinantes produzidas em sistemas de expressão  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
bacterianos). Nas condições testadas, ambas as variantes 
recombinantes da PP1γ apresentaram propriedades enzimáticas
semelhantes, o que confirma que a sua especificidade funcional é 
provavelmente adquirida pela ligação de proteínas reguladoras. Neste
trabalho iremos focar em duas proteínas que ligam a PP1 e que foram
recentemente identificadas no laboratório, denominadas I2L e Nek2C.
A I2L (Inhibitor 2-like) é >90% idêntica ao I2, tanto ao nível 
nucleotídico como ao nível da sequência de amino ácidos, e constitui
uma isoforma nova do I2. Previamente tinha sido identificada como um
pseudogene, no entanto apresentamos evidências que apoiam a sua
expressão no testículo. A ausência da Thr-73 da I2L é muito 
significativa e pode ter consequências fisiológicas importantes. Esta
ausência resulta numa inibição permanente da actividade da PP1γ2 
pela I2L, promovendo potencialmente o desenvolvimento
unidireccional da motilidade à medida que os espermtozóides viajam 
através do epidídimo. A Nek2C é uma nova variante de ‘splicing’ da
Nek2A, diferenciando-se apenas pela ausência de 8 aminoácidos N-
terminais à sequência consenso de ligação à PP1. Contudo a falta
destes 8 aminoácidos tem consequências evidentes, resultando na
expressão funcional de um NLS (sinal de localização nuclear). Deste
modo, o mecanismo de ‘splice’ alternativo controla a translocação
nuclear desta proteína cinase reguladora do ciclo celular, fornecendo
um mecanismo pouco usual de modulação da localização da Nek2 e
permitindo que a cinase desempenhe funções tanto nucleares como
citoplamáticas. A PP1 encontra-se também em ambos os locais,
regulando uma enorme variedade de processos celulares. No futuro
espera-se que o presente trabalho possa contribuir para uma melhor
compreensão dos eventos moleculares envolvidos no controlo da
motilidade dos espermatozóides e na fertilização. Estas proteínas que
interagem com a PP1 podem constituir alvos para interferir com
diferentes funções específicas da PP1. Tanto a I2L como a Nek2C
exibem características únicas, podendo constituir candidatos
interessantes para futuros desenvolvimento no âmbito do diagnóstico e
terapêutica baseadas na transdução de sinais para a contracepção e
para o tratamento da infertilidade masculina. 
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abstract 
 
Male infertility is a problem of growing concern in our society. Various
factors contribute to this condition including motility defects in sperm. 
The molecular basis of sperm motility has not been fully elucidated, but
non-motile immature sperm acquire motility when incubated with protein
phosphatase inhibitors. Thus, protein phosphorylation is a key
regulatory mechanism in sperm motility. In eukaryotic cells protein 
phosphorylation is a major general mechanism regulating signal
transduction cascades. Consequently, protein kinases and protein
phosphatases are central players in these reversible and dynamic
processes. Among them, the serine/threonine-specific protein 
phosphatase 1 (PP1) appears to play a particularly important role in the
control of sperm motility and in the testsis. In somatic cells, PP1 is
known to be involved in many diverse processes, including cell cycle
control, muscle contraction, gene expression, neuronal activity and
glycogen metabolism. Functional specificity is provided by PP1 catalytic
subunit interacting proteins, which bind the catalytic subunit and target it
to a specific substrate or subcellular location, and/or modify its activity 
towards those substrates. To date more than 50 unrelated and
biochemically diverse regulatory subunits have been described.  
PP1 diversity can also arise from the expression of various isoforms:
three PP1 genes occur in the human genome, termed PP1α, PP1β and 
PP1γ. Further complexity derives from alternative splicing events,
known to occur at least for PP1α and PP1γ. The PP1γ gene produces a 
ubiquitously expressed PP1γ1 variant and the alternatively spliced 
PP1γ2 variant that is highly enriched in testis and is the main PP1
protein found in mammalian sperm. Therefore, it is the latter which has
been implicated in the control of sperm motility. Hence, in this work we
set out to identify and characterize PP1γ2 interactors expressed in 
human sperm, which could be targeted for male infertility therapeutics
and contraception. Yeast two-hybrid screens of a human testis cDNA 
library were carried out using either PP1γ1 or PP1γ2 as bait. Several 
novel PP1 binding proteins were identified and interactions were 
validated using a variety of methods, both in vivo and in vitro (using 
purified recombinant PP1γ1 and PP1γ2 expressed in a bacterial 
expression system). Both recombinant PP1γ variants exhibited similar  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
Enzymatic profiles under the conditions tested, thus confirming that
functional specificity is likely acquired by the binding of regulatory
proteins. Here, we will address two recently identified novel PP1
binding proteins, namely I2L and Nek2C. 
I2L (Inhibitor 2-Like) is >90% identical to I2, both at the nucleotide and
amino acid levels, and constitutes a novel I2 isoform. Previously
identified as a pseudogene, we present evidence supporting its testis-
specific expression. The lack of Thr-73 from I2L is highly significant 
and may have important physiological consequences. The missing Thr-
73 results in I2L being able to permanently inhibit PP1γ2 activity and 
potentially promote the unidirectional development of motility as sperm
travel through the epidydimis. Nek2C is a novel splice variant of
Nek2A, differing solely from the latter in missing 8 amino acids
immediately N-terminal to the consensus PP1 binding motif. However,
the lack of those 8 amino acids also appears to have marked
consequences, resulting in the expression of a functional NLS (nuclear
localization signal). Thus, alternative splicing controls nuclear
translocation of this cell cycle regulated protein kinase, providing an
unusual mechanism for modulating Nek2 localization and enabling it to
undertake both nuclear and cytoplasmic functions. PP1 is known to
occur in both locations, where it regulates many different cellular
processes. In the future, it is hoped that the present work may
contribute to a better understanding of the molecular events underlying 
sperm motility and fertilization. Clearly, such PP1 interacting proteins
may provide interesting targets to interfere with specific PP1 functions.
Thus, since both I2L and Nek2C exhibit unique characteristics, they
may constitute interesting candidates for future developments in signal
transduction diagnostics and therapeutics for contraception and the
treatment of male infertility. 
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TBS-T    tris-buffered saline tween solution 
Tris    tryptophan 
Ypi1    yeast phosphatase inhibitor 1 
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I INTRODUCTION 
 
I.1 PROTEIN PHOSPHORYLATION AS A DYNAMIC PROCESS 
 
The reversible phosphorylation of structural and regulatory proteins is a major 
intracellular control mechanism in eukaryotes. It is involved in almost all cellular functions, 
from metabolism to signal transduction, cell division and memory. The phosphorylation 
state of a protein is a dynamic process controlled by both protein kinases and protein 
phosphatases. 
Protein kinases and protein phosphatases, the key controlling elements, are regulated 
by a myriad of extracellular and intracellular signals. Unlike the protein kinases that all 
belong to a single gene family, the protein phosphatases are divided into several distinct 
and unrelated protein/gene families. The Ser/Thr-specific protein phosphatases (Ser/Thr-
PPs) comprise two distinct families, the PP1/PP2A/PP2B gene family and the PP2C gene 
family. The Tyr-specific phosphatase family, as well as including the Tyr-specific 
phosphatases, also comprises the so-called dual specificity phosphatases (capable of 
dephosphorylating Ser, Thr and Tyr residues). Besides these intracellular phosphatases 
involved in signal transduction, there are also unrelated non-specific alkaline and acid 
phosphatases that are usually found either in specialized intracellular compartments or in 
the extracellular milieu. 
The sequencing of entire genomes has revealed that approximately 3% of all 
eukaryotic genes encode protein kinases or protein phosphatases (Plowman et al., 1999). 
Surprisingly, there appear to be 2-5 times fewer protein phosphatases than protein kinases. 
This imbalance is even more pronounced when the analysis is limited to Ser/Thr-PPs and 
kinases, particularly in vertebrates. The human genome, for instance, encodes 
approximately 20 times fewer Ser/Thr-PP than Ser/Thr-kinases. Thus, whereas the 
diversity of the Ser/Thr-protein kinases has kept pace with the increasing complexity of 
evolving organisms, that of Ser/Thr-PP apparently has not. In the past decade it has 
become apparent that functional diversity of the Ser/Thr-PPs is achieved not only by the 
evolution of new catalytic subunits, but also by the ability of a single catalytic subunit to 
interact with multiple regulatory (R) subunits. 
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I.1.1 SER/THR-SPECIFIC PROTEIN PHOSPHATASES AND THEIR 
CLASSIFICATION 
 
The Ser/Thr-PPs, based on biochemical parameters, were initially divided into two 
classes: the type-1 phosphatases (PP1) that were inhibited by two heat-stable proteins, 
inhibitor-1 (I-1) and inhibitor-2 (I-2), and preferentially dephosphorylated the β-subunit of 
phosphorylase kinase; and the type-2 phosphatases, insensitive to heat-stable inhibitors and 
that preferentially dephosphorylated the α-subunit of phosphorylase kinase (Cohen, 1989; 
Ingebritsen and Cohen, 1983). Type-2 phosphatases were further subdivided into cation 
independent (PP2A), Ca2+-dependent (PP2B) and Mg2+-dependent (PP2C) types. The use 
of okadaic acid, a specific phosphatase inhibitor, further facilitated the discrimination 
between the different classes (Cohen et al., 1989). Although widely in use, this 
classification does not reflect the currently known phylogenetic relationship between the 
different Ser/Thr-PPs. Molecular cloning revealed that PP2A was in fact much more 
related to PP1 than to PP2C (Berndt et al., 1987; Honkanen and Golden, 2002). From a 
phylogenetic point of view it is more reasonable to group PP1, PP2A and PP2B in family I 
or PPP [that also includes the bacteriophage λ, orf221 phosphatase (Cohen et al., 1988b)] 
and PP2C in the unrelated family II or PPM (Fig. I.1). Here, only the PPP family will be 
further addressed. 
 
 
 
Figure I.1: Phylogenic tree depicting the evolutionary relationship between known 
phosphatases based on their primary amino acid sequence. PP1-PP7 belong to a single gene 
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family (PPP) that is structurally distinct and unrelated from the PP2C family (PPM). The phosphatases above 
the dashed line are highly sensitive to inhibition by naturally occurring toxins, such as okadaic acid, 
mycrocystin and calyculin A (Honkanen and Golden, 2002). 
 
 
 
I.1.2 THE PPP FAMILY 
 
The application of recombinant DNA techniques to the field yielded not only the 
primary structure of all four phosphatase types, but also documented the existence of 
isoforms for each type and revealed the existence of previously undetected phosphatases in 
a variety of eukaryotic cells (Berndt et al., 1987; Cohen et al., 1988a; da Cruz e Silva and 
Cohen, 1987; da Cruz e Silva et al., 1987; da Cruz e Silva et al., 1988). Three genes are 
known to encode mammalian type 1 phosphatase catalytic subunits, termed PP1α, PP1β 
and PP1γ. At least PP1γ is known to undergo tissue-specific processing to yield an 
ubiquitously expressed PP1γ1 isoform and a testis/sperm-enriched PP1γ2 isoform (da Cruz 
e Silva et al., 1995b; da Cruz e Silva and Greengard, 1995). Two genes are known to 
encode mammalian PP2A catalytic subunits, termed PP2Aα and PP2Aβ, and the three 
known mammalian PP2B catalytic subunit genes (Aα, Aβ and Aγ) are also subject to 
complex regulation to yield several alternatively spliced isoforms from each. 
Perhaps more surprising was the discovery, from a variety of tissues and species, of 
previously unknown phosphatase catalytic subunit isoenzymes, that were termed novel 
phosphatases (da Cruz e Silva et al., 1988). For esample, PP4, PP5 and PP6 (Cohen, 1997) 
are present in all mammalian tissues examined. In contrast, human PP7 (Huang and 
Honkanen, 1998), also found in Arabidopsis thaliana (Andreeva et al., 1998), and two 
Drosophila phosphatases appear to be exhibit tissue specific expression (PPY is testis-
specific and RdgC is restricted to photoreceptor organs and a small region in the brain). 
PP7 has been detected in the human retina and also in specialized sensory cells in plants. 
An overall comparison of their structures is shown in Fig. I.2. 
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Figure I.2: Comparison of domain organization of PPP family members. The numbers of 
amino acids in each are indicated on the right. 
 
 
 
I.1.3 PP1 - PROTEIN PHOSPHATASE 1 
 
Eukaryotic genomes contain between one (Saccharomyces cerevisiae) and eight 
(Arabidopsis thaliana) genes that encode PP1 catalytic subunits. These isoenzymes 
typically show an overall sequence identity of approximately 90% and cannot be 
distinguished by either their in vitro substrate specificity or by their ability to interact with 
R subunits in vitro (Schillace and Scott, 1999; Zhang et al., 1993a). The sequence of the 
catalytic core of PP1 (corresponding to residues 41-269 of mammalian PP1α) is almost 
identical in all isoforms, showing a high degree of similarity with the corresponding 
fragment of the catalytic subunits of PP2A and PP2B (Egloff et al., 1995; Goldberg et al., 
1995). 
 
I.1.3.1 PP1 Expression and distribution 
 
By using specific antibodies raised against the different PP1 isoforms (α, β and γ1) 
it was shown that all the three isoforms were expressed in a variety of mammalian cells 
tested, although they localize in a distinct and characteristic manner within these cells. All 
the isoforms were present both in the cytoplasm and nucleus during interphase. Within the 
nucleus PP1α associates with the nuclear matrix, whereas PP1γ1 concentrates in nucleoli in 
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association with RNA, and PP1β localizes to non-nucleolar chromatin. During mitosis 
PP1α is localized to centrosomes, PP1γ1 is associated with microtubules and 
PP1β associates with chromosomes (Andreassen et al., 1998). 
In the brain the mRNAs for PP1α, PP1β and PP1γ1 were found to be particularly 
abundant in hippocampus and cerebellum (da Cruz e Silva et al., 1995b). At the protein 
level PP1α and PP1γ1 were found to be more highly expressed in brain than in peripheral 
tissues (Table I.1), with the highest levels being measured in the striatum, where they were 
shown to be relatively enriched in the medium-sized spiny neurons (da Cruz e Silva et al., 
1995b). At the electron microscopic level, PP1 immunoreactivity was demonstrated in 
dendritic spine heads and spine necks and also in postsynaptic density (Ouimet et al., 1995). 
PP1 immunoreactivity has also been reported in human hippocampal neuronal cytoplasm 
(Pei et al., 1994). In addition, most neuronal nuclei were not immmunoreactive for PP1γ1 
but were usually strongly immunoreactive for PP1α (Ouimet et al., 1995). 
 
 
Table I.1: Tissue distribution of the main PP1 isoforms  (Fardilha 2004a) 
 PP1α PP1γ1 PP1γ2 PP1β 
Brain ++ 
 
+++ 
 
- 
 
+++ 
 
Heart + 
 
+ 
 
 + 
 
Liver + 
 
+ 
 
 -  
 
Intestine + 
 
+ 
 
- 
 
+++ 
 
Kidney + 
 
+ 
 
- 
 
+ 
 
Spleen + 
 
++ 
 
- 
 
+ 
 
Adrenal 
gland 
+ 
 
++ 
 
- 
 
+ 
 
Lung ++ 
 
++ 
 
 +++ 
 
Skeletal 
muscle 
+ 
 
+ 
 
 - 
 
Testis ++ 
 
+ 
 
+++ 
 
++ 
 
-, below detection limit. 
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I.1.3.2 PP1 Structure and function 
 
Protein phosphatase 1 (also known as phosphorylase phosphatase) has been studied 
since the 1940s as the enzyme responsible for the conversion of phosphorylase a to 
phosphorylase b (Cori G, 1943). The discovery that this activity (PP1) was a phosphatase 
came at the same time as the discovery of phosphorylase kinase (Keller and Cori, 1955; 
Sutherland and Wosilait, 1955). These hallmark findings marked the beginning of an era: 
the study of protein phosphorylation/dephosphorylation as a regulatory mechanism. 
Investigation of PP1 in the following three decades focused on defining its enzymology 
and role in glycogen metabolism (Bollen and Stalmans, 1992; Brautigan, 1994; Shenolikar, 
1994; Shenolikar and Nairn, 1991), and progress in the isolation and characterization of 
PP1 activity was very slow. The study of the enzymology of this enzyme is still incomplete 
today and PP1 continues to provide many surprises, as well as stimulating new questions 
about its cellular functions. 
 
I.1.3.2.1 PP1c crystal structure and catalytic mechanism 
 
During the past decade and a half there has been major progress in the elucidation 
of the atomic structures of the Ser/Thr-PPs in general. Crystal structures for PP1-
microcystin (Goldberg et al., 1995), PP1-tungstate (Egloff et al., 1995), PP1-GM peptide 
complexes (Egloff et al., 1997) and, more recently, PP1-okadaic acid (Maynes et al., 2001) 
have been determined. Two structures for PP2B have been solved, the auto-inhibited 
enzyme and a ternary complex of a truncated PP2B with FKBP12/FK506 (Griffith et al., 
1995; Kissinger et al., 1995). These structures show that the molecular architecture of the 
catalytic cores of PP1 and PP2B are conserved [a review can be found in (Barford, 1996)], 
and that both contain a bimetal center at the active site which is structurally similar to that 
present in the purple acid phosphatase (Strater et al., 1995). PP1, like PP2B, is a 
metalloprotein possessing a bimetal center that is bridged by a water molecule at the active 
site. The use of proton induced X-ray emission spectroscopy revealed the presence of Mn 
and Fe in the ratio 1 to 0.5 in PP1 (Egloff et al., 1995). The nature of the metal ions in 
cellular PP1 is unknown, although it can be speculated that it may be a Fe/Zn pair as in 
PP2B (King and Huang, 1984; Kissinger et al., 1995). The current views of the catalytic 
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mechanism for PP1 are that the metals serve as ligands for the phosphate oxygens and for 
the generation of a hydroxide ion which serves as the nucleophile that is involved in the 
catalysis, while H125 serves as a proton donor for the leaving alcohol group. Other 
residues in the active site which serve to stabilize the proposed pentacoordinate state of the 
phosphate intermediate are R96, N124 and R221. Mutation of the metal ligands H66, D64, 
D92 and H248 residues led to severe loss of catalytic function (Zhang et al., 1996a). 
Mutation of H125 and H173 did not result in readily expressed proteins. Although small 
amounts of the H125S and H125A mutant proteins could be isolated, these mutants were 
inactive. Mutation of D95, which is proposed to stabilize the protonation of H125 by a salt 
bridge, also resulted in significant reduction in catalytic activity. Mutations of R96 and 
N124 have also supported their proposed roles in phosphate binding. 
 
I.1.3.2.2 Binding region for naturally occurring toxins 
 
Several mutants of PP1 which exhibit a general loss of sensitivity towards several 
natural toxins show that these toxins have a common binding region on PP1. It was shown 
that a mutated PP2A (Cys269 to Gly) had reduced sensitivity to okadaic acid (OA) (Shima 
et al., 1994). By comparing the amino acid sequence of PP1 and PP2A in this region (Fig. 
I.3), it was noted that the region was well conserved except for a four residue difference, 
YRCG in PP2A (267-270) and GEFD (274-277) in PP1. 
 
 
 
Figure I.3: Alignment of C-terminal regions of PP1, PP2A and PP2B. The boxed region 
shows the loop regions that connect beta sheets 12 and 13 in the structures of PP1 and PP2B. 
 
 
 
The chimeric PP1 mutant in which GEFD was changed to YRCG resulted in 
increased sensitivity to OA (Zhang et al., 1994), consistent with the fact that PP2A is more 
sensitive to okadaic acid than PP1. The same occurred when F276 was mutated to Cys 
(Zhang et al., 1996a). It was also shown that Y272 is important for the binding of all of the 
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inhibitors tested, as its conservative mutation to phenylalanine caused decreases in PP1 
toxin sensitivity. These mutagenesis studies indicate that binding of the toxins must all 
involve some common contacts on PP1, and that Y272 is particularly important in this 
context. Y272 is located close to the active site with its hydroxyl group within a few 
angstroms of the Fe ion (Egloff et al., 1995). The mutation of Y272 without deleterious 
effects on its catalytic activity suggests that it is not involved in the catalysis. This region 
of PP1 represents the loop region connecting beta strands 12 and 13 in PP1 structure (Fig 
I.4).  
If the toxins bind to the same site on PP1, this may reflect the possibility that these 
chemically diverse molecules must present topographically similar surfaces at the points of 
interaction with PP1. This idea has been supported by molecular modeling studies (Bagu et 
al., 1997; Gauss et al., 1997; Lindvall et al., 1997). 
The structure of PP1 bound to okadaic acid (Maynes et al., 2001) is remarkably 
similar to the two structures of PP1 and PP2B determined previously. Even with only the 
phosphate-mimic tungstate present the architecture of the active site of the tungstate-bound 
PP1 structure is virtually identical to OA-bound PP1 complex. 
 
 
     
Figure I.4: The β12/β13 loop 
of PP1. The diagram shows a ribbon 
model of the PP1 structure. The two 
beta sheets that are the scaffold for the 
active site are shown in yellow (beta 
sheet 1) and magenta (beta sheet 2). 
Beta strands 12 and 13 are shown in 
red. Microcystin is shown in 
wireframe and the two metal ions as 
black spheres. (Goldberg et al., 1995). 
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In contrast, the microcystin-bound structure reveals large changes in the 
conformation of the active site. These changes are mainly restricted to the β12/β13 loop 
(Fig. I.4). The loop in the microcystin-bound PP1 structure folds back on itself, causing 
significant shifting of residues 273-278. One critical difference between microcystin and 
OA is the presence of a dehydroalanine residue in microcystin that covalently alkylates the 
Sγ of Cys273 in a time dependent reaction (Dawson and Holmes, 1999). This covalent 
linkage is not the primary cause of inhibition of PP1 by microcystin (Goldberg et al., 1995). 
Given the strong similarity of the PP1-interacting domains of OA and microcystin it is 
likely that the primary mode of inhibition of PP1 by microcystin is similar to that of OA 
and that the movement of the β12/β13 loop in the microcystin complex is a secondary 
event accompanying the covalent binding reaction. An important interaction between PP1 
and microcystin that is not present in the PP1-OA complex is the hydrogen bond that 
occurs between Arg96 (PP1) and the acid of the methyl-aspartate residue (microcystin). 
This interaction may account for the 100-fold greater inhibition of PP1 by microcystin over 
OA (Holmes and Boland, 1993). The structure of PP1-OA is very similar to the structure 
of PP2B despite the fact that OA does not strongly inhibit PP2B. 
 
I.1.3.2.3 Substrate binding 
 
The active site of PP1 lies at the confluence of three shallow grooves, a C-terminal 
groove, an acidic groove and a hydrophobic groove, which are potential binding sites for 
substrates and inhibitors (Egloff et al., 1995; Goldberg et al., 1995). Microcystin binds in a 
manner such that it occupies the active site, while its extended ADDA side chain occupies 
the hydrophobic groove. The hydrophobic groove forms the obvious binding site for 
peptide substrates. The two PP1 inhibitors, I-1 and DARPP-32, both carry four basic 
residues N-terminal to the phosphothreonine residue and its binding to PP1 has been 
hypothesized to be that of a pseudosubstrate (Goldberg et al., 1995). Binding of 
peptide/polypeptide substrates to PP1 can be considered to be composed of three elements: 
interaction of the basic residues N-terminal to the phosphoserine with the acidic residues in 
the acidic groove, binding of the phosphoserine to the active site and an interaction of the 
region C-terminal to the phosphoserine (or phosphothreonine) to the hydrophobic groove. 
In the active site region the structure of the PP1-tungstate complex has shown that R96, 
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N124 and R221 are involved in the binding of the phosphate oxygens (Egloff et al., 1995). 
R221 and R96 are well positioned to form salt bridges with two of the phosphate oxygens, 
while the amino group of N124 can be hydrogen bound to the third oxygen. D208 was 
hypothesized to be important for the orientation of R221 via a salt bridge interaction. It 
was also indicated that W206 and Y134 are well positioned to interact with the Ser or Thr 
carrying the phosphate residue (Egloff et al., 1995). 
 
I.1.3.3 PP1 targeting/binding proteins 
 
During the last decade evidence has accumulated that the substrate specificity of 
PP1 is achieved by the interaction with other proteins that can act as targeting subunits or 
activity modulators. Targeting, as the requirement for the molecular juxtaposition of 
proteins for the generation of signaling events, is well established as a paradigm in a 
number of growth regulated signaling systems involving tyrosine phosphorylation 
(Kuriyan and Cowburn, 1997; Lemmon and Schlessinger, 1994; Pawson, 1994), as well as 
in the anchoring of Ser/Thr-protein kinases by A-kinase anchoring proteins (AKAPs), one 
of which also binds PP2B (Lemmon and Schlessinger, 1994; Rubin, 1994) . The concept of 
targeting as it relates to PP1, however, has a major twist in terms of the large number of 
PP1 binding proteins that have been reported during the past years, as it expands the 
number of PP1 heterodimers/heterotrimers that may exist and consequently the repertoire 
of cellular functions that involve PP1. 
Genetic studies of yeast mutations that affect glycogen metabolism and cell cycle 
regulation, and the use of the yeast two-hybrid system have revealed many genes that 
encode putative PP1-binding proteins [reviewed in (Stark, 1996)]. These include GAC1, 
REG1, REG2, SCD5, GIP1, SHP1, GIP2 and SDS22 in S. cerevisiae. These genes are 
required for the control of glycogen metabolism, protein synthesis, glucose repression, 
meiosis, sporulation and mitotic cell cycle regulation. Rigorous biochemical demonstration 
that these PP1-binding proteins actually interact with PP1, or the nature of the targeting 
function or the substrates, have not been shown in all cases. A key element of the targeting 
hypothesis is that the cellular activity of PP1 is only expressed when it is targeted. This 
explains why the PP1 catalytic subunit exhibits a relatively nonspecific phosphatase 
activity in vitro. The strongest experimental support for a targeting function of a PP1 
regulator (R) has come from genetic and biochemical studies of yeast glycogen metabolism. 
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The glycogen-deficient yeast mutant glc7-1 was found to express PP1 with a R73C point 
mutation (Peng et al., 1990). This does not affect PP1 activity but resulted in loss of its 
ability to bind to the yeast homolog (Gac1p) of the mammalian glycogen binding protein 
(Stuart et al., 1994). The activation of glycogen synthase requires its dephosphorylation by 
PP1 and it has been shown that glycogen synthase in this mutant strain is largely in the 
inactive phospho-form. Overexpression of Gap1p, on the other hand, led to increased 
glycogen accumulation. These findings demonstrated that the physiological functioning of 
PP1 in glycogen metabolism was dependent on it being targeted to the appropriate micro-
environment and that other cellular functions were not affected when targeting to glycogen 
was disrupted. 
Several mammalian PP1-binding proteins have also been identified and shown to 
be responsible for the involvement of PP1 in a number of diverse cellular functions 
[(Fardilha et al., 2004a).; Table I.2]. Based on their effect on PP1c, the best characterized 
R subunits can be divided into three groups. The first group is represented by activity-
modulating proteins, including true inhibitors such as I-1 (Connor et al., 1999) and CPI-17 
(Koyama et al., 2000) that in their phosphorylated form block the activity of PP1c towards 
all substrates. Other members of this group act instead as substrate-specifiers of PP1c. For 
example, I-1PP2A (PHAP-I) and I-2PP2A (PHAP-II), which are potent inhibitors of PP2A, 
promote the dephosphorylation of specific substrates by PP1c (Katayose et al., 2000). A 
second group of R subunits includes the targeting proteins which bind both PP1c and one 
of its substrates. For example, MYPT1 binds PP1c as well as specific substrates, such as 
myosin (Fukata et al., 1998; Hartshorne and Hirano, 1999; Toth et al., 2000a). Other 
targeting subunits do not bind the substrate directly but instead associate with a subcellular 
structure that contains the substrate. For example, the G subunits target PP1 to glycogen 
particles, which also bind the substrate glycogen synthase (Liu and Brautigan, 2000). The 
targeting proteins of PP1 also include scaffolding proteins that mediate the formation of 
protein complexes. Often, these complexes function as signaling modules that contain both 
protein kinases and phosphatases, and are localized in close proximity to the substrates of 
these enzymes. The third group of proteins that directly and tightly associates with PP1c 
defines a subset of its substrates. Some of these substrates also function as targeting 
proteins. Thus, the centrosomal protein kinase Nek2 not only binds its substrate C-Nap1, 
but also binds PP1c, and both Nek2 and C-Nap1 are proposed substrates of the associated 
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PP1c (Helps et al., 2000). Some PP1c-bound substrates also function as activity 
modulators. For example, the retinoblastoma protein interacts with PP1c both as a substrate 
and as a noncompetitive inhibitor (Tamrakar and Ludlow, 2000). 
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Table I.2: Classification of the regulatory R subunits of PP1. 
Regulatory subunit General Function Reference 
I-1 PPP1R1A (Huang and Glinsmann, 1976a) 
DARPP-32 PPP1R1B (Hemmings et al., 1984d) 
I-2 PPP1R2 
PP1 inhibitors 
 
(Huang and Glinsmann, 1976a) 
GM (RGL, R3) PPP1R3A (Stralfors et al., 1985) 
GL (R4) PPP1R3B 
(Doherty et al., 1995; Moorhead et al., 
1995) 
R5(PTG) PPP1R3C (Doherty et al., 1996) 
R6 PPP1R3D 
Glycogen metabolism 
(Armstrong et al., 1997) 
Sds22 PPP1R7 Mitosis/Meiosis (Dinischiotu et al., 1997) 
NIPP-1 (Ard-1) PPP1R8 (Van Eynde et al., 1995) 
SIPP-1  (Llorian et al., 2004) 
PSF1  
RNA splicing 
(Hirano et al., 1996) 
Neurabin I PPP1R9A Neurite outgrowth, synapse morphology (MacMillan et al., 1999) 
Spinophilin (neurabin 
II) 
PPP1R9B 
Glutamatergic synaptic transmission, 
dendritic morphology 
(Allen et al., 1997) 
p99 (R111, PNUTS) PPP1R10 RNA processing or transport? (Allen et al., 1998) 
Hox11  Cell cycle checkpoint (Kawabe et al., 1997) 
Inhibitor-3 (HCG-V) PPP1R11 Inhibits PP1 (Zhang et al., 1998) 
HCF  Transcription, cell cycle (Ajuh et al., 2000) 
MYPT1 (M110, MBS, 
M130) 
 (Alessi et al., 1992) 
MYPT2 (PP1bp55, 
M20-spliced form) 
PPP1R12B (Moorhead et al., 1998) 
P85 PPP1R12C (Tan et al., 2001) 
Phactr1  
Myosin/actin targeting 
(Allen et al., 2004) 
L5 ribossomal protein  (Hirano et al., 1995) 
RIPP1  
Protein synthesis? 
(Beullens et al., 1996)  
53BP2 (TP53BP2, p53-
binding protein 2) 
PPP1R13A Cell cycle checkpoint? (Helps et al., 1995) 
CPI-17 PPP1R14A Inhibits the myosin bound PP1 complex (Eto et al., 1997) 
PHI-2 PPP1R14B (Eto et al., 1999) 
PHI-1  (Eto et al., 1999) 
KEPI  
Inhibits PP1 
(Liu et al., 2002) 
GBPI-1  
Inhibits PP1 when phosphorylated 
(Brain/Stomach) 
(Liu et al., 2004) 
GBPI-2  
Inhibits PP1 when phosphorylated 
(Testis) 
(Liu et al., 2004) 
I-4   (Shirato et al., 2000) 
GADD34 PPP1R15A Protein synthesis (Connor et al., 2001) 
CReP PPP1R15B Protein synthesis (Jousse et al., 2003) 
AKAP 149  
Nuclear envelope reassembly 
(dephosphorylation of B-type lamins) 
(Steen et al., 2000) 
NF-L  Synaptic transmission? (Terry-Lorenzo et al., 2000) 
AKAP-220  Coordination of PKA/PP1 signalling (Schillace et al., 2001) 
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Yotiao  
Synaptic transmission (NMDA receptor 
ion channel activity) 
(Feliciello et al., 1999; Westphal et al., 
1999) 
BH-protochaderin c  Neuronal cell-cell interaction (Yoshida et al., 1999) 
Rynanodyne receptor  Calcium ion channel activity? (Zhao et al., 1998) 
NKCCl  Cl transport (Darman et al., 2001) 
AKAP 350 (CG-NAP, 
AKAP450) 
 (Takahashi et al., 1999) 
Nek2  
Centrosomal function 
(Helps et al., 2000) 
Tau  Microtubule stability? (Liao et al., 1998) 
Bcl2  Apoptosis (Ayllon et al., 2001) 
RB  Cell cycle progression (Durfee et al., 1993) 
PRIP-1 (p130, PLC-
L1) 
 Calcium signalling? (Yoshimura et al., 2001) 
PFK  Glycolisis? (Zhao and Lee, 1997b) 
PP1bp80  (Damer et al., 1998) 
MYPT3 PPP1R16A 
Myosin targeting 
(Skinner and Saltiel, 2001) 
I1PP2A(PHAPI)  (Katayose et al., 2000) 
I2PP2A(SET, PHAPII, 
TAF1β) 
 
Stimulation of PP1 and Inhibition of 
PP2A (Katayose et al., 2000) 
G-substrate  Inhibition of PP1 (Aitken et al., 1981) 
Grp78  Unknown (Chun et al., 1994) 
NCLK  Activates PP1 (Agarwal-Mawal and Paudel, 2001) 
Myr8  Brain development (Patel et al., 2001) 
FAK  
PP1 dephosphorylates FAK in cells 
released from mitosis 
(Fresu et al., 2001) 
Herpes vírus γ1 34.5 
protein 
 Inhibits protein synthesis (He et al., 1997) 
mGluR7b  Unknown (Enz, 2002) 
Histone H3  Mitosis (Hsu et al., 2000) 
Scapinin  
Associated with the nuclear 
nonchromatin structure 
(Sagara et al., 2003) 
14-3-3  sperm (Huang et al., 2004)  
SARP  ? (Browne et al., 2007) 
Abbreviations: PTG, Protein targeting to glycogen; MYPT, myosin phosphatase targeting subunit; MBS, 
myosin binding subunit; NIPP, Nuclear inhibitor of PP1; PSF, polypyrimidine tract-binding protein 
associated splicing factor; PNUTS, phosphatase 1 nuclear targeting subunit; Hox11, Homeodomain 
transcription factor; HCF, host cell factor or human factor C1; RIPP1, ribosomal inhibitor of PP1; PHI, 
phosphatase holoenzyme inhibitor; KEPI, kinase-enhanced protein phosphatase type 1 inhibitor; GADD34; 
growth arrest and DNA damage protein; AKAP, A-kinase anchoring protein; NKCCl, Na-K-Cl cotransporter; 
Nek2; NIMA-related protein kinase; Rb, retinoblatoma protein; PRIP-1; phospholipase C-related inactive 
protein; PFK, Phosphofrutokinase; G-substrate, cGMP-dependent protein kinase substrate; Grp-78, glucose-
regulated protein, member of the HSP-70 family; NCLK, neuronal cdc2-like kinase; FAK; Focal adhesion 
kinase. The human genome nomenclature for the regulatory subunits that are only classified as PP1 
regulators is indicated in column 2. PPP1R4, PPP1R5 and PPP1R6 have recently been re-classified as 
PPP1R3B, PPP1R3C and PPP1R3D. 
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I.1.3.4 The consensus PP1 binding “RVxF motif” 
 
Members of all groups of R subunits have been shown to bind to PP1c via a short 
sequence that is now referred to as the “RVxF motif” (Barford et al., 1988; Egloff et al., 
1997; Zhao and Lee, 1997a), although the sequences that correspond to the RVxF motif are 
degenerate. The consensus sequence is [K/R]-X0-1-[V/I/L]-(Agarwal-Mawal and Paudel, 
2001){P}-[F/W] (Wakula et al., 2003). The residues of PP1c that are necessary for binding 
to the RVxF motif (in particular residues 287-293) are invariant in all isoforms from all 
species (Barford et al., 1988; Egloff et al., 1997). However, they are not conserved in the 
catalytic subunits of PP2A or PP2B, which explains why most regulators of PP1 do not 
interact with these highly homologous and structurally related phosphatases. Conversely, 
some proteins that bind PP1 but are also able to interact with the catalytic subunit of PP2A 
(HOX11, I-1PP2A and I-2PP2A) do not contain an RVxF sequence (Katayose et al., 2000; 
Kawabe et al., 1997). 
The binding of the RVxF sequence does not cause important conformational 
changes in the catalytic subunit (Egloff et al., 1997) and does not have major effects on the 
activity of the phosphatase (Beullens et al., 1999; Endo et al., 1996; Kwon et al., 1997). 
Studies on MYPT1 and I-2 have indicated that the RVxF motif can function as an anchor 
for PP1c and enables these R subunits to make additional contacts with the phosphatase in 
an ordered and cooperative manner (Toth et al., 2000b; Yang et al., 2000a). For example, 
four phosphatase-interaction sites, in addition to the RVxF motif, have been identified for 
MYPT1 and I-2 (Hartshorne and Hirano, 1999; Toth et al., 2000b; Yang et al., 2000a). 
Another recurring theme is that the R subunits have common or overlapping binding sites 
on PP1c, in addition to the RVxF-binding channel. For example, the inhibition of PP1c by 
phosphorylated I-1 (Endo et al., 1996), DARPP-32 (Kwon et al., 1997) and MYPT1 
(Hartshorne and Hirano, 1999) have all been attributed to the binding of the 
phosphorylated residue at or near the catalytic site as a pseudo-substrate. The sharing of 
interaction sites is also in accordance with findings that various point mutants of PP1c 
show altered affinity for multiple R subunits (Baker et al., 1997; Ramaswamy et al., 1998). 
As expected from the unusually high conservation of residues on the surface of PP1c, 
mutagenesis studies in yeast have identified many surface residues as being essential for 
the binding of R subunits (Baker et al., 1997; Ramaswamy et al., 1998). A site that lies 
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adjacent to the RVxF–binding groove has been identified as a binding pocket for the N-
terminal “IKGI” motif of inhibitor-2 (Connor et al., 2000). 
The picture that emerges shows that the binding of the R subunits to PP1c is 
mediated by multiple, degenerate, short sequence motifs and that the R subunits can share 
interaction sites. It should be pointed out that this combinatorial control (Bollen, 2001) of 
PP1c does not rule out the possibility that some R subunits might have unique binding sites. 
The combinatorial control of PP1 allows for exquisite physiological regulation of PP1 
holoenzymes by hormones, growth factors and metabolites at the molecular level. Work on 
the various holoenzymes has demonstrated that their physiological regulation involves 
modulation of subunit interaction, often mediated by reversible phosphorylation or 
allosteric regulation of the R subunits. For three unrelated R subunits it has been shown 
that the phosphorylation of Ser residue(s) within or close to the RVxF motif disrupts the 
binding of this motif to PP1c (Beullens et al., 1999; Liu et al., 2000; McAvoy et al., 1999). 
This results in altered activity of the holoenzyme or the release of the catalytic subunit. In 
contrast, phosphorylation of other subunits strengthens their interaction with PP1c. 
Examples include I-1 and DARPP-32, in which an additional binding site for PP1c is 
created by phosphorylation. A different type of regulation involves the binding of allosteric 
regulators. The allosteric binding of phosphorylase a to the C-terminal tail of the liver-type 
G subunit (GL) abolishes the activity of the associated PP1c towards glycogen synthase 
(Armstrong et al., 1998). An additional level of regulation of PP1 holoenzymes is provided 
by targeting of these enzymes to specific substrates or subcellular structures. Bollen and 
coworkers, by a combination of bioinformatics tools and mutagenesis studies, have 
delineated the consensus sequence and function of three PP1 binding motifs as being 
[K/R]-X0-1-[V/I/L]-(P)-[F/W], where X denotes any residue and P any residue except 
proline (Wakula et al., 2003). This sequence is very similar to the consensus sequence 
previously proposed ([R/K]-[K/R]-X0-2-V-[R/H]-[F/W]-X-[DE]) by panning of a random 
peptide display library (Zhao and Lee, 1997a). The main differences are the presence of an 
N-terminal basic residue and a C-terminal acidic residue in the second. 
The RVxF-consensus sequence is present in about one third of all eukaryotic 
proteins, but only a small fraction are thought to be PP1-binding proteins. It seems that 
RVxF-consensus sequences function as PP1 interaction sites only when they are present in 
a flexible and exposed loop that can be modeled into a β-strand. Additionally, other low 
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affinity regions on the PP1 regulators further strengthen the binding. Thus, the RVxF-
consensus sequence functions like an anchor and other low affinity interactions have to 
occur that have regulator-specific effects on PP1 activity and specificity (Wakula et al., 
2003). Recently, another PP1 binding motif has been proposed, F-X-X-R-X-R, that also 
appears to exist in several PP1 interactors (Ayllon et al., 2002). A combined bioinformatics 
and mutagenesis approach could also be used to study this new consensus motif. The 
existence of common binding sites for the various R subunits explains why a relatively 
small protein such as PP1c can interact with numerous different R subunits and why the 
binding of most R subunits is mutually exclusive. 
 
I.1.4 PHOSPHATASE INHIBITORS 
 
One of the most significant advances in the study of Ser/Thr-PPs, and for the 
elucidation of the cellular events they control, was the identification of several naturally 
occurring toxins as powerful and specific phosphatase inhibitors. Among these are okadaic 
acid (Fujiki and Suganuma, 1993), cantharidin (Laidley et al., 1997), calyculin A (Ishihara 
et al., 1989), microcystins (Carmichael, 1992; Carmichael, 1994; Fujiki and Suganuma, 
1993) and tautomycin (Hori et al., 1991; MacKintosh and Klumpp, 1990), to name a few. 
Another class of phosphatase inhibitors are the physiological protein inhibitors readily 
available inside the cell. The diverse specificity of the naturally occurring toxins for the 
different types of phosphatase has led to their use in the laboratory as key tools in the study 
of phosphorylation-dependent processes. However, below only the protein inhibitors are 
further addressed. 
 
I.1.4.1 Inhibitor 1 
 
Inhibitor 1 (I-1) and Inhibitor 2 (I-2) were originally identified by Huang and 
Glinsmann (Huang and Glinsmann, 1976b). They share unusual physical properties: both 
are heat stable and are not precipitated by 1% trichloroacetic acid, in contrast to most other 
proteins. I-1 comprises 171 amino acids (Aitken et al., 1982; Elbrecht et al., 1990; Endo et 
al., 1996). Differences between the rabbit, rat and human I-1 sequences were only detected 
in the C-terminus (Endo et al., 1996). I-1 from rabbit skeletal muscle and human brain has 
a calculated molecular mass of 18.7 and 19.2kDa, respectively  (Aitken et al., 1982; 
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Elbrecht et al., 1990; Endo et al., 1996), but the apparent molecular mass on SDS-PAGE is 
26kDa. This discrepancy has been explained by a low degree of order in the protein. I-1 
binds to and inhibits PP1 only after being phosphorylated on Thr-35 by cAMP-dependent 
protein kinase or cGMP-dependent protein kinase (Hemmings et al., 1984c). It is highly 
selective for PP1, inhibiting PP1 and PP2A with IC50 values of 1.1 and 21,000nM, 
respectively (Endo et al., 1996). I-1 is a cytosolic protein and has been used as a tool to 
study whether a process involves PP1. Amino acids 9KIQF12 are conserved in rat, rabbit 
and human and seem to be crucial for binding and inhibition of PP1 (Egloff et al., 1997). 
 
I.1.4.2 Inhibitor 2 
 
I-2 from rabbit skeletal muscle comprises 204 amino acids and has a calculated 
mass of 22.9kDa (Holmes et al., 1986). Similarly to I-1, its apparent molecular mass on 
SDS-PAGE is much larger (31kDa). It binds to and inhibits PP1 regardless of its 
phosphorylation state. Mutational analysis suggests that I-2 inhibits via interaction with 
amino acid Tyr-272 on PP1 because its IC50 changed from 13 to 180ng/ml in the Y272K 
mutant (Zhang et al., 1996b). Interestingly, I-2 inhibition of PP1 can be reversed by GSK3 
phosphorylation of I-2. 
 
I.1.4.3 DARPP-32 
 
DARPP-32 (dopamine and cyclic AMP-regulated phosphoprotein, Mr 32,000Da) 
resembles I-1 in function but is derived from a different gene. Further, DARPP-32 is 
expressed almost exclusively in the brain (Hemmings et al., 1984a), whereas I-1 exhibits a 
much more ubiquitous tissue distribution. It is a cytosolic protein and has a predicted 
molecular mass of 22.6kDa, but again a higher apparent molecular mass of 32kDa by SDS-
PAGE (Williams et al., 1986). The same Thr residue on DARPP-32 is phosphorylated by 
cAMP-dependent protein kinase and by cGMP-dependent protein kinase. Phosphorylation 
of DARPP-32 changes its IC50 for PP1 from >1μM to 2nM (Desdouits et al., 1995a; 
Desdouits et al., 1995b), underscoring its high selectivity. Under physiological conditions, 
I-1 and DARPP-32 are dephosphorylated and inactivated by PP2A and even more 
efficiently by PP2B (Desdouits et al., 1995c; Hemmings et al., 1984b; Hemmings et al., 
1990). The dephosphorylation by PP2B is dependent on the presence of calcium, 
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suggesting that this may represent a mechanism for Ca2+ levels to control I-1 and DARPP-
32 phosphorylation and consequently PP1 activity (Hubbard and Cohen, 1989). 
Thiophosphorylated I-1 and DARPP-32 are relatively resistant to dephosphorylation and 
the corresponding synthetic peptides have been successfully used to study the 
physiological role of PP1-mediated processes. 
 
I.1.4.4 Inhibitor 3 
 
Inhibitor 3 (I-3) is another heat stable protein and potent inhibitor of PP1 that was 
more recently identified in a yeast two-hybrid screen (Zhang et al., 1998) It inhibits PP1 
activity toward glycogen phosphorylase a with an IC50 in the nanomolar range, similar to 
the behavior of the other well-studied PP1 inhibitors: I-1, DARPP-32, and I-2. I-3 shares 
sequence homology with the yeast protein Yfr003c, also called Ypi1 (yeast phosphatase 
inhibitor 1). I-3 co-localizes with PP1γ1 in nucleoli and with PP1α in centrosomes (Huang 
et al., 2005a), possibly indicating that I-3 may act as modulator of PP1 functions in 
cytokinesis and nucleolar events. 
 
I.1.4.5 Inhibitor 4 
 
Kikuchi and coworkers isolated a human cDNA for a novel PP1 inhibitory protein, 
named I-4, from a cDNA library of germ cell tumors (Shirato et al., 2000). I-4, composed 
of 202 amino acids, is 44% identical to I-2. I-4 conserves some of the functionally 
important structures of I-2 and exhibits similar biochemical properties. I-4 inhibits the 
activity of the catalytic subunit of PP1 with an IC50 of 0.2nM, relatively more potent than 
I-2 (with an IC50 of approximately 2nM). Gel overlay experiments showed that I-4 binds 
PP1c directly through a multiple-point interaction. 
 
I.1.5 SIGNAL TRANSDUCTION THERAPEUTICS 
 
Cellular health and vitality are dependent on the fine equilibrium of protein 
phosphorylation systems. Not surprisingly many diseases and dysfunctional states are 
associated with the abnormal phosphorylation of key proteins (e.g. cancer, diabetes, etc.). 
Thus, protein phosphorylation systems represent attractive targets for diagnostics and 
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therapeutics. However, unlike the myriad of known protein kinases that all belong to a 
single gene superfamily, the protein phosphatases belong to several unrelated families. 
Furthermore, relatively few protein phosphatase catalytic subunits exist, exhibiting broad 
and overlapping substrate specificities in vitro. From a medical perspective, non-selective 
or marginally-selective phosphatase inhibitors have broad biological activity and are highly 
toxic to eukaryotic cells due to the inhibition of a number of critical cellular processes. 
Therefore, the development of low specificity inhibitors (e.g. calyculin A, microcystin or 
cantharidin) into therapeutic agents for systemic use seems unlikely. However, the 
development of type and isoform specific inhibitors seems very promising. Both ISIS 
15534 (Zuo et al., 1998) and ISIS 14435 (Cheng et al., 2000) have been employed to 
specifically suppress the expression of human PP5 and PP1γ1, respectively. More 
interesting, however, is data indicating that in vivo, as phosphatases possess exquisite 
specificities, both in terms of substrates and localization, the key control mechanism must 
reside in the nature of the proteins to which they bind. An increasing number of proteins 
are being identified in diverse cell types that are responsible for regulating the catalytic 
activity of protein phosphatases. Indeed, the diversity of such phosphatase regulatory 
subunits explains not only the need for few catalytic subunit types, but also make them 
attractive targets for pharmacological intervention. The functional diversification of PP1 is 
controlled via its interaction with such regulatory proteins. 
The importance of PP1 and its binding proteins as potential targets for signal 
transduction therapeutics is further strengthened by the work of Greengard and co-workers 
demonstrating the central role played by DARPP-32 in mediating many of the most 
important neuronal signalling pathways (Greengard et al., 1999). To date more than twenty 
primary signalling cascades have been shown to be under the regulation of the 
PP1/DARPP-32 system in the striatum, and the PP1/I-1 system in other brain regions and 
tissues. PP1 also appears to play a central role in the molecular mechanisms underlying the 
actions of several drugs of abuse. Furthermore, several lines of evidence also link PP1 to 
the basic processes thought to underlie memory and learning, such as LTP (long term 
potenciation) and LTD (long term depression). In fact, the relevance of PP1 within the 
context of aging and memory loss was recently given a rather intriguing boost. PP1 has 
been linked to the efficacy of learning and memory by limiting the acquisition of new 
knowledge and favouring memory decline (Genoux et al., 2002). PP1 inhibition prolongs 
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memory when induced after learning, suggesting that PP1 promotes forgetting. These 
findings may account for aging-related cognitive decline and emphasize the physiological 
importance of PP1 as a suppressor of learning and memory. Thus, at least in mice, the 
molecular machinery is not completely deteriorated with aging and the results show that 
near normal cognitive functions can be restored simply by inhibiting PP1. Altered PP1 
activity may therefore be associated not only with the normal cognitive decline during 
aging, but may also explain the accelerated decline observed in Alzheimer’s disease 
patients and in other neurodegenerative diseases. 
 
I.2 PROTEIN PHOSPHATASE INHIBITOR-2 
 
As mentioned above, two heat-stable phosphorylase phosphatase inhibitors were 
isolated from rabbit muscle (Huang and Glinsmann, 1976a). Inhibitor 1 (I1) was an active 
inhibitor only if in a phosphorylated form, while Inhibitor 2 (I2) did not need to be 
phosphorylated to inhibit PP1. The specificity of I2 led to its use for functionally defining 
type1 versus type 2 Ser/Thr protein phosphatases, since it is a potent inhibitor of the former 
but not the latter (Ingebritsen and Cohen, 1983). I2 is a highly charged protein of 204 
amino acids with a predicted molecular mass of 22.9kDa, but an apparent molecular mass 
of 30-33kDa as determined by SDS-PAGE. 
 
I.2.1 I2 AS A PHOSPHOPROTEIN AND MODULATOR OF PP1 
 
The PP1-I2 complex was first identified as a Mg-ATP-dependent protein 
phosphatase activity (Hemmings et al., 1982). This inactive protein phosphatase needed to 
be preincubated with Mg-ATP and glycogen syntase kinase 3 (GSK-3) in order to exhibit 
biological activity (Goris et al., 1979; Hemmings, 1981; Hemmings et al., 1982). 
Activation results from the phosphorylation of I2 on a threonine residue and is 
accompanied by the time-dependent dissociation of the complex (Hemmings et al., 1982). 
Further studies indicated that GSK-3 phosphorylated I2 on Thr-72 and that casein kinase II 
(CKII) phosphorylated Ser-86, Ser-120, and Ser-121 (Aitken et al., 1984; Puntoni and 
Villa-Moruzzi, 1995). Interestingly, the in vitro phosphorylation of I2 Ser-86 by CKII 
enhances the phosphorylation of Thr-72 by GSK-3 (Park et al., 1994), which correlates 
with the synergistic activation of the ATP-Mg dependent protein phosphatase by GSK-3 
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and CKII (DePaoli-Roach, 1984). Comparing the two isoforms of GSK-3, it was found that 
GSK-3β was a significantly better I2 kinase than GSK-3α (Wang et al., 1994). I2 can also 
be phosphorylated by other kinases in biochemical assays, like cdc2-Cyclin B, ERK and 
CKI (Marin et al., 1994; Puntoni and Villa-Moruzzi, 1995; Wang et al., 1995). However, 
physiological regulation of Thr-72 phosphorylation in I2 is not yet clearly understood. 
Overexpression of GSK-3 and I2 in COS7 cells showed that the kinase could 
phosphorylate Thr-72 in vivo. In HeLa cells, phosphorylation of I2 on Thr-72 during 
mitosis was not carried out by GSK-3 but by a Cdk (cyclin dependent kinase), later shown 
to be cdk1/cyclinB1 (Leach et al., 2003). In neurons, a Cdk2-like protein kinase (Cdk5/p25) 
was shown to phosphorylate I2 on Thr-72 (Agarwal-Mawal and Paudel, 2001). On the 
other hand, PP1 activity in sperm maturation was correlated with changes in GSK-3 
activity, supporting the PP1/I2/GSK-3 biochemical partnership (Vijayaraghavan et al., 
1996). Moreover, the PP1/I2 complex was found to directly regulate GSK-3β in cultured 
mammalian cells (King et al., 2006). All these results suggest that I2 can be 
phosphorylated at Thr-72 by different kinases depending on the cellular environment. 
Interestingly, the highly species conserved I2 phosphorylatable motif containing Thr-72, 
can be phosphorylated by multiple Pro-directed kinases but with large differences in 
reactivity (Li et al., 2007). I2 was also reported to be phosphorylated on tyrosine residues 
by purified insulin receptor kinase in vitro, losing its inhibitory activity toward PP1 
(Williams et al., 1995). 
I2 may not only function as a PP1 inhibitor, but there is also experimental evidence 
indicating it may also function as a chaperone. That is, bacterial expressed recombinant 
PP1 protein exhibits some significant biochemical differences from native PP1 catalytic 
subunit, most notably recombinant PP1 is dependent on Mn2+ for activity. However, these 
differences were abolished after interaction of the expressed PP1 with I2 (Alessi et al., 
1993; MacKintosh et al., 1996). 
 
I.2.2 I2 INTERACTION WITH PP1 
 
Different functional domains of I2 interact with distinct regions of PP1 (Park and 
DePaoli-Roach, 1994). Mutagenesis studies have shown that the N-terminal residues 
10IKGI13 are critical for I2 inhibition and that the C-terminal residues 144KLHY147 
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constitute a sequence analogous to the consensus RVxF PP1 binding binding motif (Huang 
et al., 1999; Yang et al., 2000b). Although the I2 structure is mostly random coil, it was 
possible to resolve the 3-D structure of the PP1-I2 complex showing three regions of order 
which corresponded to three sites of interaction (Hurley et al., 2007). The first and shortest 
region of interaction involves residues 12KGILKN17 with hydrophobic associations and 
hydrogen bonds. The second interaction includes the I2 residues 44KSQKWDEMNILAT56 
of which 44KSQKW48 bind to the RVxF groove of PP1. The previously identified 
144KLHY147 motif is included in the third stretch of interaction comprising residues 130-
169. Residues 130-146 lie along the “acidic groove”, to position amino acids 147-151 in 
the active site of PP1, while residues 152-169 exit the active site to the adjacent proposed 
“hydrophobic substrate-binding groove”. Interestingly, the residues that interact with the 
catalytic center of PP1 displace essential metal ions, accounting for rapid inhibition and 
slower inactivation of PP1. 
 
I.2.3 PHYSIOLOGICAL FUNCTION OF THE PP1-I2 COMPLEX: 
FORMATION OF TRIMERIC COMPLEXES WITH OTHER PP1 
REGULATORY SUBUNITS 
 
I.2.3.1 The cell cycle 
 
Evidence suggests that I2 is involved in cell cycle regulation. I2 contains both a 
putative nuclear localization signal (137KKRQFEMKRK147) and a sequence resembling a 
leucine-rich nuclear export signal (155LNIKLARQLI165), and it can differentially localize 
to the cytoplasm or nucleus in different phases of the cell cycle of human HS68 fibroblast 
cells (Kakinoki et al., 1997). Starting from a low level, I2 expression increases during G1, 
peaking during S phase, dropping during G2 and then reaching its highest peak during 
mitosis (Brautigan et al., 1990; Kakinoki et al., 1997). During mitosis, I2 localizes to 
centrosomes and is highly phosphorylated at Thr-72 (Leach et al., 2003), suggesting that 
reversible phosphorylation of I2 may control centrosome-associated PP1 activity. 
Moreover, I2 is involved in the regulation of centrosome separation by forming a 
heterotrimeric complex with PP1 and Nek2 (Eto et al., 2002). 
Aurora A kinase, that is necessary for centrosome maturation and is an oncogene, 
associates with and is negatively regulated by PP1. Thus, PP1 inhibition is potentially 
Characterization of Two Novel PP1 Regulators: I2L and Nek2C                                                          Chapter I 
________________________________________________________________________________________ 
Centre for Cell Biology                                                                                                                                       43 
University of Aveiro 
 
involved in the activation of the kinase (Carmena and Earnshaw, 2003). However, I2 
directly and specifically stimulated recombinant human Aurora-A activity in vitro 
(Satinover et al., 2004). The I2 stimulated increase in kinase activity was not simply due to 
inhibition of PP1, since it was not mimicked by other phosphatase inhibitors. Furthermore, 
activation of Aurora-A was unaffected by deletion of the I2 N-terminal PP1 binding motif 
but was eliminated by deletion of the I2 C-terminal domain. Aurora-A and I2 were 
recovered together from mitotic HeLa cells (Satinover et al., 2004) and it was further 
demonstrated that Xenopus extracts endogenous I2 and Aurora A regulate mitotic entry 
(Satinover et al., 2006). 
Meiotic maturation of amphibian oocytes is induced by progesterone and regulated 
by protein phosphorylation. I2 caused over a 3-fold increase in the half-time for oocyte 
maturation, also implicating I2 in the control of meiosis by regulating PP1 activity 
(Foulkes and Maller, 1982). More recently it was suggested that I2 is one of the important 
endogenous regulators of PP1 during mouse oocyte development and meiosis (Wang et al., 
2004). 
 
I.2.3.2 Neuronal I2 
 
The neuronal actin-binding proteins, Neurabin I and Neurabin II/Spinophilin are 
highly concentrated in dendritic spines and post-synaptic densities, being responsible for 
recruiting PP1 to the post-synaptic sites (Terry-Lorenzo et al., 2002). It was found that I2 
could form a complex with the neurabins through PP1, which enhanced the targeting of 
PP1 and I2 to polymerized F-actin (Terry-Lorenzo et al., 2002). Immunocytochemistry in 
epithelial cells and cultured hippocampal neurons showed that endogenous neurabin II and 
I2 colocalized at actin-rich structures, consistent with the ability of neurabins to target the 
PP1-I2 complex to the actin cytoskeleton and regulate cell morphology. 
NMDA (N-methyl-D-aspartate) receptors are critical for neuronal plasticity and 
survival, while their excessive activation produces excitotoxicity and may accelerate 
neurodegeneration. A recent study reported that stimulation of NMDA receptors in 
cultured rat hippocampal or cortical neurons, and in the adult mouse brain in vivo, 
activated GSK-3β which further stimulated PP1, through mediation of transient 
phosphorylation of I2 (Szatmari et al., 2005). In cortical neurons, inhibition of PP1 with 
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okadaic acid produced accumulation of phospho-I2, which could be blocked by LiCl, 
suggesting that GSK-3 phosphorylates I2 in intact neurons. 
PP1 has also been involved in the hyperphosphorylation of tau in Alzheimer’s 
disease. More particularly, it was found that oxidative stress promotes tau 
dephosphorylation via the complex PP1/cdk5/I2 (Zambrano et al., 2004). 
As with Nek2 and Aurora, PP1 and I2 can form a trimeric complex with a 
transmembrane kinase termed KPI-2 (Kinase/Phosphatase/Inhibitor-2), also known as 
Lmr2, LMTK2, AATYK2, KIAA1079, Cprk, and BREK (Wang and Brautigan, 2002; 
Wang and Brautigan, 2006). The KPI-2 C-terminal domain associates with I2, with or 
without PP1, revealing that it can bind both proteins through different sites. The KPI-2 
kinase domain could perform autophosphorylation and also phosphorylate PP1 at Thr-320, 
that leads to inhibition of PP1 activity. The substrate specificity for Ser/Thr residues was 
further demonstrated by using a microarray peptide analysis, which revealed two main 
protein substrates: cystic fibrosis transmembrane conductance regulator (CFTR) and 
glycogen phosphorylase (phos-b) (Wang and Brautigan, 2006). KPI-2 (as BREK) has been 
implicated in NGF signaling in PC12 cells, based on indirect evidence of cell shape 
changes in response to NGF after cells were stably transfected with active or inactive 
kinase (Kawa et al., 2004). The activity of KPI-2 was observed to decrease after adding 
NGF to living cells, consistent with the direct involvement of KPI-2 in the NGF signaling 
(Wang and Brautigan, 2006). 
  
I.2.3.3 Cardiac contractility 
 
In addition to the long known and relatively well characterized role for PP1 in 
muscle contraction, recent work also indicates it may also play an important role in cardiac 
contractibility (Carr et al., 2002). Transgenic mice overexpressing I2 in heart showed 
decreased PP1 activity and consequent enhanced contractility (Kirchhefer et al., 2005). 
Moreover, it was found that overactivated PP1 present in failing hearts could be due to 
inhibition of the activity of I1 and I2 (Gupta et al., 2005). 
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I.2.3.4 Spermatozoa maturation and motility 
 
Mammalian sperm acquire the capacity for motility and fertilization during 
epididymal transit, which was associated with decreased GSK-3 and PP1γ2 activity 
(Vijayaraghavan et al., 1996). Heat stable I2-like activity was also detected in mammalian 
sperm, suggesting a biochemical mechanism for regulating sperm motility involving 
PP1/GSK-3/I2 (Smith et al., 2006; Vijayaraghavan et al., 1996). 
Besides its ubiquitously expressed I2 family member, Drosophila melanogaster also 
expresses a testis-specific PP1 heat-stable inhibitor called inhibitor-t (Helps and Cohen, 
1999; Helps et al., 1998). It was speculated that, as inhibitor-t is not the D. melanogaster 
homologue of mammalian I2, it may play an alternative role in the regulation of PP1c 
function in the testis. Further evidence for the existence of different testis-specific I2 
isoforms was also found in rats (Osawa et al., 1996). I2α1 and I2α2 are alternatively spliced 
variants, while I2β is derived form a different gene. I2α2 and I2β are expressed exclusively 
in the testis and the expression of all three isoforms coincides with sperm cell maturation. 
 
I.3 NIMA-RELATED KINASE 2 (NEK2) 
 
Nek2 is a mammalian protein kinase structurally homologous to the yeast protein 
NIMA (never in mitosis A) and termed from NIMA-related kinase 2. It is a centrosomal 
serine/threonine kinase and is thought to modulate centrosome cohesion together with its 
substrate protein C-Nap 1 (centrosome Nek associated protein 1) and PP1 (Fry et al., 1999; 
Fry et al., 1998a; Uto et al., 1999). It is also involved in chromosome condensation and 
segregation, along with several related proteins found in mammalian cells. Until now, three 
alternative splice variants of Nek2 have been identified, which are Nek2A, Nek2B and 
Nek2C, originally called Nek2A-T (Fardilha et al., 2004b; Uto et al., 1999). These splice 
variants differ in their C-terminal exon 8 amino acid sequence (Fardilha et al., 2004b). 
Nek2A and Nek2B are expressed in different centrosome cycle phases (Fry et al., 2000a). 
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I.3.1 NEK2 IS THE HUMAN HOMOLOG OF NIMA 
 
Nek2 kinase is the most closely related human gene to NIMA, being 44% identical 
over the amino acid sequence of the catalytic domain (Fry, 2002). The in vitro substrate 
specificity and many biochemical properties of Nek2 are similar to those of NIMA. Both 
Nek2 protein levels and activity are comparable to NIMA through the cell cycle (Fry et al., 
1995). However, significant differences between Nek2 and NIMA have also been revealed. 
NIMA activity is low in G1 but increases though S and G2, to reach maximal levels in 
mitosis. The protein accumulates when cells are arrested in G2, but disappears as they 
progress through mitosis (Fry et al., 1995; Osmani et al., 1991b). However, Nek2 activity 
is high during S and G2 phases but low during M phase arrest (Fry et al., 1995). Unlike 
NIMA, Nek2 appears to have no function in the onset of centrosome entry into mitosis 
(Schultz et al., 1994) and contains no Cdc2 phosphorylation site motifs in the C-terminal 
region (Schultz et al., 1994). 
 
I.3.2  NEK2 STRUCTURE  
 
Glycerol gradient assays indicate that endogenous Nek2 is present in HeLa cells as 
a salt-resistant 6S complex, the predicted size of a Nek2 homodimer (Fig. I.6). 
Additionally, recombinant Nek2 overexpressed in insect cells also formed a 6 S complex. 
Nek2 can form dimers both in vivo and in vitro, as shown by yeast two-hybrid interaction 
analysis and co-immunoprecipitation assays. Dimerization specifically requires the leucine 
zipper motif and allows Nek2 trans-autophosphorylation. Deletion of the leucine zipper 
prevents the trans-autophosphorylation reaction on the C-terminal domain of Nek2 and 
strongly reduces Nek2 kinase activity on exogenous substrates (Fry et al., 1999) 
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Figure I.6: Nek2 dimerization occurs through an unusual leucine zipper motif. A) 
helical wheel representation of amino acids 306–340 of the Nek2 protein showing the regular heptad repeat 
of leucine residues at position d flanked by a basic arm of residues at position g and by an acidic glutamate 
arm of residues at position a. B) a hypothetical wire diagram model of a Nek2 leucine zipper dimer The 
individual α-helices are right-handed and run parallel, and the coil of the helices is left-handed. Leucine 
residues in position d of each monomer are indicated in yellow, whereas the acidic glutamate residues in 
position α of one monomer are in red, and the basic lysine or arginine residues in position g of the other 
monomer are in blue. The symmetrical pair of glutamate and basic residues on the back side of the molecule 
is omitted for clarity. C) schematic model illustrating the interaction of two full-length Nek2 molecules is 
shown. Dimerization is shown to occur between parallel leucine zippers (LZ) such that it allows the C-
terminal domain (C-term) of one molecule to be phosphorylated by the catalytic domain (CAT) of the second 
molecule. P, phosphate. (taken from (Fry et al., 1999) 
 
 
 
I.3.3  NEK2 IS A CENTROSOME KINASE 
 
The centrosome is the major microtubule (MT) organizing center (MTOC) in 
animal cells. It is composed of two cylindrical centrioles surrounded by a non-membranous 
amorphous mass termed the pericentriolar matrix (PCM). It influences all MT-dependent 
processes, including organelle transport, cell shape, polarity and motility, and plays an 
important role in the assembly and function of the bipolar mitotic spindle in mitosis, 
influencing the reliability of chromosome segregation. Furthermore, the centrosome 
anchors MT which acts as tracks for molecular motor based transport and positioning of 
vesicles and organelles in interphase. The centrosome cycle has been subdivided into a 
series of discrete events (Fig. I.7). Among them, centrosome cohesion plays a critical role 
in centrosome separation and is regulated by the balance of kinase and phosphatase 
activities and by proteolysis (Hames et al., 2001). 
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Nek2 plays an important role in the regulation of centrosome separation. It was 
observed by both immunofluorescence microscopy and subcellular fractionation that Nek2 
is a centrosome kinase (Fry et al., 1998b). Endogenous human Nek2 kinase is highly 
enriched at the MTOC and is associated with the centrosome throughout the cell cycle (Fry 
et al., 1998a; Fry et al., 1998b), including all stages of mitosis. After transfecting myc-
Nek2 into cells, the exogenous Nek2 can be seen in centrosomes at low expression levels 
and also in the cytoplasm and nucleus at high expression levels. Ectopic expression of 
Nek2 affected centrosome structure by causing centrosome splitting or dispersion, or by 
leading to spindle pole defects, consistent with a loss of centrosome cohesion (Fry et al., 
1998b). Similar effects could also be observed using antibodies against other centrosomal 
components. Transfection of a catalytically inactive Nek2 mutant (Nek2A-K37R) also 
caused dispersion of centrosome material, but did not trigger any centrosome splitting. 
This demonstrates that centrosome splitting depends on kinase activity. Nek2 activity is an 
earlier step in the process of centrosome separation that precedes the action of MTs and 
protein motors (Mayor et al., 1999). From either perspective, the experiments emphasize 
the importance of Nek2A as a critical scaffold element of the centrosome (Faragher and 
Fry, 2003). 
The centrosome localization of Nek2 results in its interaction with bona fide 
components of the centrosome. PCM-1 is a major component of centriolar satellites and 
there is a partial overlap of PCM-1 and Nek2 localization in the cytoplasm. PCM-1 and 
proteasomal degradation also play important roles in the assembly and turnover of Nek2 at 
the centrosome (Hames et al., 2005). Down-regulation of PCM-1 using siRNA proved that 
Figure I.7: Schematic view of the 
centrosome cycle in relation to the cell 
cycle. Mature centrioles are shown in dark 
blue, immature centrioles in blue, pro-centrioles 
in light blue and PCM in green. (taken from 
(Meraldi and Nigg, 2002). 
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the recruitment of Nek2 and its substrate C-Nap1  to the centrosome was dependent on 
PCM-1. PCM-1 is a major component of centriolar satellites, 70-100nm cytoplasmic 
granules that are found in the vicinity of the centrosome although not at the centrosome 
itself (Dammermann and Merdes, 2002; Kubo et al., 1999). Trafficking of certain proteins 
to the centrosome is known to be dependent on the PCM-1 protein, and recruitment of 
Nek2 to the centrosome also depends on its localized degradation (Hames et al., 2005). 
APC/C is a key regulator of mitotic destruction, catalyzing the covalent attachment of 
ubiquitin molecules to a substrate and thereby targeting it for degradation by the multiple 
peptidase activities of ATPase-dependent 26S proteasome (Hershko and Ciechanover, 
1998). The substrates for APC/C are not all targeted for destruction at the same time, but in 
a sequential mode. What regulates this sequential destruction of proteins by the APC/C is 
still not clear (Hames et al., 2001). Two kinases, Cdc20 and Cdh1, have been related to the 
activation of APC/C by phosphorylation of APC subunits. Nek2A itself is destroyed upon 
entry into mitosis, in a process mediated by the proteasome and is dependent on the 
APC/C-Cdc20 ubiquitin ligase. Nek2 activity is not required for APC/C catabolism instead 
of Nek2 degradation. But Nek2 destruction depends upon a cyclin A-like destruction box 
(D-box) motif or KEN-box in its C-terminus. Human Nek2A contains putative versions of 
both motifs: a KEN-box (KENIMRSEN) at amino acids 391-399 and a poorly defined 
extended D-box consisting of the C-terminal 25 amino acids (residues 420-445). Further 
work has indicated that the Nek2A MR-tail (444-445) binds directly to the APC/C and 
interferes with APC/C activity (Hayes et al., 2006). Truncation of the Nek2A C-terminus 
delays its degradation until late mitosis. D-box and KEN-box motifs in Nek2A are targeted 
by APC/C-Cdc20 in early mitosis, whereas the KEN-box is targeted by APC/C-Cdh1 in 
mitosis and G1 (Hames et al., 2001; Pfleger and Kirschner, 2000). This degradation may 
somehow be necessary to allow re-establishment of the intercentriolar linkage in late 
mitosis (Hames et al., 2001). 
The MT cytoskeleton undergoes intracellular framework during cells dynamic 
actions. Besides localizing to the centrosome, Nek2A is present in small particles 
distributed throughout the cytoplasm, which partially localize with MT. These Nek2A 
particles were disseminated along the MT, upon which Nek2 trafficks towards or 
backwards the centrosomes. In vitro MT binding assays indicated that Nek2 binds MT 
through a motif in its C-terminal domain (amino acids 335-370) and this MT binding motif 
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is also important for Nek2 centrosome localization. It is hypothesized that Nek2 may be 
anchored to the centrioles via its microtubule binding domain (Hames et al., 2005). Nek2 
was also proposed to have a function in organization of the microtubule (Rapley J, 2005). 
It is a primer kinase for the Plk1 substrate Nlp (ninein-like protein), which is a microtubule 
minus end binding protein. After being first phosphorylated by Nek2, Nlp can be further 
phosphorylated by Plk1 and removed from the centrosome at the G2/M transition. 
Protein phosphorylation constitutes a major mechanism regulating centrosome 
cohesion during the cell cycle. PP1α was reported to have a marked localization at 
centrosomes during mitosis (Andreassen et al., 1998). A balance between Nek2 and the 
interacting PP1α is particularly critical. The immunoprecipitation of endogenous Nek2A 
with a Nek2A specific antibody and subsequent detection of PP1 activity in the cell lysate 
immunoprecipitate indicated that both Nek2A and PP1 form a complex in vivo (Helps et al., 
2000). The amino acids sequence KVHF, corresponding to the consensus RVxF PP1 
binding motif, is responsible for the binding of Nek2A to PP1. In vivo co-expression of 
PP1α with Nek2A strongly suppressed centrosome splitting and this effect was specific for 
Nek2A. These results indicated that PP1α and Nek2 regulate centrosome cohesion by 
counteracting each other (Meraldi and Nigg, 2001). Co-expression of PP1 also antagonizes 
Nek2A function via dephosphorylation of Nek2A, itself and the Nek2A substrate C-Nap1, 
indicating that PP1 acts as a negative regulator for centrosome separation (Helps et al., 
2000; Meraldi and Nigg, 2001). On the other hand, phosphorylation of PP1c by Nek2A 
reduces the phosphatase activity of the complex (Helps et al., 2000). The kinase-
phosphatase complex is expected to function as a bistable switch, potentially creating a 
double-negative feedback circuit for regulation of centrosome dynamics (Ferrell J.E., 
2002). 
The protein C-Nap1, isolated through a two-hybrid screen using Nek2A as bait, has 
been identified as a Nek2A substrate (Fry et al., 1998a). The C-terminal domain of C-Nap1 
could be readily phosphorylated by Nek2A both in vitro and in vivo (Fry et al., 1998a). It 
has a predicted molecular mass of 281kDa and comprises extended domains of coiled-coil 
structure. It was found concentrated at the centrosome in all interphase cells, with its 
immunoreactivity being found at mitotic spindle poles. In agreement with a role in the 
maintenance of centrosome cohesion after its duplication in S phase, C-Nap1 associates 
with the proximal ends of both mother and daughter centrioles, but dissociates from these 
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structures at the onset of mitosis. It has been suggested that C-Nap1 participates in 
providing a link that hold the old centrioles together. After centrosome duplication, this 
linkage is dissolved upon phosphorylation of C-Nap1 by Nek2A, which in turn, triggers 
the observed loss of C-Nap1 from centrosomes to allow the separation of the duplicated 
centrosomes before mitosis. Further work points to C-Nap1 as a key component of 
centrosome dynamics, including centriole-centriole cohesion (Mayor et al., 2000).  
Nek2A was further observed to form a complex with the catalytic subunit of PP1 
and the large coiled-coil C-Nap1 protein (Helps et al., 2000). The kinase-phosphatase 
complex (Nek2A-PP1) can influence the phosphorylation state of C-Nap1, which has 
implications in the regulation of centrosome separation and cell cycle progression. C-Nap1 
phosphorylated by Nek2A could be dephosphorylated by the endogenous Nek2A-PP1 
complex (Fry et al., 1998a). Nek2A is also able to phosphorylate itself, PP1 and C-Nap1, 
whereas PP1 can dephosphorylate both Nek2A and C-Nap1 (Faragher and Fry, 2003; Fry 
et al., 1999; Fry et al., 1998a), and can autodephosphorylate after being phosphorylated by 
Nek2. 
One model for Nek2A regulation of cohesion between mother and daughter 
centrosome involves phosphorylation of C-Nap1 at G2/M transition. This phosphorylated 
C-Nap1 may trigger its displacement from centrioles, promoting their separation and 
subsequent bipolar spindle formation (Fig. I.8) (Faragher and Fry, 2003). 
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Figure I.8: Cell cycle-regulated centrosome association of C-Nap1. This schematic model 
summarizes current information about the function and precise subcellular localization of C-Nap1. (taken 
from (Mayor et al., 2000). 
 
 
 
PP1 interacts with Nek2 and can dephosphorylate both Nek2 and C-Nap1 (Fry et al., 
1998b). Phosphorylation may regulate C-Nap1 function, and the phosphorylation state of 
C-Nap1 may depend on the balance between Nek2 and PP1 activity. In support of such a 
model, centrosome splitting can be induced by overexpression of active Nek2 (Fry et al., 
1998b), as well as by drug-induced inhibition of PP1 (Meraldi and Nigg, 2001). 
C-Nap1 has a tendency to aggregate when expressed in cultured cells (Mayor et al., 
2002). These aggregates are reduced in the presence of increased levels of active Nek2A 
protein kinase, but only around the centrosomal region suggesting that C-Nap1 aggregation 
is locally regulated by Nek2A. The mitotic C-Nap1 signal is reduced as a consequence of 
M-phase-specific phosphorylation, and the dissociation of C-Nap1 from mitotic 
centrosomes is regulated by localized phosphorylation rather than generalized proteolysis. 
As C-Nap1 is an in vivo substrate of Nek2A, Nek2A activity may thus be responsible for 
the dissociation of C-Nap1 from mitotic spindle poles (Mayor et al., 2002). Using 
inducible stable cell lines expressing moderate levels of active Nek2, these authors have 
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shown that only half of the C-Nap1 protein remains at the centrosome after its separation. 
This suggests that total removal of C-Nap1 from centrosome might be regulated by other 
mechanisms and/or that Nek2A might phosphorylate other centrosome proteins to trigger 
centrosome separation (Faragher and Fry, 2003). 
Several lines of evidence suggest an involvement of I2 in cell cycle regulation. The 
expression levels of I2 fluctuate during the cell cycle and are enhanced at mitosis 
(Brautigan et al., 1990). I2 is a regulator of the Nek2A-PP1 complex and of centrosome 
separation in cells (Eto et al., 2002). In a yeast two-hybrid system, I2 was seen to interact 
with PP1c and Nek2A. Indeed, I2, PP1 and Nek2A form a trimeric complex in vitro (Eto et 
al., 2002). Endogenous I2 was seen to occur concentrated into a cloud in the perinuclear 
region, and centrosomes were embedded within this cloud of I2 (Eto et al., 2002). Co-
expression of PP1 with Nek2A suppresses centriole splitting, whereas ectopic expression 
of I2 stimulates splitting (Fry et al., 2000b; Meraldi and Nigg, 2001). I2 can enhance the 
kinase activity of the Nek2-PP1c complex via inhibition of the phosphatase activity, in 
order to initiate centrosome separation (Eto et al., 2002). Hence, I2 is a regulator of the 
Nek2-PP1c complex and centrosome separation in cells, creating new potential links for 
coordination of cell cycle signals. Using yeast conjugation and other assays, Eto et al. 
(2002) have demonstrated that the I2 interaction with the Nek2 C-terminus requires the 
bindings of both PP1c and the C-terminal domain of I2. I2 is capable to interact with PP1c 
on Nek2. Interaction between I2 and Nek2 requires PP1c, further supporting the notion that 
PP1c forms a bridge binding to both proteins at the same time (Agostino et al., 2002). 
 
I.3.4 NEK2 AND CHROMOSOMES 
 
The mitogen-activated protein kinase (MAPK) pathway is known to be required for 
chromosome condensation and it triggers Nek2A activation at the same time (Agostino et 
al., 2002). Extracellular signal-regulated kinase 2 (Erk2) is a serine/threonine kinase which 
belongs to MAPK kinase family (Boulton et al., 1991; Tanoue et al., 2000). Nek2A and 
Erk2 co-localize in the centrosomes and can form a complex in the centrosomes of mitotic 
cells via the Nek2A C-terminal 414KKR416 sequence (a typical docking motif for Erk2) 
(Tanoue et al., 2000). The centrosome localization of Nek2A is independent of Erk2 kinase 
activity, whereas the centrosomal localization of Erk2 depends on Nek2A, suggesting that 
Nek2A links extracellular signaling cascades to the centrosome via Erk2 (Lou et al., 
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2004a). Nevertheless, further studies are required to evaluate precisely the significance of 
the interaction between Nek2A and Erk2 in the centrosome. 
High mobility group protein A2 (HMGA2) belongs to the HMG superfamily which 
is associated with DNA (Giancotti et al., 1991; Postnikov and Bustin, 1999a). It is an 
abundant component of chromatin that modulates DNA conformation and gene expression 
(Bustin, 1999; Di Agostino et al., 2004b; Herrera et al., 1999; Postnikov and Bustin, 
1999b). HMGA2 is highly expressed in male meiotic cells (Di Agostino et al., 2004b) and 
directly and specifically interacts with Nek2A, after which it is activated by the MAPK 
pathway in mouse pachytene spermatocytes. This interaction requires the C-terminal 
regulatory region of the kinase, but it does not account for the activity of Nek2A and seems 
consititutive. Nek2A directly phosphorylates HMGA2 in vitro, and decreases the affinity 
of HMGA2 for DNA (Di Agostino et al., 2004b; Fardilha et al., 2004b). 
The protein encoded by the human gene Hec (Highly expressed in cancer) contains 
642 amino acids and a long series of leucine heptad repeats at its C-terminus . It is most 
abundantly expressed in the S and M phases of rapidly dividing cells, but not in terminally 
differentiated cells. Hec localizes to the nuclei of interphase cells and a portion distributes 
to centromeres during M phase. It apparently plays an important role in chromosome 
segregation during M phase (Chen et al., 2002). Nek2 was first found to interact with Hec1 
in a yeast two-hybrid screen using Hec1 as bait (Chen et al., 2002; Zheng et al., 1999). 
Human Hec1 is a serine phosphoprotein that binds specifically to the mitotic regulatory 
kinase Nek2A during G2/M. Nek2A phosphorylates Hec1 on the serine residue 165, both 
in vitro and in vivo, with a peak of activity during G2/M phase (Chen et al., 2002). Cell 
cycle-regulated serine phosphorylation of Hec1 by Nek2A is critical and essential for 
faithful chromosome segregation and cell survival (Chen et al., 2002). The in vitro binding 
of Hec1 to Nek2A was established using GST pull-down assays. Using Hec1 deletion 
constructs and yeast two-hybrid assays, it was found that Hec1 interacts with Nek2A via 
the first (aa 251-431) or second (aa 361-547) coiled-coil domain (Chen et al., 2002). Co-
immunoprecipitation of Nek2A and Hec1 occurred specifically during G2 and M phases. 
The initiation of Hec1 phosphorylation corresponded to the same time period during which 
Nek2 was most abundant, suggesting that Nek2 may phosphorylate Hec1 in vivo during 
G2/M phase (Lou et al., 2004b). All these results indicated an involvement of Nek2 in the 
chromosome condensation and segregation process. 
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MAD (mitotic arrest deficiency) proteins are spindle checkpoint components 
transiently associated with the kinetochore (Lou et al., 2004b). The immunoprecipitation of 
FLAG-MAD1 and GFP-Nek2A in co-transfected 293T cells first indicated an interaction 
between MAD1 and Nek2A. Interaction of Nek2A with MAD1 further demonstrated that 
Nek2A plays a critical role in kinetochore dynamics, in addition to its function in 
centrosome regulation. This is in accordance with the observation that knock-down of 
Nek2A with siRNA leads to a typical chromosome segregation defect. Full-length Nek2A 
does not bind MAD1, but binds with MAD2. Mutated Nek2A induced inability to 
assemble MAD2 onto kinetochores or leads to insufficient assembly of MAD2 to 
kinetochores. Hence, Nek2A is a kinetochore-associated protein kinase essential for 
faithful chromosome segregation, and it was hypothesized that Nek2A links MAD2 
molecular dynamics to spindle checkpoint signaling. However, it remains unclear whether 
MAD2 is a substrate or not for Nek2 (Lou et al., 2004b). 
All these results implicate Nek2 kinase in the control of chromosome condensation, 
conformation and separation. 
 
I.3.5 ALTERNATIVELY SPLICED VARIANTS OF NEK2  
 
Nek2A and Nek2B were the first alternatively spliced variants to be identified and 
are known to be expressed in vertebrates (Fry et al., 2000a; Hames and Fry, 2002; Twomey 
et al., 2004; Uto et al., 1999; Uto and Sagata, 2000). Both Nek2A and Nek2B localize to 
centrosomes (Hames and Fry, 2002). These two variants differ in that the C-terminal 384-
445 amino acids are absent from Nek2B, resulting from an alternative exon 8 splice event. 
In human adult somatic cells, Nek2A is the predominant isoform although Nek2B is also 
present (Hames and Fry, 2002). 
Nek2A is required for separation of duplicated centrosomes and formation of a 
bipolar mitotic spindle (Faragher and Fry, 2003). A number of important regulatory motifs 
have been identified within the Nek2A molecule. It has a N-terminal catalytic domain and 
a C-terminal regulatory domain within which are found a leucine zipper dimerization motif, 
a PP1 binding motif and two degradation motifs recognized by the anaphase promoting 
complex/cyclosome (APC/C) (Fig. I.9) (Fry, 2002). 
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Figure I.9: Human Nek2 protein structure. A schematic representation of human Nek2A and Nek2B 
is shown. The relative positions of the catalytic domain (kinase), leucine zipper (LZ), coiled coil (CC), splice 
site, PP1 binding motif, KEN-box and extended cyclin A-type destruction box are indicated. Numbers above 
and below the structures indicate amino acid positions. (taken from (Fry, 2002). 
 
 
 
Nek2B is the only isoform present and required for the assembly and maintenance 
of centrosomes in Xenopus early embryos (Fry et al., 2000a; Uto and Sagata, 2000). It is 
rapidly recruited to sperm basal bodies in a microtubule (MT)-independent manner during 
formation of the zygotic centrosome (Twomey et al., 2004). Fragmentation of centrosomes 
was observed following either injection of anti-Nek2 antibodies or expression of a 
dominant-negative variant of the XINek2 kinase in Xenopus embryos (Uto and Sagata, 
2000). Nek2B contains the same kinase domain and leucine zipper motif as Nek2A, but 
lacks the PP1 binding site and degradation signals (Hames and Fry, 2002). 
Immunodepletion of Xenopus Nek2B from cell-free extracts led to a failure of centrosome 
components to be recruited to sperm centrioles (Fry et al., 2000a). 
 
I.4 AIMS 
 
The aim of this work was to express, purify and characterize two recently discovered 
new regulators of PP1, obtained by yeast two-hybrid screening of a human testis cDNA 
library, and to study how these new interactors regulate the activity of PP1γ1 and PP1γ2 
(the main PP1 isoforms expressed in human testis and sperm) both in vitro and in vivo. 
Some of the specific aims included the following: 
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1. To express recombinant PP1γ1 and PP1γ2 isoforms in bacteria both with and 
without a His-tag, and to optimize their purification. 
2. To express and purify the new PP1 regulators Nek2C (or Nek2A-T) and I2-L. 
3. To investigate the properties of I2-L and Nek2C. 
4. To compare I2-L and Nek2C with I2 and Nek2A in terms of their putative 
physiological roles as regulators of endogenous PP1γ1 and PP1γ2 in mammalian 
sperm and testis. 
5. To address the importance of these new regulators of PP1 in the control of sperm 
motility. 
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II EXPRESSION AND PURIFICATION OF PROTEIN 
PHOSPHATASE 1 GAMMA ISOFORMS 
 
II.1 INTRODUCTION 
 
The serine/threonine-specific protein phosphatase-1 (PP1) is a major eukaryotic 
protein phosphatase that regulates a diverse range of cellular processes, such as cell cycle 
progression, protein synthesis, muscle contraction, carbohydrate metabolism, transcription, 
neuronal signaling and the splicing of RNA (Aggen et al., 2000; Llorian et al., 2005; 
Shenolikar, 1994; Shenolikar and Nairn, 1991; Wera and Hemmings, 1995). PP1 regulates 
cellular processes by dephosphorylation of specific serine and threonine residues in key 
target proteins (Bollen and Stalmans, 1992; Cohen, 1989). The pleiotropic functions of 
PP1 depend on its association with a host of function-specific and substrate-specific 
targeting and regulatory proteins. The catalytic subunit of PP1 (PP1c) associates with 
many different regulatory subunits in vivo that may target PP1c to specific subcellular 
locations, alter its substrate specificity and allow its activity to be modified by extracellular 
signals (Helps et al., 2000). 
Three genes are known to encode mammalian type 1 phosphatase catalytic subunits, 
termed PP1α, PP1β and PP1γ (da Cruz e Silva et al., 1995a; da Cruz e Silva et al., 1995b; 
Strack et al., 1999). PP1γ1 and PP1γ2 are alternatively spliced isoforms generated from the 
PP1γ gene (Sasaki et al., 1990; Wera and Hemmings, 1995), that are identical except for 
their extreme C-terminus. It is interesting that the unique 21 amino acid carboxy terminus 
of PP1γ2 is conserved in all mammalian species (Mishra et al., 2003). In contrast to PP1γ1 
that is ubiquitously expressed, although PP1γ2 was found to be present in the brain (Strack 
et al., 1999), it is most highly expressed in germ cells, being the predominant PP1 isoform 
in testis and sperm (Smith et al., 1996; Strack et al., 1999).  
Recombinant PP1 has been reported to be expressed and purified from a variety of 
systems, including E. coli and insect cells (Berndt and Cohen, 1990; Watanabe et al., 2003; 
Zhang et al., 1992; Zhang et al., 1993). PP1α was first expressed in insect cells (Berndt and 
Cohen, 1990), where 5% was soluble and represented a 15-fold increase over the 
endogenous activity. The remaining 95% recombinant insoluble PP1α was fully reactivated 
by denaturation with 6M guanidinium chloride followed by extensive and rapid dilution 
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with buffers containing Mn2+ (Berndt and Cohen, 1990). Recombinant PP1α, PP1γ1 and 
PP1γ2 were also expressed in E. coli (Zhang et al., 1992; Zhang et al., 1993). The 
enzymatic properties of such recombinant proteins were examined in terms of substrate 
specificity and sensitivity to OA (okadaic acid) and I2 (inhibitor-2). Furthermore, 
expression of recombinant His-tagged PP1α and PP1γ1 was also reported in Sf9 insect 
cells and E. coli-DH5α cells. E. coli expressed PP1α exhibits high specific activity, 
comparable to native PP1c (usually prepared from rabbit skeletal muscle as a mixture of 
isoforms) (Watanabe et al., 2003; Zhang et al., 1992; Zhang et al., 1993). The E. coli 
expressed enzyme is also normal in terms of inhibition by a variety of well characterized 
inhibitors, including microcystin, calyculin A (CA) and OA. However, recombinant E. coli 
PP1α exhibits several anomalous properties in comparison to the non-recombinant enzyme. 
These include the fact that it is dependent on Mn2+ for activity and that it is able to 
dephosphorylate phospho-tyrosine-containing substrates and paranitrophenyl phosphate. 
Recombinant E. coli PP1α is also relatively insensitive to inhibition by phospho-inhibitor-1 
and phospho-DARPP-32 (Watanabe et al., 2003). It is notable that recombinant E. coli 
PP1α also exhibits a marked ability to auto-dephosphorylate phospho-Thr320 when 
incubated with cdc2 kinase, in contrast to native or recombinant Sf9 expressed PP1c 
(Watanabe et al., 2003). In contrast, recombinant E. coli PP1α appears to be inhibited 
normally by full length inhibitor-2 (Watanabe et al., 2003). Recombinant Sf9 expressed 
PP1α and PP1γ1 also exhibited high specific activities under standard assay conditions 
(Watanabe et al., 2003). The two enzyme preparations produced in Sf9 insect cells were 
also normal in terms of inhibition by microcystin, CA and OA. They did not require Mn2+ 
for activity and, similarly to native PP1c, addition of 1 mM Mn2+ inhibited their activities. 
Notably, Sf9 expressed PP1α and PP1γ1 did not dephosphorylate phospho-DARPP-32 or 
phospho-inhibitor-1 (Watanabe et al., 2003). 
In this work methods were developed to express in E. coli and to purify the two 
alternatively spliced variants known to be produced from the human PP1γ gene (PP1γ1 and 
PP1γ2). To facilitate the purification process, a poly-histidine tag was added to the N-
terminus of the recombinant proteins. Furthermore, the purified recombinant proteins were 
compared by a variety of methods. 
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II.2 MATERIAL AND METHODS  
 
II.2.1 PLASMIDS CONSTRUCTION   
 
To generate the expression plasmid pTAC-His-PP1γ2, the primers “His-PP1 
gamma I” and “PP1 gamma2 T” were used for PCR amplification using pAS-PP1γ2 
(Fardilha, 2004) as the template. The “His-PP1 gamma I” oligonucleotide (5’-
GGAATTCATATGCATCATCATCATCATCACATGGCGGATTTAGAT-3’) was 
designed to contain a Nde I endonuclease restriction site at the initiating methionine codon 
and 6 histidine codons. The “PP1 gamma2 T” primer (5’-
GCTCTAGACTGCAGGTCGACGGATC-3’) introduced a Xba I endonuclease restriction 
site following The stop codon. The His-tagged PP1γ2 DNA fragment amplified by PCR 
was detected by agarose gel electrophoresis, and inserted into the pBlueScript vector (pKS-
His-PP1γ2), where its sequence was fully confirmed. It was then recovered from pKS-His-
PP1γ2 and inserted into Nde I and Xba I cut pTACTAC vector to yield pTAC-His-PP1γ2, 
whose sequence was also fully verified by automatic DNA sequencing. 
To construct the pKS-His-PP1γ1 plasmid, a C-terminal fragment was excised from 
pKS-His-PP1γ2 with Pst I and Hind III restriction enzymes and replaced with the 
corresponding Pst I-Hind III fragment from pKS-PP1γ1 (da Cruz e Silva and Greengard, 
1995). pKS-His-PP1γ1 was digested with Nde I and Hind III and the insert recovered and 
then also subcloned into pTACTAC cleaved with the same restriction enzymes to yield 
pTAC-His-PP1γ1, whose sequence was fully verified by DNA sequencing. 
 
II.2.2 IMMUNOBLOT SCREENING OF RECOMBINANT PROTEINS   
 
After transformation into E. coli strain DH5α, single clones were grown in 3 ml of 
LB medium plus 100 μg/ml ampicillin and 1 mM Mn2+ (LB/Amp/Mn2+) at 37ºC overnight 
with shaking. Overnight cultures (30 μl) were transferred into 3 ml of new LB/Amp/Mn2+ 
and grown at 37ºC with vigorous shaking to on A600 of 0.6. IPTG was then added to 0.5 
mM final concentration to induce recombinant protein expression. After 3 hours of 
induction, the cells were collected by centrifuging at 14,000 rpm for 1 min. Cultured cells 
(1 ml) were resuspended in 100 μl of 1 % SDS. Samples (10 μl) were loaded onto SDS-
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PAGE gels after adding sample buffer. Electrophoresis was performed at 100 V for 2 hours. 
Proteins were transfered to nitrocellulose membrane, and the expression of recombinant 
proteins was analysed by immunobloting with appropriate antibodies. 
 
II.2.3 MEDIAL AND LARGE SCALE EXPRESSION OF RECOMBINANT 
PROTEINS   
 
A single clone was taken from a fresh plate and grown in 10 ml LB/Amp/ Mn2+ 
medium at 37ºC overnight with shaking at 250 rpm. 500 μl or 5 ml of the overnight culture 
were transferred into 50 ml or 500 ml respectively of LB/Amp/Mn2+ medium and grown at 
37ºC with shaking to the A600 of 0.6. IPTG was then added to 0.5 mM final concentration 
and incubation was continued at 26ºC for 15 hours to induce expression of the recombinant 
protein. 
 
II.2.4 PURIFICATION OF THE TWO ISOFORMS OF HIS-TAGGED PP1 
GAMMA UNDER DIFFERENT CONDITIONS  
 
For recovery of the induced recombinant His-tagged PP1γ isoforms, the bacterial 
suspension was centrifuged at 4,000 rpm for 20 min and the cell pellet was resuspended in 
lysis buffer. Different concentrations of imidazole (5 mM, 10 mM and 30 mM) lysis  
buffer were tried in a pH 8.0 buffer system (10 mM Tris-HCl，300 mM NaCl，1 mM 
MnCl2 ， 10% Glycerol). After binding the His-tagged PP1γ isoforms with the resin 
separately, the resin was washed with 30 mM imidazole (pH 8.0) buffer and the 
recombinant protein was eluted with 500 mM imidazole (pH 8.0) elution buffer. 
Different pH buffer systems (10 mM Tris-HCl, 300 mM NaCl, 30 mM imidazole, 1 
mM MnCl2, 10% Glycerol) were also used to purify the His-tagged PP1γ isoforms. In 
these cases, the cells were lysed with 30 mM imidazole (pH 5.0, pH 6.0 or pH 7.0) buffer, 
respectively. After binding the His-tagged PP1γ isoforms to the resin, it was washed with 
the same buffer used for cell lysis. Then the protein was eluted with 500 mM imidazole 
buffer of the same pH as was used for the lysis and wash buffers. 
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II.2.5 THE PROTEIN PHOPHATASE ACTIVITY ASSAY   
 
II.2.5.1 Preparation of 32P-labelled phosphorylase a  
 
20 mg Phosphorylase b (Sigma) was phosphorylated with 16 µg phosphorylase 
kinase (Sigma) in 1.6 ml reaction buffer containing 31 mM ATP (Sigma), and [γ-32P] ATP 
(Amersham) (500 µCi). A final concentration of 100 nM microcystin was added to inhibit 
endogenous protein phosphatases. The reaction mixture (Table II.1) was incubated at 30ºC 
for 2 hours, then 1.6 ml of 90 % saturated ammonium sulfate was added (to 45 % 
saturation), kept on ice for 30 min and centrifuged at 19,000×g for 15 min at 4ºC. The 
pellet was resuspended in 0.4 ml of Buffer C [50 mM Tris-HCl (pH 7.0), 0.1% (v/v) 2-
mercaptoethanol] and 0.4 ml of 90 % saturated ammonium sulfate was added. The mixture 
was incubated on ice for another 30 min and centrifuged at 19,000×g for 15 min at 4ºC. 
The pellet was resuspended in 0.4 ml Buffer C and dialyzed against 4×1 L of Buffer D [10 
mM Tris-HCl (pH 7.0), 0.1% (v/v) 2-mercaptoethanol] for 24 hours at 4ºC. Precipitated 
phosphorylase a was taken from the dialysis tube and left at 4ºC overnight. After 
centrifuging at 19,000×g for 15 min at 4ºC, the precipitated phosphorylase a was 
resuspended in 0.5 ml of Buffer E [50 mM Tris-HCl (pH 7.0)]. 
 
 
Table II.1:  Reaction mixture for Preparation of 32P-labelled phosphorylase a  
Component Volume (µl) 
Phosphorylase kinase (20 mg/ml) 
Magnesium acetate (100mM) 
16 
32 
CaCl2 (100 mM) 2 
Microcystin (50 µM) 3.2 
Phosphorylase b (100mg/ml) 200 
Buffer B* 846.8 
[γ-32P] ATP (250 μCi – 3000 Ci/mmol) 500 
Total 1600 
           *125 mM Na-2-glycerophosphate (Sigma) pH 8.5 
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II.2.5.2 Assay of protein phosphatase1 activity   
 
The prepared 32P-labelled phosphorylase a was diluted with 0.1 ml of caffeine and 
0.4 ml of Buffer C to a final concentration of 30 μM. Recombinant PP1 isoforms were 
diluted in Buffer A [50 mM Na-2-glycerophosphate (pH 7.5), 10% (v/v) glycerol, 0.1 mM 
EGTA, 0.2% (v/v) 2-mercaptoethanol] and 10 µl of diluted PP1 was mixed with 10 µl of 
Buffer B [125 mM Na-2-glycerophosphate (pH 8.5)]. The blank control consisted of 10 µl 
of Buffer A mixed with 10 μl of Buffer B. After incubating the mixtures at 30ºC for 2 min, 
10 μl of 32P-labelled phosphorylase a was added. After 10 min, the reaction was stopped by 
the addition of 100 μl of 20 % TCA. The mixture was centrifuged at 15,000×g for 2 min at 
room temperature and 100 μl of the supernatant was transferred to another microtube. The 
32P released from the substrate was quantified using a Scintillation Counter, and all 
samples were assayed in duplicate three times. 
 
Unit Definition - 1 unit of PP1 activity releases 1 μmol phosphate from phosphorylase a 
per minute in a standard assay.  
 
Therefore the 10 min assay used 
 
 c.p.m. released = SAMPLE c.p.m. – Blank c.p.m.                (1) 
 
      Activity (mU/mL) = 
100
130100
10
3.0
...
... ×××
TOTALmpc
releasedmpc         (2) 
 
The number 0.3 refers to the number of nanomoles of phosphorylase in the assay, 10 is the 
incubation time in minutes, 100 is the factor necessary to convert the results for 1 ml rather 
than 10 μl of enzyme, and 130/100 corrects for the fraction of the TCA supernatant that is 
counted. All calculations made use of Microsoft Excel. 
 
 
 
 
Characterization of Two Novel PP1 Regulators: I2L and Nek2C                                                        Chapter II 
_______________________________________________________________________________________ 
66                                                                                                                                     Centre for Cell Biology 
University of Aveiro 
 
II.2.6 ASSAY OF PROTEIN PHOSPHATASE 1 ACTIVITY INHIBITED 
BY I2   
 
I2 was diluted in Buffer B to yield a range of different concentrations. 10 μl of each 
I2 dilution solution were mixed with 10 μl of His-tagged PP1γ isoform, diluted in buffer A, 
separately. A control was prepared by mixing 10 μl of Buffer B with 10 μl of the 
corresponding His-tagged PP1γ isoform diluted in buffer A. The blank was prepared by 
mixing 10 μl of buffer A with 10 μl of buffer B. These mixtures were then incubated at 
30ºC for 15 min and 10 μl of 32P-labelled phosphorylase a substrate was added. The 
reaction was stopped after 10 min by adding 100 μl of 20 % TCA. The mixture was 
centrifuged at 15,000×g for 2 min at room temperature and 100 μl of the supernatant was 
transferred to another microtube. The 32P released from the substrate was quantified and 
the phosphatase activity calculated as described above. All samples were assayed in 
duplicate three times. 
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II.3 RESULTS 
 
II.3.1 CONSTRUCTION OF RECOMBINANT PLASMIDS FOR 
EXPRESSION OF HIS-TAGGED PP1 GAMMA 1 AND PP1 GAMMA 
2    
 
PCR amplification of the pAS-PP1γ2 template using “His-PP1 gamma I” and “PP1 
gamma2” primers yielded a fragment of the expected size (Fig. II.1): 
 
 
 
 
 
 
This DNA fragment was then inserted into pBlueScript to yield pKS-His-PP1γ2, 
and the construct was completely verified by automatic DNA sequencing. The Nde I/Xba I 
fragment containing the His-PP1γ2 sequence was then transferred into pTACTAC to yield 
pTAC-His-PP1γ2. The recombinant expression plasmid was screened by restriction 
analysis with Nde I and Xba I. After transforming E. coli strain DH5α, several clones were 
analyzed by inducing small scale expression. Both SDS-PAGE (Fig. II.2A) and 
immunoblot (Fig. II.2B) confirmed His-PP1γ2 expression: 
 
 
 
 
 
1 Kb
1  2 
Figure II.1: Agarose gel analysis of the PCR 
amplification of His-tag PP1γ2. Lane1. 1 Kb 
DNA molecular weight. Lane2. PCR amplified His-tag 
PP1γ2 cDNA fragment with the expected molecular 
weight of 1.1 kb.       
  His-PP1γ2 DNA 
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Figure II.2: Small scale expression for detection of His-tagged PP1γ2 A. Coomassie blue 
stained. SDS-PAGE gel; B. Immunoblot with Anti-PP1γ2 antibody. Lane 1: Protein Molecular Weight 
Marker; Lane 2: Positive control of rat testis; Lane 3-9: Bacterial clones 1-7.  
 
 
 
The Coomassie blue stained SDS-PAGE gel showed a strong band of 
approximately 40 KDa, except for lane 8 (Fig. II.2A), that was absent from the non-
induced and non-transformed controls (not shown). The corresponding immunoblot with a 
specific anti-PP1γ2 antibody (Fig. II.2B) confirmed that the expression of the 40 KDa 
protein likely corresponded to the expression of His-tagged PP1γ2. These results 
confirmed that the pTAC-His-PP1γ2 recombinant expression plasmid was constructed and 
that this plasmid can express the recombinant His-PP1γ2. 
The correct construction of the recombinant plasmid pKS-His-PP1γ1 was also 
confirmed by sequencing, as previously described. After transferring the insert into the 
pTACTAC vector, the resulting construct was screened with the restriction enzymes Nde I 
and Hind III (Fig. II.3): 
 
 
 1        2       3       4       5       6       7       8       9 
1      2       3        4       5       6       7        8       9 
52 KDa 
52 KDa 
37 KDa 
37 KDa 
His-PP1γ2 
A 
B 
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Small scale expression of His-tagged PP1γ1 in DH5α and immunoblot analysis also 
indicated that His-tagged PP1γ1 can be expressed by the resulting pTAC-His-PP1γ1 
expression plasmid (Fig. II.4). 
 
 
                                          
  
II.3.2 PURIFICATION OF HIS-TAGGED PP1 GAMMA 1 AND PP1 
GAMMA 2 USING NI-NTA RESIN   
 
After induction of recombinant PP1 expression from pTAC-His-PP1γ1 and pTAC-
His-PP1γ2 in DH5α with IPTG at 26ºC in 50 ml LB, His-tagged PP1γ1 and PP1γ2 were 
purified under different conditions to determine the best method to obtain pure and active 
His-tagged PP1γ1 and PP1γ2 phosphatase enzymes. His-tagged PP1γ1 and PP1γ2 were 
1     2     3 
1 Kb 
1.6 Kb 
2 Kb 
3 Kb 
4 Kb 
5 Kb 
Figure II.3: Restriction enzyme analysis 
of pKS-His-PP1γ1 and pTAC-His-
PP1γ1 by agarose gel electrophoresis. 
Lane 1: 1 Kb DNA molecular weight; Lane 2: 
pKS-His-PP1γ1/Nde I+Hind III; Lane 3: pTAC -
PP1γ1-His /Nde I+Hind III.
His-PP1γ1 DNA 
A B 
52 KDa 
37 KDa 37 KDa 
52 KDa 
1        2         3        4 1        2        3          4 
Figure II.4: SDS-PAGE (A) and immunoblot with Anti-PP1γ1 antibody (B) 
detected the expression of His-tagged PP1γ1. Lane 1: Protein molecular Marker; lane 2: 
Positive Control of rat cotex; Lane 3: Negative contro.l Lane 4. Expresszion of pTAC-His-PP1γ1 in 
DH5α.   
 
His-PP1γ1
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purified in 5 mM, 10 mM and 30 mM imidazole (Fig. II.5). After scanning the SDS-PAGE 
gel using a Bio-Rad GS-710 Calibrated Imaging Densitometer, the density of the expressed 
protein bands was analyzed using Quantity One software. The percentage purification of 
His-tagged PP1γ1 and PP1γ2 obtained for each method are listed below (Table II.2). The 
results obtained indicated that the highest degree of purification was obtained in 30 mM 
imidazole, both for His-PP1γ1 and His-PP1γ2. 
 
 
 
 
 
Table II.2: Yield of purified His-PP1γ 1 and His-PP1γ2 with different concentration 
of imidazole 
Method of purification Concentration 
of PP1γ1(OD) 
% PP1γ1 Concentration of 
PP1γ2(OD) 
% PP1γ2 
5mM imidazole, pH 8.0 lysis 3295 58.39 5181 57.61 
10mM imidazole, pH 8.0 lysis 4866 49.38 3889 54.67 
30mM imidazole, pH 8.0 lysis 2745 88.61 1743 60.43 
      
 
 
S D L W1W2W3E M M S D L W1W2W3 E  M S  L W1 W2W3 E  
L     D  S    M   W1W2W3 E1E2  L   D  S W1W2 W3M E1E2  M  H    S    L W1 W2 W3 E1E2  
D E F
B A C
52 KDa 52 KDa 
37 KDa 
52 KDa 
37 KDa 37 KDa 
37 KDa 
52 KDa
Figure II.5: SDS-PAGE analsis of expression proteins for His-PP1γ1 (A-C) 
and His-PP1γ2 (D-E), under different concentrations of imidazole (A and D 5 
mM; B and E 10 mM; C and F 30 mM). D, cell debris; E, eluted protein; E1, eluted 
fraction with 250 mM imidazole (pH 8.0); E2, eluted fraction with 500 mM imidazole (pH 8.0); H, 
cell homogenate; L, loading flow through; M, molecular weight markers; S, supernatant from cell 
lysis; W1, first wash flow though; W2, second wash flow though; W3, third wash flow though. 
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Furthermore, His-tagged PP1γ1 and PP1γ2 were also purified under different pH 
conditions in 30 mM imidazole (Fig. II.6). Following SDS-PAGE analysis, gels were 
scanned with a Bio-Rad GS-710 Calibrated Imaging Densitometer and the density of the 
protein bands was analyzed using Quantity One software. The percentage of His-PP1γ1 
and His-PP1γ2 recovered for each method are listed (Table II.3). The results indicate that 
using 30 mM imidazole (both pH 7.0 and pH 8.0 buffer systems), the quantity and quality 
of His-PP1γ1 recombinant protein recovered was better than using other pH buffer systems. 
Thus, for large scale purification the two different methods were compared to purify His-
PP1γ1. 
In the case of His-PP1γ2, the best method appeared to be 30mM imidazole (pH 5.0). 
Thus, for the large scale purification of His-PP1γ2, the 5 mM imidazole (pH 8.0) and 30 
mM imidazole (pH 5.0) conditions were compared. 
 
 
  
 
 
M   S   D   L W1 W2 W3 E 
M    S    D   L W1 W2 W3 E1 E2 
52 KDa 
37 KDa 
D 
M   S   D   L  W1W2 W3 E M   S    D    L W1 W2 W3 E 
M   S    D    L W1 W2 W3 E1 E2 
52 KDa 
52 KDa 52 KDa52 KDa 
52 KDa 
37 KDa 37 KDa 
37 KDa 37 KDa 37 KDa 
E F 
C B A 
Figure II.6: SDS-PAGE analysis of purification reactions for His-PP1γ1 (A-C) 
and His-PP1γ2 (D-F) under different conditions of pH (A and D, pH 5.0; B 
and E, pH 6.0; C and F, pH 7.0). D, cell debris; E, eluted protein; E1, eluted fraction with 
250 mM imidazole (pH 8.0); E2, eluted fraction with 500 mM imidazole (pH 8.0); L, loading flow 
through; M, molecular weight markers; S, supernatant from cell lysis; W1, first wash flow though; 
W2, second wash flow though; W3, third wash flow though. 
M   S   D     L W1 W2 W3 E1 E2 
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Table II.3: Yield of purified His-PP1γ1 and His-PP1γ2 with 30 mM imidazole 
and different pH condition. 
Method of purification Concentration 
of PP1γ1(OD)
% PP1γ1 Concentration of 
PP1γ2(OD) 
% PP1γ2 
 pH 5.0 buffer 2474 69.64 3854 93.14 
pH 6.0 buffer 3113 69.05 2702 85.49 
pH 7.0 buffer 4478 72.20 1273 73.25 
 
 
 
II.3.3 LARGE SCALE PURIFICATION OF HIS-PP1 GAMMA 1 AND HIS-
PP1 GAMMA 2 
 
Given the previous results, it seemed sensible to test two different methods for the 
large-scale expression and purification of His-PP1γ1 (comparing imidazole buffer systems 
of pH 7.0 and pH 8.0). Using 30 mM imidazole (pH 8.0), the eluted fractions were 
recovered from the purification column and analyzed by SDS-PAGE followed by 
Coomassie blue staining (Fig. II.7): 
 
 
 
 
 
 
52 KDa 
37 KDa 
M       1       2        3        4        5        6       7       8        9       10      11    12      13      14 
Figure II.7: SDS-PAGE gel analsis of eluted His-PP1γ1 for large scale purification 
in pH 8.0 buffer system Coomassie blue (Sigma) stained gel of eluted fractions. M, 
Protein Molecular Weight Marker; Lanes 1-14: Elution fractions 1 to 14. 
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The identity of the eluted protein was confirmed by immunoblotting using a 
specific antibody (Fig. II.8). 
 
 
 
 
The results obtained seem to indicate that the pH 8.0 buffer system is more efficient 
than the pH 7.0 buffer system for large scale purification of His-PP1γ1. Specifically, the 
yield of purified protein obtained with the pH 8.0 system appears to be better, as judged by 
Coomassie staining (see Figs. II.7 and 9), although the same expression condition were 
used. This suggests that, for His-PP1γ1, the optimal method for large scale purification 
involves suspension of cells in 30 mM imidazole (pH 8.0) lysis buffer, followed by the 
addition of 1 µg/ml lysozyme on ice for 30 min. After sonication, the supernatant is 
collected by centrifugation. The resin is packed into the column and equilibrated with the 
lysis buffer used. The collected supernatant is loaded into the column and the column is 
M       1        2         3          4          5          6          7        8       9        10        11       12    13      14 
52 KDa 
37 KDa 
Figure II.8: Immunoblot analysis of eluted fractions of His-PP1γ1 from pH 
8.0 buffer system. Immunoblot analysis was performed using a anti-PP1γ1 
antibody (CBC-3C). M, Protein Molecular Weight Marker. Lanes 1-14: Elution fractions 1 
to 14. 
M        1      2      3      4      5       6      7       8       9   M   10    11    12   13    14    15     16     17    18 
52 KDa 
37 KDa 
Figure II.9: SDS-PAGE gel analysis of large scale purification of His-PP1γ1 in 
pH 7.0 buffer system Coomassie blue (Sigma) stained gel of eluted fractions. 
M, Protein Molecular Weight Marker; Lanes 1-18: Eluted fractions 1 to 18.  
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washed with the same buffer. His-PP1γ1 is eluted with a linear concentration gradient of 
imidazole from 30 mM to 500 mM with 30 ml total volume. 
For large scale purification of His-PP1γ2, the two methods compared consisted of 
30 mM imidazole (pH 5.0) and 5 mM imidazole (pH 8.0) for the lysis of the cells. After 
loading the cell lysis supernatant, each column was washed with the corresponding buffer. 
His-PP1γ2 was eluted with a linear concentration gradient of imidazole from 30 mM to 
500 mM. The eluted fractions were analyzed by SDS-PAGE (Figs. II.10 and 11): 
 
 
 
 
Immunoblot analysis of the eluted fractions using a specific anti-PP1γ2 antibody 
(CBC-G502) confirmed the expression and purification of His-PP1γ2 (Fig. II.12).  
 
52 KDa 
37 KDa 
M        1        2         3        4          5          6          7          8         9        10        11        12        13      14 
Figure II.10: SDS-PAGE analysis eluted fractions of His-PP1γ2 with 5 mM 
imidazole (pH 8.0) buffer. M, Protein Molecular Weight Marker; Lanes 1-14: Eluted 
fractions 1 to 14. 
M        1        2        3         4         5         6        7         8         9        10       11      12      13        14 
52 KDa 
37 KDa 
Figure II.11: SDS-PAGE gel analysis of eluted fractions of His-PP1γ2 using 
30 mM imidazole (pH 5.0). M, Protein Molecular Weight Marker; Lanes 1-14: Eluted 
fractions 1 to 14. 
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The result obtained (compare Figs. II.10 and 11) indicated that the second method, 
30 mM imidazole (pH 5.0), appears to be more efficient for the purification of His-PP1γ2, 
as judged by recovery of a relatively abundant higher molecular weight contaminating 
protein using the other method (Fig. II.10). This contaminating protein was largely 
eliminated with the method of choice (Fig. II.11). Thus, this second method was chosen for 
routine large scale purification of His-PP1γ2. 
 
II.3.4 PHOSPHATASE ACTIVITY OF RECOMBINANT HIS-TAGGED 
PP1 GAMMA 1 AND PP1 GAMMA 2   
 
Activity of confirm the biological recombinant His-tagged PP1γ1 and PP1γ2, the 
phosphatase activity presenting each eluted fraction was assayed using 32P-phosphorylase a 
as a substrate (Fig. II.13).   
   
 
 
52 KDa 
Figure II.12: Immunoblot analysis of eluted fractions obtained from large 
scale purification of His-PP1γ2. M, Protein Molecular Weight Marker; Lanes 1-14. Eluted 
fractions 1 to 14. 
M    1    2     3     4      5     6    7    8     9    10   11   12   13   14 
37 KDa 
A B
Figure II.13: Phosphatase activity of His-PP1γ1 (A) and His-PP1γ2 (B) eluted 
fractions, using 32P-phosphorylase a as substrate. U, Unit of protein phosphatase. 
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The above results indicated that both recombinant His-tagged PP1γ1 and PP1γ2 
were expressed in the bacterial system and could be purified essentially in their active 
forms in a high degree of homogeneity. Approximately 1.4 g (wet weight) of bacterial cells 
was collected from a 500 ml starting bacterial culture. Following the purification protocols 
described above, about 0.7 mg of PP1γ1 and 0.8 mg of PP1γ2 were obtained on average, 
exhibiting specific activities of around 10.7 U/mg and 9.2 U/mg for PP1γ2, respectively. 
After scanning Coomassie blue stained SDS-PAGE gels containing samples of the purified 
proteins, using a Bio-Rad GS-710 Calibrated Imaging Densitometer, the density of visible 
protein bands was analyzed using the Quantity One software and the purity of the 
recombinant PP1 preparations was estimated to be, on average, approximately 81% for 
His-PP1γ1 and 92% for PP1γ2. 
In order to compare the properties of recombinant proteins to their physiological 
counterparts, their sensitivity to inhibitor by I2 was also assayed (Fig. 14 and Table II.4). 
 
 
 
 
 
Figure II.14: I2 inhibition curves for recombinant His-pp1γ1 and His-PP1γ2, 
using phosphorylase a as substrate. 
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Table II.4: Inhibitory potency of I2 against His-PP1γ1 and His-PP1γ2. 
Phosphatase IC50 
His-PP1γ1 0.141 nM 
His-PP1γ2 0.145 nM 
                            .    
 
 
 
The results obtained indicated that recombinant His-PP1γ1 and His-PP1γ2 exhibited 
near normal sensitivity to inhibition by I2, comparable to that previously determined for 
rabbit skeletal muscle PP1 preparations. The respective IC50 values were calculated to be 
approximately 0.41 nM for His-PP1γ1 and 0.415 nM for His-PP1γ2. 
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II.4 DISCUSSION 
 
PP1 is generally thought to be one of the most important protein phosphatases, 
being ubiquitously expressed and involved in the regulation of wide variety of cellular 
signal transduction mechanisms. However, mammals possess three genes encoding highly 
homologous PP1 isoforms (PP1α, PP1β and PP1γ) exhibiting different abundance and 
tissue distributions. Furthermore, PP1 complexity is further enhanced by the process of 
alternative splicing. Splice variants have been identified and partially characterized, at least 
for the PP1α and PP1γ genes. The latter is known to exhibit tissue-specific alternative 
splicing to yield two main variants: the ubiquitous PP1γ1 and PP1γ2 that is predominantly 
expressed in testis and sperm. Indeed, PP1γ2 is thought to be the main PP1 isoform 
expressed in mammalian sperm, including humans. Therefore, while PP1γ1 has a broad 
range of roles, including relatively well characterized roles in neuronal function, PP1γ2 
function appears to be relatively more restricted. Given its relative abundance and 
preponderance in testis and sperm, PP1γ2 is probably involved in the control of many of 
the underlying reproductive cellular processes. Thus, in our laboratory, we have been 
interested in the identification and isolation of PP1γ1 and PP1γ2 interacting proteins, the 
two main PP1 phosphatases expressed in human testis. Several such proteins were 
identified using the yeast two-hybrid system (Fardilha et al., 2004), including various 
previously unknown and novel PP1 regulators. The biochemical characterization and 
physiological importance of the latter is currently being addressed using a variety of 
approaches. However, in order to facilitate such studies, it is of the utmost importance to 
have at our disposal a ready source of pure PP1γ1 and PP1γ2 proteins. Thus, to this end, 
we set up to develop and establish large scale expression and purification methods for 
obtaining high quality recombinant PP1γ1 and PP1γ2, an essential step for the in vitro 
study of the newly identified PP1 regulators. 
Initially, we attempted to obtain recombinant PP1γ1 and PP1γ2 from different 
expression systems, including the Pichia pastoris expression system. Although the Pichia 
system has been used to express a wide variety of proteins in very large amounts, in our 
hands PP1 was only expressed in relatively small quantities. However, most significant 
was the fact that the expressed recombinant PP1 isoforms migrated with larger apparent 
molecular masses than expected, as determined by SDS-PAGE and immunoblotting (data 
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not shown). After rechecking the expression plasmids by DNA sequencing, it was 
concluded that the observed anomalous Pichia expressed PP1 migration might be due to an 
unexpected post-translation modification (possibly glycosylation), and the Pichia method 
was not further pursued. 
Next, we turned to the relatively well characterized bacterial expression systems. 
Different expression methods were attempted for these proteins, including expression of 
the native proteins without any tags, in order to avoid possible interference of such tags 
with the properties of the enzymes. Expression of native untagged PP1γ2 in bacteria, 
although yielding a reasonable amount of expressed recombinant soluble protein, was 
eventually abandoned as the routine method of choice. Without a tag to facilitate the 
process, the purification method was very complex and morose, requiring several complex 
and lengthy steps. The final yield and the degree of purification of recombinant PP1γ2 
obtained were not the desirable for downstream biochemical applications (data not shown). 
In previous studies, the baculovirus expression system was used to express both 
untagged PP1α and PP1γ1 (E. F. da Cruz e Silva, unpublished results) and His-tagged 
PP1α (Watanabe et al., 2003), revealing that the recombinant PP1 isoforms obtained from 
insect cells exhibited virtually identical biochemical properties to the native enzyme. 
However, since bacterial expression of His-tagged PP1γ1 (Watanabe et al., 2003) also led 
to the isolation of recombinant protein whose properties were similar (except for the 
dependence on Mn2+), given the much easier and straightforward bacterial expression 
methodology, we also elected to develop large scale expression methods for obtaining high 
quality His-tagged PP1γ1 and PP1γ2 using the bacterial system. 
Various previous studies found that expression of PP1γ1 in pET28a, or other T7 
promotor vectors, led the expression of large quantities His-PP1γ1 but that it was mostly 
expressed as an insoluble protein (only a small fraction was recoverable as a soluble 
protein). Most likely, such results derive from the strong nature of the T7 promotor 
(Watanabe et al., 2003). Thus, in order to try to minimize this problem, we decided to 
express His-tagged (to aid purification) PP1γ1 and PP1γ2 using the pTACTAC vector. The 
relatively weaker nature of its promoter might be expected to lead to the expression of 
larger quantities of soluble PP1. Different concentrations of IPTG were also tried to induce 
the expression of PP1γ1 and PP1γ2 (data not shown here), in an attempt to optimize the 
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conditions for obtaining maximal amounts of both isoforms in the soluble fraction (0.5 mM 
IPTG was found to be the best concentration to use for both). 
Using the methods described, both His-PP1γ1 and His-PP1γ2 were successfully 
expressed in the DH5α bacterial host and purified using Ni-NTA resin. As expected, the 
activity of the purified phosphatase isoforms was also dependent on the presence of Mn2+, 
as was previously observed for other PP1 isoforms expressed in bacteria. From 500 ml 
bacterial culture approximately 05-1 mg of relatively homogeneous recombinant protein 
could be obtained (similar yields and specific activities were obtained for His-PP1γ1 and 
His-PP1γ2). Comparing His-PP1γ1 and His-PP1γ2 in the presence of their physiological 
counterpart I2, indicated that both exhibited near normal sensitivity to inhibition by I2, 
giving IC50 values in the nanomolar range (similar to native PP1). These recombinant His-
tagged phosphatase isoforms produced in this study will be very important for the study the 
new regulators of PP1 identified in the laboratory. 
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III I2L, A NEW TESTIS-SPECIFIC ISOFORM OF PP1 
INHIBITOR-2 
 
III.1 INTRODUCTION 
 
Mature spermatozoa are particularly specialized cells as they are highly 
compartmentalized, transcriptionally inactive and unable to synthesize new proteins. 
Therefore, it is likely that post-transcriptional events, like protein phosphorylation, play a 
major role in controlling sperm function, including motility, capacitation and the acrosome 
reaction. Sperm motility defects appear to be one of the main underlying causes of male 
infertility, a growing concern in industrialized nations. The biochemical mechanisms 
underlying sperm maturation and the development of motility are still far from being 
completely understood. However, Ser/Thr protein phosphorylation by protein phosphatase 
1 (PP1) and glycogen synthase kinase-3 (GSK3), seem to be one of the controlling 
processes. PP1γ2, a testis-specific PP1 isoform, was found to be the only PP1 isoform 
present in bovine, rhesus monkey and human sperm (Smith et al., 1996; Vijayaraghavan et 
al., 1996). Its direct involvement in sperm motility is consistent with the fact that PP1 has 
two-fold higher activity in immotile bovine caput epididymal sperm compared to mature 
motile caudal sperm (Vijayaraghavan et al., 1996). Moreover, inhibition of PP1γ2 activity 
by okadaic acid and calyculin A causes both initiation and stimulation of motility 
(Vijayaraghavan et al., 1996). 
The evolutionary conservation and the importance of Ser/Thr phosphatases in 
regulating flagellar motility is highlighted by the involvement of a PP1 homolog in the 
regulation of rooster sperm motility (Ashizawa et al., 1995; Ashizawa et al., 1994) and by 
the involvement of a Ser/Thr phosphatase in the regulation of microtubule sliding velocity 
in Paramecium and Chlamydomonas (Habermacher and Sale, 1995; Habermacher and Sale, 
1996; Habermacher and Sale, 1997; Klumpp et al., 1990; Klumpp and Schultz, 1991). 
Bovine sperm immunocytochemistry showed that PP1γ2 is present along the entire 
flagellum including the mid-piece, consistent with a role in sperm motility, but also in the 
posterior and equatorial regions of the head, suggesting a role in the acrosome reaction 
(Huang et al., 2002). PP1γ2 is expressed during germ cell differentiation in testis (da Cruz 
e Silva et al., 1995b; Kitagawa et al., 1990; Sasaki et al., 1990). It has also been involved 
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in the onset of hyperactivated motility and the acrosome reaction (Si and Okuno, 1999; 
Smith et al., 1996; Smith et al., 1999; Vijayaraghavan et al., 1996). 
PP1 activity towards different substrates appears to be mediated via binding to 
specific regulatory proteins. The increasing diversity of such PP1 regulatory subunits and 
their tissue specificity make them attractive pharmacological targets. An example of such a 
regulatory protein involved in sperm motility is a homologue of the yeast protein 
phosphatase binding protein sds22 (Huang et al., 2002). In caudal sperm PP1γ2 was found 
to be complexed with sds22 and to be catalytic inactive, whereas in caput sperm PP1γ2 and 
sds22 do not interact (Mishra et al., 2003). Another mechanism of PP1 regulation likely to 
be directly involved in sperm motility involves the long-known PP1 inhibitor 2 (I2) and 
GSK3. Interestingly, an I2-like activity detected in sperm could be reversed by purified 
GSK3 (Vijayaraghavan et al., 1996). PP1 and I2 form a stable but catalytically inactive 
complex. Phosphorylation of rabbit I2 at Thr72 by GSK3, releases the inhibition and the 
complex becomes active (Hemmings et al., 1982). Additionally, the phosphorylation of I2 
by GSK3 is enhanced when Ser86, 120 and 121 are also phosphorylated by casein kinase II 
(CKII), particularly Ser86 (DePaoli-Roach, 1984; Park et al., 1994). Endogenous sperm 
GSK3 activity was also demonstrated by activation of purified PP1-I2 complex, and 
immotile caput sperm was shown to contain six-fold higher GSK3 activity than motile 
caudal sperm (Vijayaraghavan et al., 1996). The presence and activity of GSK3 in sperm 
has been further characterised sustaining its role in sperm motility regulation (Payaningal 
et al., 2004; Vijayaraghavan et al., 2000). However, the role of I2, which would make the 
regulating bridge between PP1 and GSK3, has remained more elusive. 
In order to find out which PP1 partners might be involved in the control of sperm 
motility, we embarked on a study aimed at defining the testis specific interactomes of 
PP1γ1 and PP1γ2 (the two known alternatively spliced variants of PP1γ). To this end, 
exhaustive screens were performed on a human testis cDNA library using the Yeast Two 
Hybrid method (Fardilha et al., 2004a). Here we report the discovery of a new PP1 binding 
protein, termed Inhibitor 2-like (I2L) that is 95% identical to I2, including the human I2 
substitutions of the main PP1 regulatory residues Thr73 and Ser87. The presence of I2 in 
sperm was confirmed by both immunoblot and immunocytochemistry and the importance 
of both I2 and I2L in regulating sperm PP1 is discussed. 
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III.2 MATERIALS AND METHODS 
 
III.2.1 LIBRARY SCREENING 
 
Microbial strains and methods for performing yeast two-hybrid screens of human 
testis cDNA libraries using human PP1 cDNAs as bait have been described (Fardilha et al., 
2004a). Positive colonies were obtained on selective media from which pACT plasmids 
were recovered into E. coli. DNA sequence analysis was performed in-house using an 
Automated DNA Sequencer (Applied Biosystems). The DNA sequences obtained were 
compared to the GenBank data base, using the BLAST algorithm 
(http://www.ncbi.nlm.nih.gov/BLAST/), to identify the corresponding encoded proteins. 
Protein sequence analysis used PROSITE at the ExPASy site (http://www.expasy.org) and 
ELM (http://elm.eu.org). Multiple sequence alignments were performed using the 
ClustalW program (http://www.ebi.ac.uk/clustalw/). 
 
III.2.2 I2L CLONING, EXPRESSION AND PURIFICATION 
 
In order to correct the nucleotide sequence of clone 48, a single adenine insertion 
was made by PCR using appropriate oligonucleotide primers and the complete corrected 
I2L sequence was verified by DNA sequencing. For expression and purification purposes, 
the I2L cDNA was inserted into pET28c expression vector (Novagen), between EcoR I and 
Xho I restriction sites, adding a histidine tag to the N-terminal of the protein. The pET-I2L 
construct sequence was fully verified by DNA sequencing and transformed into E. coli 
Rosetta (DE3) strain (Novagen). The expression of recombinant His-tagged I2L (His-I2L) 
was induced with 1mM IPTG for 3h at 37ºC and the protein was purified using Ni-NTA 
resin (Qiagen), according to the supplier’s instructions. Briefly, the cells were lysed in 10 
mM imidazole, sodium phosphate buffer (pH 8.0), centrifuged at 15,000×g for 30 min at 
4ºC, and the supernatant was applied to the resin. The resin was washed with 20mM 
imidazole and His-I2L was eluted with 500 mM imidazole. The eluate was further purified 
from a 12% SDS-PAGE gel. A portion of the lane containing His-I2L was stained with 
Commassie blue and the corresponding band containing the remaining protein cut out. The 
gel band was washed three times with water and cut into smaller pieces. After adding 1 ml 
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of 100 mM Tris-HCl (pH 8.5), 0.1% SDS it was frozen at -20ºC overnight. The slurry was 
frozen and thawed another three times and then passed through a 0.22 μm filter membrane. 
The gel-free filtrate was then dialyzed against 4x 500 ml of 10 mM Tris-HCl (pH 7.5) 
buffer for 24 hours at 4ºC. The protein concentration of His-I2L was determined by the 
BCA method (Pierce). 
The I2L cDNA was also inserted in the pTACTAC expression vector (Zhang et al., 
1993b), using Nde I and Xba I restriction sites. The sequence was verified by DNA 
sequencing and then transformed into the E. coli Rosetta strain mentioned above. The 
expression of recombinant holo-I2L, without any tags, was induced with 0.4 mM IPTG for 
3 h at 37ºC. The protein was partially purified from a bacterial heat extract as previously 
described for I2 (Helps et al., 1994). 
 
III.2.3 CONSTRUCTION OF AN I2L-GFP FUSION AND EXPRESSION IN 
MAMMALIAN CELLS 
 
Using appropriate oligonucleotide primers, PCR amplification was used to sub-
cloned I2L into the vector pEGFP-N1 (Novagen) between the EcoR I and BamH I sites, 
and with the elimination of the original STOP codon. After confirming the correctness of 
the construct by DNA sequencing, the fusion vector for expression of I2L-GFP was then 
transfected into cultured HeLa and COS-7 cells, as previously described (Rebelo et al., 
2007). The fluorescent recombinant fusion protein was visualized using an Olympus IX-81 
inverted epifluorescence microscope. 
 
III.2.4 YEAST CO-TRANSFORMATION WITH PLASMID DNA 
 
Competent AH109 yeast cells were prepared by the lithium acetate method. In a 
microtube 0.1 μg of the PP1 bait plasmid and 0.1 μg of the I2L prey plasmid were added to 
100 μg of herring testes carrier DNA. Then, 100 μl of freshly prepared competent cells 
were added, followed by 600 μl of sterile PEG/LiAc (40% PEG 4000/1X TE/1X LiAc). 
The solution was incubated at 30ºC for 30 min with shaking (200 rpm). After adding 70 μl 
of DMSO, the solution was mixed gently and heat shocked for 15 min at 42ºC. The cells 
were pelleted after being chilled on ice, centrifuged for 5 sec at 14,000 rpm and 
resuspended in 0.5 ml of 1X TE buffer. These cells were plated in the appropriate selection 
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media, incubated at 30ºC for 2 days, and replated in selective media containing X-α-Gal 
(Clontech, USA). 
 
III.2.5 BLOT OVERLAY ANALYSIS 
 
For blot overlay analysis, 0.3 μg of purified I2 (NEB) and His-I2L were run on a 
SDS-PAGE gel and then transferred to a nitrocellulose membrane. After blocking, the 
membrane was incubated with purified recombinant PP1γ1 or PP1γ2 diluted in TBS-
T/BSA. After washing to remove excess protein, the bound PP1 isoforms were detected by 
incubating the membrane with specific anti-PP1γ and anti-PP1γ2 antibodies. 
Immunoreactive bands were revealed by incubating with horseradish peroxidase 
conjugated secondary antibody and developed by ECL (Amersham). 
 
III.2.6 PHOSPHATASE ACTIVITY ASSAYS 
 
The IC50 values of I2 and I2L for purified PP1γ1 and PP1γ2 isoforms were 
determined using 32P-phosphorylase a as substrate. The substrate was prepared from 
phosphorylase b (Sigma) using [γ-32P]ATP (Amersham) and phosphorylase kinase (Sigma), 
as previously described (Watanabe et al., 2003). An appropriate range of concentrations of 
purified I2 and I2L were incubated with the purified PP1 catalytic subunits and the 
phosphatase activity determined. The IC50 was calculated using BioDataFit 1.02 software. 
 
III.2.7 PREPARATION OF HUMAN SPERM HEAT EXTRACT OF I2/I2L 
 
Human sperm samples [kindly provided by Dr. Mário de Sousa (Clínica de 
Reprodução Dr. Alberto Barros, Porto, Portugal)] were used to partially purify endogenous 
I2/I2L based on published procedures (Vijayaraghavan et al., 1996). Briefly, human sperm 
samples were centrifuged at 1,200 rpm for 10 min at 4ºC and washed two times with PBS. 
The pellet was resuspended in homogenization buffer [50 mM Tris-HCl (pH 7.0), 1 mM 
EDTA, 1 mM EGTA, supplemented with 6 μg/mL Pepstatin A, 2 μM Leupeptin, 10 mM 
Benzamidine, 10 μg/mL Aprotinin and 1 mM PMSF] and boiled for 10 min. The mix was 
sonicated twice for 15 sec, boiled again for 30 min and centrifuged at 16,000×g for 15 min. 
The supernatant was adjusted to 10% TCA and, after centrifugation, the precipitate was 
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dispersed in 0.5 M Tris base and then dialysed overnight against 5 mM Tris-HCl (pH 7), 1 
mM EDTA and 1mM EGTA. The dialysate was boiled for 10 min and, after centrifugation, 
the supernatant (termed human sperm heat extract or HSI2) was stored in aliquots at -20ºC. 
 
III.2.8 IMMUNOBLOT ANALYSIS 
 
I2/I2L containing samples were separated on 12% SDS-PAGE gels and transferred 
to nitrocellulose membranes. The membranes were blocked with 5% nonfat dry milk in 
TBS-T for 1h, followed by incubation with sheep polyclonal anti-I2 antibody [diluted 
1:5000; kindly provided by PT Cohen (Medical Research Council Protein Phosphorylation 
Unit, Dundee, Scotland) or DL Brautigan (Center for Cell Signalling, Virginia, USA)] for 
1h at room temperature with shaking. After washing, the blots were incubated with anti-
sheep secondary antibody conjugated with horseradish peroxidase (diluted 1:1000; Dako) 
for 1h at room temperature. Blots were washed and developed with an ECL 
chemiluminescence kit (Amersham). 
 
III.2.9 PHOSPHORYLATION OF I2 AND I2L 
 
Recombinant I2, or bacterial heat extract of recombinant I2L, or human sperm heat 
extract of native I2/I2L [about 200 ng of inhibitor protein in 50 mM Tris-HCl (pH 7.5), 0.1 
mM EGTA and 0.03% Brij-35] were phosphorylated by GSK-3β (Calbiochem) or by CK-
II (Calbiochem), or both, as previously described (Park et al., 1994). The phosphorylation 
reaction was performed at 30ºC for 90 min and then terminated with the addition of 4X 
SDS loading buffer. Aliquots (1/10 and 9/10) of the reaction volume were separated in two 
separate 12% SDS-PAGE gels. The 1/10 reaction was analysed by immunoblot analysis. 
The other gel was dried and autoradiographed. When the phosphorylation was carried out 
in the presence of PP1, the inhibitor proteins were pre-incubated at 30ºC for 15 min with 
200 ng of purified His-tagged PP1γ1 or PP1γ2 in the presence of 1 mM MnCl2. 
 
III.2.10 DEPHOSPHORYLATION OF HSI2 
 
HSI2 was incubated overnight with either Protein Tyrosine Phosphatase 1B 
(Upstate Biosystems) at 37ºC, or Calf Intestinal Phosphatase (NEB) at 37ºC, or with PP1γ1, 
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at 30ºC, in the respective assay buffers. The reactions were stopped with the addition of 4x 
SDS loading buffer and analysed by immunoblotting as described above. 
 
III.2.11 TWO DIMENSIONAL (2D) GEL ELECTROPHORESIS 
ANALYSIS 
 
Both HSI2 without and with the addition of 10 ng of purified I2 were acetone 
precipitated and the pellets resuspended in 250 µl of 2D rehydratation solution (8 M 
Urea/2 M Thiourea/2% CHAPS/0.002% bromophenol blue) and supplemented with 2.5 μl 
of IPG buffer (in the pH 4-7 range) and 14 mg of DTT. The first dimension separation 
conditions were the following: 1 h at 30 V, 2 h at 150 V, 1 h at 500 V, 1 h at 1000 V and 2 
h at 8000 V. For the second dimension the samples were separated on 12% SDS-PAGE 
gels and, after electrophoretic transfer to nitrocellulose, the results were analysed by 
immunoblotting. 
III.2.12 IMMUNOCYTOCHEMISTRY OF SPERMATOZOA 
 
Human sperm samples were centrifuged at 1,200 rpm for 10 min at room 
temperature and washed twice with PBS. Spermatozoa were then resuspended in PBS and 
were attached to poly-ornithine coated coverslips for 15min. After fixation with 4% 
paraformaldehyde and washing with PBS, spermatozoa were permeabilized with methanol 
for 2 min and immediately washed with PBS. Sperm cells were incubated overnight 4ºC 
with anti-I2 antibody (diluted 1:500 in 3% BSA in PBS). After washing with PBS, the 
secondary antibody (FITC-conjugated rabbit anti-sheep at 1:50 dilution) was placed over 
the sperm cells for 1 h at room temperature. Following further washing with PBS, the 
procedure was repeated with the anti-PP1γ2 antibody (diluted 1:300) and Texas Red-
conjugated goat anti-rabbit secondary antibody (diluted 1:300; Molecular Probes). 
Coverslips were mounted in one drop of DAPI (Vector Laboratories) in a glass slide. 
Sperm cells were visualized using an Olympus 1X-81 epifluorescence microscope. 
 
III.2.13 IMMUNOPRECIPITATION OF HUMAN SPERM SAMPLES 
 
Human sperm samples (~1 mg of protein) were centrifuged at 1,200 rpm for 7 min 
at room temperature and washed twice with PBS. The pellet was then resuspended in 1 ml 
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lysis buffer [50 mM Tris-HCl (pH 8.0)/120 mM NaCl/4% CHAPS/0.1 mg/ml Pepstatin 
A/0.03 mM Leupeptin/145 mM Benzamidine/0.37 mg/ml Aprotinin/4.4 mM PMSF] for 15 
min on ice and sonicated for 30 sec. The lysates were precleared with 25 µl of Protein A 
Sepharose slurry (Pharmacia) for 1 h at 4ºC with orbital agitation. After centrifuging the 
sample for 1 min at 4ºC and 10,000×g, the supernatant was transferred to a new tube. 
Protein A Sepharose slurry (50 µl) and 1 µl of anti-PP1γ2 antibody were added and the 
mixture incubated overnight at 4ºC with orbital agitation. The mixture was centrifuged for 
1min at 4ºC and 10,000×g and the pellet washed twice for 15 min with 500 µl of 50 mM 
Tris-HCl (pH 8.0)/120 mM NaCl. The pellet was resuspended in SDS-PAGE loading 
buffer and analysed by immunoblotting with anti-I2 antibody. 
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III.3 RESULTS 
 
III.3.1 IDENTIFICATION OF A NEW I2 ISOFORM FROM A YEAST TWO 
HYBRID SCREEN 
 
To identify putative regulatory subunits of PP1γ1 and PP1γ2, yeast two-hybrid 
screens were performed using the respective phosphatases isoforms as baits to screen a 
human testis cDNA library (Fardilha et al., 2004a). One of the 120 positive clones (clone 
48) isolated from the PP1γ1 screen, encoded the complete coding sequence of a new 
protein exhibiting a high degree of identity with the known PP1 regulator PPP1R2 or 
inhibitor 2 (I2). We named it Inhibitor 2-like or I2L. By alignment with GenBank database 
(Fig. III.1A) clone 48 had a missing adenine at position 206 which would change the 
reading frame and thus result in an early STOP codon. Given the occurrence of the missing 
nucleotide in the corresponding genomic sequence, we concluded that it must represent a 
cloning artefact and re-introduced the missing A by PCR amplification using appropriate 
oligonucleotide primers. The clone 48 sequence aligned with sequence NR_002168, 
localized in chromosome 5, classified as an I2 pseudogene 3, and with a human testis 
mRNA sequence from the Mammalian Gene Collection program (nucleotide: BC066922; 
protein: Q6NXS1) (Fig. III.1A). Moreover, there is a human testis EST (BU854595) that 
aligns 99% to chromosome 5 at the I2L site, from nucleotide 3 to 680 of a total of 840 
(high quality sequence stops at nucleotide 539). Figure III.1B shows the alignment of I2, 
I2L and the testis EST. Where other species are concerned, the Pan troglodytes genome at 
chromosome 5 encodes a predicted one-exon protein 97% similar to human I2L 
(nucleotide: XM_001134994; protein: XP_001134994) (Fig. III.1C), having the same Thr 
and Ser substitutions characteristic of human I2L (see text below and Table III.1). 
Interestingly, the genome localization of Pan troglodytes I2 (chromosome 3) and I2L 
(chromosome 5) are similar to the corresponding human genes. There is also a testis EST 
from Pigtailed macaque (DY743031) that encodes a protein 94% similar to I2L (Fig. 
III.1C), having the characteristic Thr substitution but not the Ser one. 
I2L is 95% identical to I2 at both the nucleotide and the amino acid levels (Fig. 
III.1B and III.1C)， but with some important differences (Table III.1). I2 is encoded by 6 
exons in chromosome 3, while I2L is a one-exon protein encoded in chromosome 5. Thr73 
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and Ser87, phosphorylation sites for GSK3 and CKII, respectively, are absent in I2L. 
These residues are the main regulatory targets for PP1 regulation by I2. Using Prosite and 
ELM software, several putative CKII phosphorylation sites were identified in I2L (35-38 
SvdE, 121-124 SsgE, 122-125 SgeE, 130-133 SpeE, 193-196 TpsD). The 35-38 SvdE and 
193-196 TpsD sites represent new putative CKII phosphorylation sites in I2L that do not 
exist in I2. I2L also contains three additional putative protein kinase C (PKC) 
phosphorylation sites (7-9 ShR, 41-43 SkK, 44-46 SqK) and two protein kinase A (PKA) 
phosphorylation sites (33-35 RrS, 87-89 RdT), in comparison to I2. 
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SeqA Name             Len(nt)  SeqB Name             Len(nt)  Score 
1    I2Lgene_chr5     2043     2    I2L_Clone48      863      98 
1    I2Lgene_chr5     2043     3    I2L_cloneIMAGE   2007     99 
2    I2L_Clone48      863      3    I2L_cloneIMAGE   2007     92 
I2Lgene_chr5        CTCTGCTGTGCCGACCCTTCTCTTCGCGGACCCCACGCCAAGCAGCGACCCTGAGGCGAC 60 
I2L_cloneIMAGE      ----------------------------------------------------GAGGGGAC 8 
I2L_Clone48         CTCTGCTGTGCCGACCCTTCTCTTCGCGGACCCCACGCCAAGCAGCGACCCTGAGGCGAC 60 
                                                                        **** *** 
I2Lgene_chr5        AGCCGGAGCGCCCGGCAATGGCGGCCTCGACGGCCTCCCACCGGCCCATCAAGGGGATCT 120 
I2L_cloneIMAGE      AGCCGGAGCGCCCGGCAATGGCGGCCTCGACGGCCTCCCACCGGCCCATCAAGGGGATCT 68 
I2L_Clone48         AGCCGGAGCGCCCGGCAATGGCGGCCTCGACGGCCTCCCACCGGCCCATCAAGGGGATCT 120 
                    ************************************************************ 
I2Lgene_chr5        TGAAGAACAAGACCTCTACGACTTCCTCTATGGTGGCGTCGGCCGAACAGCCCCGCAGGA 180 
I2L_cloneIMAGE      TGAAGAACAAGACCTCTACGACTTCCTCTATGGTGGCGTCGGCCGAACAGCCCCGCAGGA 128 
I2L_Clone48         TGAAGAACAAGACCTCTACGACTTCCTCTATGGTGGCGTCGGCCGAACAGCCCCGCAGGA 180 
                    ************************************************************ 
I2Lgene_chr5        GTGTCGACGAGGAGCTGAGCAAAAAATCCCAGAAGTGGGATGAAATTAACATCTTGGCGA 240 
I2L_cloneIMAGE      GTGTCGACGAGGAGCTGAGCAAAAAATCCCAGAAGTGGGATGAAATTAACATCTTGGCGA 188 
I2L_Clone48         GTGTCGACGAGGAGCTGAGCAAAAA-TCCCAGAAGTGGGATGAAATTAACATCTTGGCGA 239 
                    ************************* ********************************** 
I2Lgene_chr5        CCTATCATCCAGCAGACAAAGGCTATGGTTTAATGAAAATAGATGAACCAAGCCCTCCTT 300 
I2L_cloneIMAGE      CCTATCATCCAGCAGACAAAGGCTATGGTTTAATGAAAATAGATGAACCAAGCCCTCCTT 248 
I2L_Clone48         CCTATCATCCAGCAGACAAAGGCTATGGTTTAATGAAAATAGATGAACCAAGCCCTCCTT 299 
                    ************************************************************ 
I2Lgene_chr5        ACCATAGTATGATGGGTGATGATGAAGATGCGTGTAGGGACACCGAGACCACTGAAGCCA 360 
I2L_cloneIMAGE      ACCATAGTATGATGGGTGATGATGAAGATGCGTGTAGGGACACCGAGACCACTGAAGCCA 308 
I2L_Clone48         ACCATAGTATGATGGGTGATGATGAAGATGCGTGTAGGGACACCGAGACCACTGAAGCCA 359 
                    ************************************************************ 
I2Lgene_chr5        TGGCGCCAGACATCCTAGCCAAGAAATTAGCTGCTGCTGAAGGCTTGGAGCCAAAGTACC 420 
I2L_cloneIMAGE      TGGCGCCAGGCATCCTAGCCAAGAAATTAGCTGCTGCTGAAGGCTTGGAGCCAAAGTACC 368 
I2L_Clone48         TGGCGCCAGACATCCTAGCCAAGAAATTAGCTGCTGCTGAAGGCTTGGAGCCAAAGTACC 419 
                    ********* ************************************************** 
I2Lgene_chr5        GGATTCAGGAACAAGAAAGCAGTGGAGAGGAGGATAGTGACCTCTCACCTGAAGAACGAG 480 
I2L_cloneIMAGE      GGATTCAGGAACAAGAAAGCAGTGGAGAGGAGGATAGTGACCTCTCACCTGAAGAACGAG 428 
I2L_Clone48         GGATTCAGGAACAAGAAAGCAGTGGAGAGGAGGATAGTGACCTCTCACCTGAAGAACGAG 479 
                    ************************************************************ 
I2Lgene_chr5        AAAAAAAGCGACAATTTGAAATGAGAAGGAAGCTTCACTACAATGAAGGACTCAATATCA 540 
I2L_cloneIMAGE      AAAAAAAGCGACAATTTGAAATGAGAAGGAAGCTTCACTACAATGAAGGACTCAATATCA 488 
I2L_Clone48         AAAAAAAGCGACAATTTGAAATGAGAAGGAAGCTTCACTACAATGAAGGACTCAATATCA 539 
                    ************************************************************ 
I2Lgene_chr5        AACTAGCCAGACAATTAATTTCAAAAGACCTACATGATGATGATGAAGATGAAGAAATGT 600 
I2L_cloneIMAGE      AACTAGCCAGACAATTAATTTCAAAAGACCTACATGATGATGATGAAGATGAAGAAATGT 548 
I2L_Clone48         AACTAGCCAGACAATTAATTTCAAAAGACCTACATGATGATGATGAAGATGAAGAAATGT 599 
                    ************************************************************ 
I2Lgene_chr5        TAGAGACTGCAGATGGAGAAAGCATGAATACGGAAGAATCAAATCAAGGATCTACTCCAA 660 
I2L_cloneIMAGE      TAGAGACTGCAGATGGAGAAAGCATGAATACGGAAGAATCAAATCAAGGATCTACTCCAA 608 
I2L_Clone48         TAGAGACTGCAGATGGAGAAAGCATGAATACGGAAGAATCAAATCAAGGATCTACTCCAA 659 
                    ************************************************************ 
I2Lgene_chr5        GTGACCAACAGCAAAACAAATTACGAAGTTCATAGAAGAGATTTGTTCAACACTGCAATT 720 
I2L_cloneIMAGE      GTGACCAACAGCAAAACAAATTACGAAGTTCATAGAAGAGATTTGTTCAACACTGCAATT 668 
I2L_Clone48         GTGACCAACAGCAAAACAAATTACGAAGTTCATAGAAGAGATTTGTTCAACACTGCAATT 719 
                    ************************************************************ 
I2Lgene_chr5        GTTTGTTAGATATAAACCCTGTGACTATAATACATTGCTTCTTGTTCTCCACAATTCATG 780 
I2L_cloneIMAGE      GTTTGTTAGATATAAACCCTGTGACTATAATACATTGCTTCTTGTTCTCCACAATTCATG 728 
I2L_Clone48         GTTTGTTAGATATAAACCCTGTGACTATAATACATTGCTTCTTGTTCTCCACAATTCATG 779 
                    ************************************************************ 
I2Lgene_chr5        ACTTAAGTACCAAAATGCATACCAGTTATTATATATTGCCAAGAATTAAATGATAAACTT 840 
I2L_cloneIMAGE      ACTTAAGTACCAAAATGCATACCAGTTATTATATATTGCCAAGAATTAAATGATAAACTT 788 
I2L_Clone48         ACTTAAGTACCAAAATGCATACCAGTTATTATATATTGCCAAGAATTAAATGATAAACTT 839 
                    ************************************************************ 
I2Lgene_chr5        AGAGACTAATTAGACTGAAAATGCCTAATTGATATATATATTCTTATGCCTAGTACTTTA 900 
I2L_cloneIMAGE      AGAGACTAATTAGACTGAAAATGCCTAATTGATATATATATTCTTATGCCTAGTACTTTA 848 
I2L_Clone48         AGAGACTAAAAAAAAAAAAAAAAA------------------------------------ 863 
                    *********  * *   ****                                        
I2Lgene_chr5        TATTCCTCTAACGCAGTAAGAATTATGTGGAATATTTTCCTTAAACGAAGTGCAGGAAAG 2040 
I2L_cloneIMAGE      TATTCCTCTAACGCAGTAAGAATTATGTGGAATATTTTCCTTAAACGAAGTGCAGGAAAG 1988 
I2L_Clone48         ------------------------------------------------------------ 
 
I2Lgene_chr5        CCC---------------- 2043 
I2L_cloneIMAGE      CCCAAAAAAAAAAAAAAAA 2007 
I2L_Clone48         ------------------- 
Figure III.1A. A new Inhibitor 2-like (I2L) isoform. ClustalW alignment of the I2L gene 
sequence in human chromosome 5 (NC000005) with clone 48 (isolated from the yeast two-hybrid screen) 
and a cDNA sequence subsequently entered in the database (BC066922). (//) indicates a gap in the sequence 
alignment at the 3’-end. The initiation and stop codons are in bold and the putative poly(A) addition signals 
are underlined. The alignment scores are indicated on top. 
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SeqA Name           Len(nt)  SeqB Name           Len(nt)  Score 
1    I2             3355     2    I2Lgene_chr5   2043     95 
1    I2             3355     3    EST_testis     840      88 
2    I2Lgene_chr5   2043     3    EST_testis     840      90 
I2                CTTTAGCCCTGAGCGGGATCTGCGGCTGCCTGCGAGTCTCTGCTGTGCCGACCCTTCTCT 180 
I2Lgene_chr5      -------------------------------------CTCTGCTGTGCCGACCCTTCTCT 23 
EST_testis        ------------------------------------------------------------ 
 
I2                TCGCGGACCCCACGCCAAGCAGCGACCCTGAGCCGACAGCCGGAGCGCCCGGCAATGGCG 240 
I2Lgene_chr5      TCGCGGACCCCACGCCAAGCAGCGACCCTGAGGCGACAGCCGGAGCGCCCGGCAATGGCG 83 
EST_testis        ------------------------------------------------------------ 
                                                  * 
I2                GCCTCGACGGCCTCGCACCGGCCCATCAAGGGGATCTTGAAGAACAAGACCTCTACGACT 300 
I2Lgene_chr5      GCCTCGACGGCCTCCCACCGGCCCATCAAGGGGATCTTGAAGAACAAGACCTCTACGACT 143 
EST_testis        ------------------------------------------------------------ 
                    
I2                TCCTCTATGGTGGCGTCGGCCGAACAGCCCCGCGGGAATGTCGACGAGGAGCTGAGCAAA 360 
I2Lgene_chr5      TCCTCTATGGTGGCGTCGGCCGAACAGCCCCGCAGGAGTGTCGACGAGGAGCTGAGCAAA 203 
EST_testis        ------------------------------------------------------------ 
                                                   *   *  
I2                AAATCCCAGAAGTGGGATGAAATGAACATCTTGGCGACGTATCATCCAGCAGACAAAGAC 420 
I2Lgene_chr5      AAATCCCAGAAGTGGGATGAAATTAACATCTTGGCGACCTATCATCCAGCAGACAAAGGC 263 
EST_testis        ------------------------------------------------------------ 
                                         *                                  * 
I2                TATGGTTTAATGAAAATAGATGAACCAAGCACTCCTTACCATAGTATGATGGGGGATGAT 480 
I2Lgene_chr5      TATGGTTTAATGAAAATAGATGAACCAAGCCCTCCTTACCATAGTATGATGGGTGATGAT 323 
EST_testis        ------------------------------------------------------------ 
                                                *                      * 
I2                GAAGATGCCTGTAGTGACACCGAGGCCACTGAAGCCATGGCGCCAGACATCTTAGCCAGG 540 
I2Lgene_chr5      GAAGATGCGTGTAGGGACACCGAGACCACTGAAGCCATGGCGCCAGACATCCTAGCCAAG 383 
EST_testis        ------------------------------------------------------------ 
                          *               *                          *      * 
I2                AAATTAGCTGCAGCTGAAGGCTTGGAGCCAAAGTATCGGATTCAGGAACAAGAAAGCAGT 600 
I2Lgene_chr5      AAATTAGCTGCTGCTGAAGGCTTGGAGCCAAAGTACCGGATTCAGGAACAAGAAAGCAGT 443 
EST_testis        ----------GGGCTGAAGGCTTGGAGCCAAAGTACCGGATTCAGGAACAAGAAAGCAGT 50 
                              *********************** ************************ 
                                                     *  
I2                GGAGAGGAGGATAGTGACCTCTCACCTGAAGAACGAGAAAAAAAGCGACAATTTGAAATG 660 
I2Lgene_chr5      GGAGAGGAGGATAGTGACCTCTCACCTGAAGAACGAGAAAAAAAGCGACAATTTGAAATG 503 
EST_testis        GGAGAGGAGGATAGTGACCTCTCACCTGAAGAACGAGAAAAAAAGCGACAATTTGAAATG 110 
                  ************************************************************ 
 
I2                AAAAGGAAGCTTCACTACAATGAAGGACTCAATATCAAACTAGCCAGACAATTAATTTCA 720 
I2Lgene_chr5      AGAAGGAAGCTTCACTACAATGAAGGACTCAATATCAAACTAGCCAGACAATTAATTTCA 563 
EST_testis        AGAAGGAAGCTTCACTACAATGAAGGACTCAATATCAAACTAGCCAGACAATTAATTTCA 170 
                  * ********************************************************** 
                   *  
I2                AAAGACCTACATGATGATGATGAAGATGAAGAAATGTTAGAGACTGCAGATGGAGAAAGC 780 
I2Lgene_chr5      AAAGACCTACATGATGATGATGAAGATGAAGAAATGTTAGAGACTGCAGATGGAGAAAGC 623 
EST_testis        AAAGACCTACATGATGATGGTGAAGATGAAGAAATGTTAGAGACTGCAGATGGAGAAAGC 230 
                  ******************* **************************************** 
 
I2                ATGAATACGGAAGAATCAAATCAAGGATCTACTCCAAGTGACCAACAGCAAAACAAATTA 840 
I2Lgene_chr5      ATGAATACGGAAGAATCAAATCAAGGATCTACTCCAAGTGACCAACAGCAAAACAAATTA 683 
EST_testis        ATGAATACGGAAGAATCAAATCAAGGATCTACTCCAAGTGACCAACAGCAAAACAAATTA 290 
                  ************************************************************ 
 
I2                CGAAGTTCATAGACGAGATTTGTTCAACACTGCAATTGTTTGTTAGATGTAAACCCTGTG 900 
I2Lgene_chr5      CGAAGTTCATAGAAGAGATTTGTTCAACACTGCAATTGTTTGTTAGATATAAACCCTGTG 743 
EST_testis        CGAAGTTCATAGAAGAGATTTGTTCAACACTGCAATTGTTTGTTAGATATAAACCCTGTG 350 
                  ************* ********************************** *********** 
                               *                                  * 
I2                ACTATAGTACGTTGCTTCTTGTTCTTCACAATTCATGACTTAAGTACCAAAATGCATACC 960 
I2Lgene_chr5      ACTATAATACATTGCTTCTTGTTCTCCACAATTCATGACTTAAGTACCAAAATGCATACC 803 
EST_testis        ACTATAATACATTGCTTCTTGTTCTCCACAATTCATGACTTAAGTACCAAAATGCATACC 410 
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                  ****** *** ************** ********************************** 
                        *   *              *  
I2                AGTTATTATATATTGCCAAGAATTAAATGATAAACTTAGAGACTGATTAGACTGAAAATG 1020 
I2Lgene_chr5      AGTTATTATATATTGCCAAGAATTAAATGATAAACTTAGAGACTAATTAGACTGAAAATG 863 
EST_testis        AGTTATTATATATTGCCAAGAATTAAATGATAAACTTAGAGACTAATTAGACTGAAAATG 470 
                  ******************************************** *************** 
                                                              *           
I2                CCTAATCGATATATATATTCTTGTGCCTAGTACTTTACCACAAATACAGTGTAATATCAT 1080 
I2Lgene_chr5      CCTAATTGATATATATATTCTTATGCCTAGTACTTTACCACAAATACAGTGTAATATCAT 923 
EST_testis        CCTAATTGATATATATATTCTTATGCCTAGTACTTTACCACAAATACAGTGTAATATCAT 530 
                  ****** *************** ************************************* 
                        *               *  
I2                CAGTCCAAAACTGCATTACTTTTGTAAAAACACTGGTTAATTTGTATAAGATATTATAGA 1140 
I2Lgene_chr5      CAGTCCAAAACTGCATTACTTTCATAAGAACACTGGTTAATTTGTATAAGATATTATAGA 983 
EST_testis        CAGTCCAAAACTGCATTACTTTCATAAGAACACTGGCTAATTTGTATAAAATATTATAGA 590 
                  **********************  *** ******** ************ ********** 
                                        **                           
I2                GCTTTTTATGCTTTAGAAGTTAAACAATATCTTTGGGGGGGAACTAATTTATTTTCATCA 1200 
I2Lgene_chr5      GCTTTTTATGCTTTAGAAGTTAAGCAATATCTTTGGGGGGGAACTAATTTATTTTCATCA 1043 
EST_testis        GCTTTTTATGCTTTAGAAGTTAAGCAATATCTTTGGGGGGGAACTAATTTATTTTCATCA 650 
                  *********************** ************************************ 
                                         *  
I2                CTTGAAATGTGGTAGCTCTTACAAAGTTTATTG-ATTTGATTTTTTTAAAAA-TCAAAAG 1258 
I2Lgene_chr5      CTCGAAATGTGGTAGCTCTTACAAAGTTTGTTG-ATTTG-TTTTTTTAAAAA-TCAAAAG 1100 
EST_testis        CTCGAAATGTGGGAGCTCTTACCAAGTTTGGTGGATTTGGTTTTTTTAAAAAATCAAAAG 710 
                  ** ********* ********* ******  ** ***** ************ ******* 
                    *                          * 
I2                CCAATT-GAACAAC--AGGATATAT---AGACTGATAAATATTTAGGCTGAATAGTATTT 1312 
I2Lgene_chr5      CCAGTT-GAACAAC--AGGATATAT---AGACTTATAAATATTCAAGCTGAATCGTATTT 1154 
EST_testis        CCAGTTTGAACCACCAGGGATATATTAGAACCTTATAAA-ATATTTCCAGGCCTGAAATC 769 
                  *** ** **** **   ********   *  ** ***** **     * *    * * *  
                     * 
I2                TAACACTTGTCTTCAACTTGATTTGTCTGTTTAATTGAAAAGAATTATAAGAGTTACTGT 1372 
I2Lgene_chr5      TAACACTTCTCTTCAACTTGATTTGTCTGTTTAATTGAAAAGAATTGTAAGAGTTACTGT 1214 
EST_testis        CGATATTTTATAACACCTT--TCTTCCTTTCAAACTCT--GGAATTTGGCGCCTGGGTTC 825 
                    * * **     ** ***  * *  ** *  ** *     *****    *  *   *   
 
I2                TGCATTTTCTGACCTACTATTTTTAAAATTCCTGTTGAGTTTCTTTGTGTTTACAAGGAA 1432 
I2Lgene_chr5      TGCATTTTCTGACCTACTACCTTTAAAATTCCTGTTGAGTTTCTTTGTGTTTACAAGGAA 1274 
EST_testis        TAAAATTGGGAAAAC--------------------------------------------- 840 
                  *  * **    *                                                 
                    *                                                         
Figure III.1B. A human testis EST of I2L. ClustalW alignment of I2 (NM_006241) with the I2L 
gene sequence (NC000005) and a human testis EST sequence (BU854595). The second line * correspond to 
mismatches between I2 and I2L. The two-sequence alignment at the 3’-end is omitted. The initiation and stop 
codons are in bold. The alignment scores are indicated on top. 
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SeqA Name                        Len(aa)  SeqB Name                       Len(aa) Score
1    I2_Human                    205      2    I2L_Human                   205      95 
1    I2_Human                    205      3    I2L_Pan_Troglodytes_Pred    205      94 
1    I2_Human                    205      4    I2L_Pigtailed_macaque_EST   150      95 
2    I2L_Human                   205      3    I2L_Pan_Troglodytes_Pred    205      97 
2    I2L_Human                   205      4    I2L_Pigtailed_macaque_EST   150      94 
3    I2L_Pan_Troglodytes_Pred    205      4    I2L_Pigtailed_macaque_EST   150      92 
I2_Human                   MAASTASHRPIKGILKNKTSTTSSMVASAEQPRGNVDEELSKKSQKWDEM 50 
I2L_Human_chr5             MAASTASHRPIKGILKNKTSTTSSMVASAEQPRRSVDEELSKKSQKWDEI 50 
I2L_Pan_Troglodytes        MAASTASHRPIKGILKNKTSTTSSMVAWAEQPRGSVDEELSKKSQKWDEI 50 
I2L_Pigtailed_macaque      MAASTASHRPIKGILKNKTSTTSSMVASAEQPRGSVDEELSKKSQKWDEM 50 
                           *************************** *****  ************** 
                                                             *              *     
I2_Human                   NILATYHPADKDYGLMKIDEPSTPYHSMMGDDEDACSDTEATEAMAPDIL 100 
I2L_Human_chr5             NILATYHPADKGYGLMKIDEPSPPYHSMMGDDEDACRDTETTEAMAPDIL 100 
I2L_Pan_Troglodytes        NILATYHPADKGYGLMKIDEPSAPYHSMMGDDEDACRDTETTEAMAPDIL 100 
I2L_Pigtailed_macaque      NILATYHPADKDYGLMKIDEPSPPYHSMMGDDEDACSDTETTEAMAPDIL 100 
                           *********** ********** ************* *** ********* 
                                      *                            * 
I2_Human                   ARKLAAAEGLEPKYRIQEQESSGEEDSDLSPEEREKKRQFEMKRKLHYNE 150 
I2L_Human_chr5             AKKLAAAEGLEPKYRIQEQESSGEEDSDLSPEEREKKRQFEMRRKLHYNE 150 
I2L_Pan_Troglodytes        AKKLAAAEGLEPKYRIQEQESRGEEDSDLSPEEREKKRQFEMRRKLHYNE 150 
I2L_Pigtailed_macaque      ANKLAAAEGLEPKYRIQEQESSGEEDSDLSPEEREKKLLFEMKRKLHYYE 150 
                           * ******************* ***************  *** ***** * 
                            *                                                
I2_Human                   GLNIKLARQLISKDLHDDDEDEEMLETADGESMNTEESNQGSTPSDQQQN 200 
I2L_Human_chr5             GLNIKLARQLISKDLHDDDEDEEMLETADGESMNTEESNQGSTPSDQQQN 200 
I2L_Pan_Troglodytes        GLNIKLARQLISKDLHDDDEDEEMLETADGESMNTEESNQGSTPSDQQQN 200 
I2L_Pigtailed_macaque      -------------------------------------------------- 
                                             
I2_Human                   KLRSS 205 
I2L_Human_chr5             KLRSS 205 
I2L_Pan_Troglodytes        KLRSP 205 
I2L_Pigtailed_macaque      ----- 
Figure III.1C. Amino acid sequence comparison between human I2 and human and 
primate I2L. ClustalW alignment of human I2 (NP_006232), human I2L (Q6NXS1), Pan troglodytes I2L 
(XP_001134994) and translated Pigtailed macaque testis EST (nucleotide: DY743031). The second line * 
corresponds to mismatches between I2 and I2L. The known I2 phosphorylatable Thr and Ser and their I2L 
substitutions are in bold. The alignment scores are indicated on top. 
 
 
 
 
Table III.1. Characteristic gene and primary protein sequence differences between I2 
and I2L 
I2 I2L 
Chr3 Chr5 
5 exons 1 exon 
Thr73 (GSK3 site) Pro73 
Ser87 (CKII site) Arg87 
4 putative CKII sites 5 putative CKII sites 
No PKC sites 3 putative PKC sites 
No PKA sites 2 putative PKA sites 
 
 
Characterization of Two Novel PP1 Regulators: I2L and Nek2C                                                       Chapter III 
_______________________________________________________________________________________ 
96                                                                                                                                     Centre for Cell Biology 
University of Aveiro 
 
Overlay
PP1γ1
I2     I2L
Overlay
PP1γ2
I2    I2L
37
29
PP1α
I2L
PP1γ1
PP1γ2
PP1γ2end
III.3.2 I2L AND I2 INTERACT SIMILARLY WITH THE VARIOUS PP1 
ISOFORMs 
 
I2L interaction in vitro with the different PP1 isoforms was confirmed using several 
techniques. The sequential co-transformation of yeast, confirmed the interaction of I2L 
with PP1α, PP1γ1, PP1γ2 and the unique C-terminal sequence of PP1γ2 (Fig. III.2A). In 
order to compare the binding of I2 and I2L to the two known PP1γ isoforms, a blot overlay 
analysis was performed. An immunoblot containing the same amount of I2 and His-I2L 
was incubated either with PP1γ1 or PP1γ2, and the interaction detected using PP1 isoform 
-pecific antibodies (Fig. III.2B). The binding of I2L by both PP1 isoforms was confirmed 
and did not appear to differ significantly in relation I2. 
 
 
A) B) 
Figure III.2. Interaction of I2L with different PP1 isoforms. A) Sequential transformation of 
yeast AH109 with bait plasmid (either pAS2-PP1α, pAS2-PP1γ1, pAS2-PP1γ2 or pAS2-PP1γ2end) and the 
prey plasmid (pACT2-I2L). PP1γ2end is the unique C-terminal tail of PP1γ2 produced by alternative splicing 
of the PP1γ gene. B) Overlay immunoblot detection of I2 and His-I2L with PP1γ1 and PP1γ2. I2 (inhibitor 2) 
and I2L (His-tagged recombinant I2L) were separated by SDS-PAGE, transferred to nitrocellulose and 
overlaid with recombinant PP1γ1 or PP1γ2, as indicated. Immunoblotting was performed with the respective 
specific antibodies. 
 
 
 
Since I2 is a potent inhibitor of PP1, we decided to determine if I2L also exhibited 
PP1 inhibitory activity, and if so, how its potency compared to that of I2. The IC50 values 
of I2L and I2 for both recombinants His-tagged PP1γ isoforms were determined using the 
phosphorylase phosphatase assay. The results presented in Table III.2 indicate that 
recombinant His-I2L is also a potent PP1 inhibitor, similar to I2, exhibiting IC50 values in 
the subnanomolar range. 
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Table III.2. Comparison of PP1γ isoform inhibition by I2 and I2L 
 IC50 (nM)a 
Isoform I2 His-I2L 
His-PP1γ1 0.141 nM 0.73 ± 0.10 
His-PP1γ2 0.145 nM 0.09 ± 0.08 
a The values are expressed as the mean ± S.E.M. of at least three independent experiments. 
 
 
 
III.3.3 I2L SUBCELLULAR DISTRIBUTION 
 
In order to investigate its cellular distribution, I2L was fused on the N-terminal side 
of GFP and resulting expression vector was transfected into different mammalian cell lines 
(HeLa and COS-7 cells). After allowing sufficient time for the recombinant fusion I2L-
GFP protein to be expressed, the cells were fixed and the nucleus was stained with DAPI 
(Fig. III.3). I2L-GFP appears to be relatively enriched in the nucleus of human HeLa cells, 
but excluded from the nucleolus. Similar results were obtained with monkey COS-7 cells 
(data not shown). 
 
 
 
Figure III.3. I2L localization in HeLa 
cells. HeLa cells were transfected with I2L-
GFP and the green fluorescence resulting 
from GFP was visualized in an 
epifluorescence microscope. DAPI was used 
to stain the nucleus. 
 
 
 
 
 
 
 
 
 
 
20 μm
GFP-I2L DAPI
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III.3.4 COMPARISON OF I2 AND I2L PHOSPHORYLATION BY GSK3 
 
The absence from I2L of the important I2 regulatory GSK3 phosphorylation site 
(Thr73) and CKII phosphorylation site (Ser87), led us to investigate the phosphorylation of 
both proteins by those kinases. Both I2 and I2L were incubated with GSK3 or CKII (or 
both), in the presence of radioactive-labeled ATP. I2 is known to be a poor in vitro 
substrate for GSK3, but if phosphorylated previously by CKII, synergistic phosphorylation 
by GSK3 can be elicited (Park et al., 1994). In our hands this was also observed (Fig. III.4). 
However, under the exact same conditions, GSK3 did not phosphorylate I2L and the 
synergistic effect produced by the previous phosphorylation with CKII was also not 
observed (Fig. III.4). The same experiments were also performed following pre-incubation 
of I2 and I2L with either PP1γ1 or PP1γ2. This resulted in a significant decrease in the 
level of phosphorylation of I2 by GSK3 and by both kinases compared to CKII alone. In 
contrast, the phosphorylation of I2L was unaffected by the pre-incubation with either PP1 
isoform. 
 
 
Figure III.4. Comparison of I2 and I2L phosphorylation by GSK3 and CKII. 
Recombinant I2 and I2L were incubated in kinase buffer with radioactive ATP (0); or in the presence of 
GSK3β kinase (G); or CKII kinase (C); or both kinases (G/C), for 90min at 30ºC. Protein phosphorylation 
was detected by autoradiography (32P) following SDS-PAGE. Immunoreactivity detected with a specific anti-
I2 antibody is shown for comparative purposes. The same experiment was repeated with a 10min pre-
incubation of I2 and I2L with either PP1γ1 or PP1γ2. 
 
 
 
III.3.5 PHOSPHORYLATION OF ENDOGENOUS I2/I2L PRESENT IN 
HUMAN SPERM 
 
Immunoblot analysis of human sperm heat extract (HSI2) revealed two bands 
migrating above both I2 and I2L (Fig. III.5A). In order to investigate the nature of the 
observed relatively slow mobility of the endogenous proteins in comparison to their 
I2                              I2L                 I2-PP1γ I2L-PP1γ
0    G    C   G/C          0    G    C  G/C        0   G    C  G/C          0    G    C   G/C
Anti-I2
32P
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29
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recombinant counterparts, human sperm heat extract was separated by two-dimensional 
electrophoresis and transferred to nitrocellulose. Immunoblot analysis revealed three 
isolated spots of different apparent molecular mass and pI (Fig. III.5B), suggesting the 
possible occurrence of different phosphorylated forms of I2 and/or I2L in human sperm. 
 
 
A) B) 
Figure III.5. Immunoblot analysis of endogenous I2/I2L from human sperm. A) 
Comparison of endogenous human sperm I2/I2L with recombinant I2 and I2L using an anti-I2 antibody. 
HSI2, Heat stable human sperm extract; I2L, Heat stable E. coli extract of recombinant I2L; I2, Purified 
recombinant I2. B) Anti-I2 immunoblot of 2D separation of heat stable human sperm extract. Left panel, 
Heat stable human sperm extract; Right panel, Heat stable human sperm extract supplemented with purified 
recombinant I2. 
 
 
 
Besides the well known threonine and serine phosphorylation sites, I2 can also be 
phosphorylated tyrosine (Williams et al., 1995). Thus, in order to investigate whether the 
abnormal relative mobility of endogenous I2/I2L might be attributable to phosphorylation, 
we attempted to dephosphorylate the human sperm heat extract protein with a variety of 
phosphatases : protein tyrosine phosphatase 1B (PTP), calf intestinal phosphatase (CIP) 
and PP1γ1 (Fig. III.6). Under the conditions used, only CIP, an unspecific phosphatase, 
yielded significant dephosphorylation of HSI2, as judged by the observed increase in 
electrophoretic mobility. However, the observed mobility was still significantly slower 
than that of recombinant dephosphorylated I2 (Fig. III.6A). When HSI2 was incubated 
with GSK3 or CKII (or both), only GSK3 was able to induce a mobility shift, which was 
abolished by pre-incubation of HSI2 with purified recombinant PP1γ (Fig. III.6B). 
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Figure III.6. Comparison of dephosphorylation and phosphorylation of endogenous 
human sperm I2/I2L. A) HSI2 was incubated in the presence of different phosphatases, in the 
respective buffers at 30ºC for 3h. 0, no phosphatase control; PTP, incubation with Protein Tyrosine 
Phosphatase 1B; CIP, incubation with Calf Intestinal Phosphatase; PP1, incubation with Protein Phosphatase 
1γ1. B) HSI2 was incubated in the presence of GSK3 (G) or CKII (C), or both (G/C), as previously described. 
Resulting changes in protein migration, probably reflecting alterations in phosphorylation, were detected by 
immunoblot analysis using an anti-I2 antibody. 
 
 
 
III.3.6 INTERACTION OF HUMAN SPERM ENDOGENOUS I2/I2L 
WITH PP1  
 
An inhibitor-2 like activity can be measured and was reported to exist in 
mammalian sperm (Smith et al., 1996; Vijayaraghavan et al., 1996). Interestingly, human 
sperm PP1γ2 co-immunoprecipitates endogenous I2/I2L proteins that co-migrate with the 
two abnormally migrating species described above (Fig. III.7A). In addition, a third faster 
migrating species was also detected, although further work will be required to assess 
whether it may be the result of proteolytic degradation. Our results indicate that 
irrespective of their nature, all endogenous I2/I2L proteins bind and therefore probably 
regulate human sperm PP1γ2 (Fig. III.7A). Here we also demonstrate by 
immunocytochemistry the co-localization of I2/I2L with PP1γ2 in human sperm (Fig. 
III.7B). Like PP1γ2, I2/I2L was also detected in the sperm neck and tail, suggesting a 
potential regulatory role in the control of sperm motility. 
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37
29
HSI2     IP-PP1γ2 
Figure III.7. Interaction of I2/I2L with PP1 in human sperm. A) HSI2, Heat stable 
human sperm extract; IP-PP1γ2, Anti-I2 immunoblot of the anti-PP1γ2 immunoprecipitate from human 
sperm. B. Co-localization of I2/I2L and PP1γ2 in human spermatozoa using anti-I2 and anti-PP1γ2 
antibodies, and specific secondary antibodies conjugated with FITC and Texas Red, respectively. DAPI 
was used to stain the nucleus. 
PHC DAPI I2/I2L PP1γ2 Merge 
A) 
B) 
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III.4 DISCUSSION 
 
I2 and I1 were the first PP1 inhibitory regulators to be discovered (Huang and 
Glinsmann, 1976a). Here, we report the finding of a novel isoform of I2, which we termed 
I2L, corresponding to one of the nine Genbank entries identified as processed pseudogenes 
of I2 (Ceulemans et al., 2002). Processed pseudogenes (retropseudogenes) are sequences 
present in the genome similar to functional genes that resulted from the process of reverse 
transcription of mRNA transcript followed by integration into genomic DNA, presumably 
in the germ line (Maestre et al., 1995). Retropseudogenes are characterized by a complete 
lack of introns, functional promoters and other regulatory elements, thus commonly being 
thought to be nonfunctional gene copies (Mighell et al., 2000). Due to the release of 
selection pressure, over time, retropseudogenes accumulate deleterious mutations (stop 
codons or frameshifts) that will disrupt their ORF. Analysis of human genome 
retropseudogenes sequences showed that there was a burst of retroposition during the 
primate lineage and that approximately 18% were “intact”, i.e. had no deleterious 
mutations in their ORF (Marques et al., 2005). Searching genomes database, we found I2L 
type sequences to occur solely in primate and human genomes, placing its origin at the 
above mentioned burst of retroposition in primates. Moreover, the I2L gene contains the 
complete ORF and is 95% similar to its parental gene, both at the nucleotide and protein 
level, suggesting a high functional constraint by natural selection. In addition to a few 
examples that started to emerge, recent studies have shown that a significant amount of 
retropseudogenes are expressed and have functional roles (retrogenes) (Marques et al., 
2005; Vinckenbosch et al., 2006). Interestingly, when the expression patterns of retrogenes 
were experimentally determined, they were found to be expressed predominantly or 
exclusively in testis, whereas the parents genes are all expressed ubiquitously (Marques et 
al., 2005). A broader study found that the proportion of testis ESTs that mapped to 
retrogenes is over twice that of multiexon genes, supporting the notion that retrogenes 
emerge “out of the testis” (Vinckenbosch et al., 2006). Our data suggest that I2L is another 
such example, as we found an additional I2L transcript in the database (clone IMAGE in 
Fig. III.1A)  following the identification of our cDNA isolate (clone 48), both originating 
from testis libraries, as well as an I2L testis EST (Fig. III.1B). I2L appears to be under the 
same low level of transcription tendency with high incidence in the testis of young 
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transcribed retrogenes that are absent from the mouse genome, in contrast to the high 
number of ESTs and lower testis transcription of older transcribed retrogenes that have an 
ortholog in the mouse (Vinckenbosch et al., 2006). These facts can be explained by the 
initial facilitated transcription of retrogenes in the testis enabling them to obtain a 
functional role in this tissue, which is known to evolve rapidly (Swanson and Vacquier, 
2002). Although we could not find a TATA box or a promoter enhancer in the immediate 
5’ vicinity of the I2L start codon, further analysis and more distant scanning will be 
required to assess this question. However, retrogene transcription is often driven by nearby 
genes, one of the mechanisms being the insertion into chromosomal domains that favour 
transcription through long-range regulatory sequences (Spitz et al., 2005; Vinckenbosch et 
al., 2006). Both I2L transcripts identified (ours and the database) possess poly(A) tails but 
inserted at different sites each apparently having used different polyadenylylation signals 
(Fig. III.1A). ATTAAA for clone 48 and possibly AATATT for the Genbank clone. Both 
are slightly atypical variants of the canonical AATAAA poly(A) signal, which usually are 
associated with tissue-specific polyadenylation (Zhao et al., 1999). Interestingly, 
AATTAAA is the most frequent variant of the typical poly(A) signal and is highly used in 
germ cell transcripts (Wallace et al., 1999; Zhao et al., 1999). 
As I2L is highly similar to I2 and with mostly single aminoacid substitutions, the 
available techniques for protein differentiation are very restricted. However, due to the 
Ser87 substitution for an arginine, in future work should be possible to identify I2L 
specific trypsin digested peptides from human sperm samples through mass spectrometry. 
Not surprisingly, I2L retains the characteristic I2 interaction with PP1, as evaluated 
through binding and phosphatise inhibition assays (Fig. III.2 and Table III.2). This is due 
to the high degree of sequence conservation observed over the three well characterized I2 
interaction regions with PP1 (Fig. III.1C): 11IKGILKN14, the main motif responsible for 
the PP1 inhibitory activity of I2; 43KSQKW47, that binds to the RVxF PP1 groove; and 
residues 147-169, which bind to the PP1 active site and occupy the hydrophobic substrate 
binding groove (Hurley et al., 2007). 
I2 contains both a putative nuclear localization signal (137KKRQFEMKRK147) and a 
sequence resembling a leucine-rich nuclear export signal (155LNIKLARQLI165), and it can 
differentially localize to the cytoplasm or nucleus in different phases of the cell cycle of 
human HS68 fibroblast cells (Kakinoki et al., 1997). I2L exhibits a conserved substitution 
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of Lys145 for Arg, that therefore does not affect significantly the putative nuclear 
localization signal of I2L. Indeed, the functionality of this signal appears to be confirmed 
since I2L-GFP was observed to be relatively enriched in the nucleus of transfected cell 
lines (Fig. III.3). During mitosis, I2 has been reported to be localized in the centrosome 
and to be highly phosphorylated at Thr73 (Leach et al., 2003), suggesting that reversible 
phosphorylation of I2 may control centrosome-associated PP1 activity. As I2L is missing 
the important regulatory Thr73, it can not be phosphorylated at this site like I2 and it 
remains to be seen how this affects its localization in centrosomes during mitosis. Indeed, 
the most significant difference between I2L and I2 is the absence of the phosphorylatable 
residues Thr73 and Ser87, as these are the main players in the regulation of the PP1-I2 
complex. We found that, as expected and contrary to I2, I2L is not phosphorylated by 
GSK3. Further, although I2L is phosphorylated by CKII, no synergistic effect was 
observed in the presence of the two kinases (Fig. III.4), as is characteristic for I2. Although 
I2L contains two different putative CKII sites from I2 (Table III.1), our results indicate 
therefore that those can not functionally substitute the missing Ser87. Pre-incubation of I2 
with PP1 either prevents the phosphorylation by GSK3 or, more likely, dephosphorylates 
Thr73 (Fig. III.4). Thus, under the same conditions, I2L phosphorylation is not affected by 
the presence of PP1. This in vitro result does not represent clearly the in vivo dynamic 
process of phosphorylation/dephosphorylation in the complex GSK3/I2/PP1, but suggests 
that PP1 can affect it own regulation by I2, through the Thr73, but not the regulation by 
I2L. 
The 1D and 2D immunoblot analysis of human sperm samples suggested that 
endogenous I2/I2L may occur in different phosphorylated forms (Fig. III.5). However, in 
vitro assays of dephosphorylation of human sperm I2/I2L by several phosphatases and of 
phosphorylation by GSK3 and CKII suggested that PP1 does not dephosphorylate the 
human sperm I2/I2L and that GSK3, but not CKII, is capable of phosphorylating it (Fig. 
III.6). Thus, the results obtained are consistent with the occurrence of I2 protein in human 
sperm, but did not allow us to reach any conclusions regarding the occurrence or not of the 
I2L protein. 
Through immunoprecipitation and immunocytochemistry we showed that human 
sperm PP1γ2 interacts endogenously with I2/I2L and that they co-localize in the sperm tail 
(Fig. III.7), consistent with a regulatory role for PP1γ2 and I2/I2L in the control of sperm 
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motility. Indeed, since sperm are terminally differentiated cells essentially devoid of 
transcriptional and translational activity, the PP1 driven endogenous regulation of protein 
phosphorylation and sperm motility could represent an important mechanism for 
physiological regulation of a cell that encounters dramatically different environments as it 
journeys through the seminiferous tubules and the female reproductive tract. The absence 
from I2L of the most important regulatory residues of I2 must have consequences on the 
regulation of PP1 and ultimately on the acquisition of sperm motility. Apparently, I2-L 
represents a constitutive inhibitor of PP1 that is independent of GSK3 phosphorylation. 
However, further work will be required to determine whether I2L may be subject to an 
alternative regulatory mechanism. Indeed, since I2L has putative PKA phosphorylation 
sites not present in I2 may represent such an alternative regulatory mechanism. PKA is 
known to have an important role in mammalian sperm capacitation and hyperactivation of 
sperm motility in the female reproductive tract by regulating downstream tyrosine 
phosphorylation events (Burton and McKnight, 2007). Nevertheless, by regulating I2L it 
would also be regulating the effect of PP1 in human sperm hyperactivation motility (Si and 
Okuno, 1999). It is interesting to speculate that PP1γ2 inhibition by I2L may represent an 
irreversible, unidirectional event, essentially paralleling the acquisition of motility as 
human sperm travel through the epidydimis. 
The notion that newly emerged retrogenes may evolve new functional roles through 
adaptive evolution of encoded proteins and/or by developing new spatial or temporal 
expression patterns, leads us to suggest that I2L expression in testis favours human sperm 
motility and enhances the chances for successful reproduction. 
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IV ALTERNATIVE SPLICING CONTROLS NUCLEAR 
TRANSLOCATION OF THE CELL CYCLE 
REGULATED NEK2 KINASE 
 
IV.1 INTRODUCTION 
 
Cell division involves the replication and segregation of genetic material between 
daughter cells. During mitotic and the second meiotic division, duplicated sister 
chromatids are segregated, whereas during the first meiotic division homologous 
chromosomes are segregated. Mitosis and meiosis are both highly complex processes 
involving condensation of chromatin, breakdown of the nuclear envelope and 
reorganization of the microtubule cytoskeleton into a spindle capable of bipolar 
segregation. These events are known to be regulated, in large part, by cell cycle-dependent 
protein kinases, most notably members of the Cdk (cyclin-dependent kinase), Plk (polo-
like kinase), Aurora and Nek (NIMA-related kinase) families (Nigg, 2001). 
The Neks represent a comparatively large family (11 members in humans) of 
serine/threonine kinases that are related to the NIMA kinase of Aspergillus nidulans 
(O'Connell et al., 2003). NIMA was first identified in a screen for conditional loss-of-
function mutants that were unable to enter mitosis (Oakley and Morris, 1983). nimA 
mutants remain blocked in G2 despite activation of Cdk1 (Osmani et al., 1991a), while 
overexpression of wild-type NIMA drives cells into mitosis from any point in the cell cycle 
with premature condensation of chromosomes and spindle formation (Osmani et al., 1988). 
Interestingly, overexpression of Aspergillus NIMA in fission yeast, Xenopus oocytes and 
cultured human cells induces aspects of a premature mitosis, including condensation of 
chromosomes, suggesting that similar pathways may be conserved in higher eukaryotes 
(Lu and Hunter, 1995; O'Connell et al., 1994). More recently, it has been reported that 
NIMA activity is essential forphosphorylation of histone H3 thereby promoting chromatin 
condensation in Aspergillus (De Souza et al., 2000).  
So far, it remains unclear which, if any, of the human Neks represents the closest 
functional homologue of NIMA. Mitotic functions have been proposed for Nek2, Nek6, 
Nek7 and Nek9 (a.k.a. Nercc1) (Belham et al., 2003; Faragher and Fry, 2003; Roig et al., 
2002; Yin et al., 2003). Nek2 is the most closely related of the human proteins to NIMA 
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based on amino acid conservation within the N-terminal catalytic kinase domain (Fry, 
2002). However, depletion studies in human cells do not support an essential role for Nek2 
in mitotic entry (Fletcher et al., 2005). Rather there is strong evidence that, in mitotic cells, 
Nek2 contributes to centrosome separation, and perhaps reorganization of the microtubule 
network, at the G2/M transition (Faragher and Fry, 2003; Fry et al., 1998b; Rapley et al., 
2005). Nek2 may have additional roles in chromatin condensation, at least in meiotic cell 
division, as it has been shown to phosphorylate the chromatin associated protein, high 
mobility protein A2 (HMGA2), and be activated during the Erk1/p90Rsk2-stimulated 
condensation of chromatin in mouse pachytene spermatocytes  (Di Agostino et al., 2004b; 
Di Agostino et al., 2002).  
In human cultured cells, Nek2 is predominantly expressed as two alternative 
splice variants, Nek2A and Nek2B (Hames and Fry, 2002). These differ at their non-
catalytic carboxyl (C)-termini as a result of an alternative polyadenylation signal within 
intron 7 which prevents splicing to the terminal exon 8 in Nek2B. Nek2A therefore 
encodes a protein of 445 amino acids (48 kDa), while Nek2B encodes a protein of 384 
amino acids (44 kDa) with the sequence diverging after amino acid 370. Downstream of 
the kinase domain, both Nek2A and Nek2B share a leucine zipper motif (amino acids 304-
340) that promotes dimerization, autophosphorylation and activation of the kinase (Fry et 
al., 1999; Rellos et al., 2007). This is followed by a short motif (amino acids 333-370) 
shown to be required for centrosome targeting and microtubule binding (Hames et al., 
2005). However, the position of splicing means that a binding site for PP1 (protein 
phosphatase 1; amino acids 383-386), and two APC/C-dependent degradation motifs, a 
KEN box (amino acids 391-399) and an MR-tail (amino acids 444-445), are present in 
Nek2A, but missing from Nek2B (Hames et al., 2001; Hayes et al., 2006; Helps et al., 
2000). This falls in line with observations that Nek2A is degraded upon mitotic entry, 
whereas Nek2B remains stable. It also suggests that Nek2B may not be subject to 
regulation by PP1, although this hypothesis is complicated by the fact that Nek2A and 
Nek2B can heterodimerize via their leucine zippers, at least in vitro (Hames and Fry, 2002). 
Recently, a third splice variant of Nek2 was identified during a yeast two hybrid 
screen using PP1γ1 and PP1γ2 as baits (Fardilha et al., 2004b). This isoform is identical to 
Nek2A except that it lacks amino acids 371-378. This 8 amino acid deletion starts at the 
splice donor position of the Nek2ANek2B splice site but uses a downstream splice 
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acceptor sequence within exon 8. This variant was originally named Nek2A-T as it was 
isolated from testis mRNA. However, we prefer now to call it Nek2C because Nek2A is 
also expressed in the testis (Arama et al., 1998; Fardilha et al., 2004b; Rhee and 
Wolgemuth, 1997; Tanaka et al., 1997) while Nek2C is clearly not exclusively expressed 
in testis (see results). In this study, we investigated the properties of Nek2C in comparison 
to those of Nek2A and Nek2B. As one would predict from the position of the regulatory 
motifs described above, Nek2C is an active kinase that can undergo autophosphorylation, 
bind microtubules, localize to the centrosome and be degraded in early mitosis. However, 
upon overexpression, there is a significant increase in accumulation of Nek2C in the 
nucleus, as compared to Nek2A or Nek2B, and, through mutagenesis, we show that this is 
the result of the 8 amino acid deletion creating a strong nuclear localization sequence (NLS) 
in Nek2C, that is weaker in Nek2A and absent in Nek2B. We speculate that the nuclear 
accumulation of Nek2C may be essential to catalyze the phosphorylation of nuclear 
substrates that promote mitotic or meiotic entry. 
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IV.2 MATERIAL AND METHODS 
 
IV.2.1 PLASMID CONSTRUCTION 
 
 pCMV-mycNek2A, pCMV-mycNek2A-K37R and pCMV-mycNek2B have been 
previously described (Fry et al., 1998b; Hames and Fry, 2002). To generate 
pCMVmycNek2C, a C-terminal fragment was excised from pCMV-mycNek2A with 
BspEI and XbaI restriction enzymes and replaced with the corresponding fragment from 
pACT-Nek2C (Fardilha et al., 2004b). Since BspEI is blocked by overlapping dam 
methylation, dam- E. coli JM110 were used for transformation. Mutations were introduced 
using the Gene TailorTM Site-Directed Mutagenesis System (Invitrogen, Paisley, U.K.). 
The GST-PP1α and His-Nek2A-CTD bacterial expression constructs were generated by 
subcloning human PP1α from pBS-mycPP1α into the pGEX-4T1 vector, and amino acids 
255-445 of Nek2A into the pET22b vector, respectively. All constructs were confirmed by 
DNA sequencing by Lark Technologies, Inc. (Saffron Walden, U.K.). 
 
IV.2.2 CELL CULTURE, TRANSFECTION AND EXTRACTION  
  
 All media and additives were obtained from Invitrogen. Human cervical epithelia 
HeLa cells were cultured in Minimal Essential Media with 1% Non-Essential Amino Acids, 
10% heatinactivated Fetal Bovine Serum (FBS) and 1% antibiotic/antimycotic (AA) mix. 
Human osteosarcoma U2OS cells and human embryonic kidney cells, HEK 293, were 
cultured in Dulbecco’s Modified Eagle Medium (DMEM) with 10% FBS and 1% AA. 
Cells were cultured at 37ºC in a 5% CO2 atmosphere. Transient transfections were carried 
out using Lipofectamine 2000 (Invitrogen), according to the manufacturer’s instructions. 
Cell extracts were prepared as previously described (Fry and Nigg, 1997). 
 
IV.2.3 REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION 
(RT-PCR)   
 
Total RNA was isolated from cultured cells using TRI Reagent (Sigma, Poole, U.K.) 
according to manufacturer’s instructions. Extracted RNA (5 μg) was used for first strand 
Characterization of Two Novel PP1 Regulators: I2L and Nek2C                                                       Chapter IV 
_______________________________________________________________________________________ 
112                                                                                                                                   Centre for Cell Biology 
University of Aveiro 
 
synthesis using SuperScript II reverse transcriptase (Invitrogen) and oligo-(dT)20 at 50ºC 
for 60 mins. PCR amplification of Nek2A and Nek2C specific fragments of 153 bp and 
129 bp, respectively, was performed in a 50 μl reaction using Taq polymerase (Invitrogen), 
2 μl of first strand cDNA synthesis mixture as template and the following primers: 1077F: 
5’- GGAACGGAAGTTCCTGTC-3’ and 1229R: 5’-CACTTGGACTTA 
GATGTGA-3’. Amplified products were purified using a PCR purification kit (Qiagen 
Ltd., Crawley, U.K.), subcloned into a pBlueScript vector, linearized with SmaI, and 
sequenced. 
 
IV.2.4 IN VITRO TRANSLATION (IVT) 
   
Nek2, Rab4 and Lamin A proteins were generated by IVT from appropriate vectors 
using the TnT-coupled transcription/translation kit (Promega, Southampton, U.K.) 
according to manufacturer’s instructions. For radioactive detection of proteins, reactions 
were carried out in the presence of [35S]-methionine, separated by SDS-PAGE and exposed 
to X-ray film. 
 
IV.2.5 IMMUNOPRECIPITATION (IP)-KINASE ASSAYS   
 
For IP of proteins generated by IVT, 10 μl prewashed protein G-sepharose beads 
(Sigma) were added to 490 μl Neb buffer (Fry and Nigg, 1997) containing 9 μl non-
radioactive IVT reaction and mixed on a rotating wheel for 30 mins at 4ºC, before 
centrifugation at room temperature (RT) for 10 secs. The pre-cleared supernatant was 
transferred to a fresh tube, 1 μl mouse anti-myc monoclonal antibody (Cell Signaling 
Technology, Beverly, Mass.) was added and incubated on ice for 60 mins. Meanwhile, 40 
μl protein G-sepharose beads were blocked with 5 μl rabbit reticulocyte lysate in 500 μl 
Neb buffer on a rotating wheel for 30 mins. The blocked beads were centrifuged at RT for 
10 secs, the supernatant removed and the beads washed three times with 100 μl Neb buffer. 
The blocked beads were resuspended in 50 μl Neb buffer and added to the antibody-IVT 
mixtures. This bead slurry was placed on a rotating wheel for 60 mins at 4ºC, before 
centrifugation for 10 secs at RT. The supernatant was removed and the beads washed twice 
with 100 μl Neb buffer and finally resuspended in 100 μl Neb buffer. A 25 μl aliquot was 
transferred to a fresh tube for Western blot analysis of the efficiency of the IP. The 
Characterization of Two Novel PP1 Regulators: I2L and Nek2C                                                       Chapter IV 
________________________________________________________________________________________ 
Centre for Cell Biology                                                                                                                                     113 
University of Aveiro 
 
remaining 75 μl aliquot was spun down and the bead pellet used for kinase assays. For IP 
of cell lysates, essentially the same protocol was followed except that to pre-clear the 
extract, 50 μl pre-washed protein G-sepharose beads were added to 40 μl cell lysate diluted 
in 500 μl icecold Neb buffer, and then 30 μl protein Gsepharose beads were added to the 
antibodyextract mixtures. Immune complexes generated by IP were washed three times 
with 100 μl kinase assay buffer (Fry and Nigg, 1997). The beads were resuspended in a 
final volume of 50 μl kinase assay buffer (containing 32P-γ-ATP and β-casein), and 
incubated at 30ºC for 30 mins. The reaction was stopped by addition of 50 μl 2x Laemmli 
sample buffer. After separation by SDS-PAGE, the gel was stained with Coomassie 
Brilliant Blue, dried and exposed to X-ray film. 
 
IV.2.6 PP1 BINDING, DIMERIZATION AND MICROTUBULE BINDING 
ASSAYS  
 
 GST, GST-PP1α and His-Nek2A-CTD were expressed in BL21 E. coli and 
purified from bacterial lysates on glutathione-sepharose (GE Healthcare, Chalfont St. Giles, 
U.K.) or Ni2+-NTA agarose beads (Invitrogen) according to standard protocols. Purified 
proteins were then dialysed against PBS for storage at -800C. For pull-down assays, 
purified proteins were rebound to glutathione-sepharose or Ni2+-NTA agarose beads for 60 
mins followed by three washes with NETN buffer (100 mM NaCl, 1 mM EDTA, 20 mM 
Tris.HCl, pH 8, 0.5% Nonidet-P40). The His-Nek2A-CTD bead complexes were blocked 
by first washing three times with 0.5% Marvel in PBS and then incubating with rabbit 
reticulocyte lysate for 30 mins, before three washes in NETN buffer. Protein-bead 
complexes were then incubated with IVT reaction mixes for 60 mins, before washing three 
times in NETN buffer containing 450 mM NaCl. Bound proteins were analysed by SDS-
PAGE and autoradiography. Microtubule pull-down assays with proteins generated by IVT 
were performed as previously described (Hames et al., 2005). 
 
IV.2.7 DEGRADATION ASSAYS  
 
Preparation of Xenopus laevis CSF egg extracts, in vitro degradation assays and 
addition of MG132 were performed as previously described (Hames et al., 2001). 
Characterization of Two Novel PP1 Regulators: I2L and Nek2C                                                       Chapter IV 
_______________________________________________________________________________________ 
114                                                                                                                                   Centre for Cell Biology 
University of Aveiro 
 
Generation of S- and M-phase arrested U2OS cells was also as described (Hames et al., 
2001).  
 
IV.2.8 IMMUNOFLUORESCENCE MICROSCOPY  
 
 Cells grown on glass coverslips were fixed at -20ºC for 30 mins using 100% 
methanol (precooled at -20ºC). Antibody staining and epifluorescence microscopy was 
performed as previously described (Faragher and Fry, 2003; Hames et al., 2005). Primary 
antibodies used were rabbit anti-γ-tubulin (0.15 g/ml; Sigma), mouse anti-myc (1:2,000; 
Cell Signaling Technology), anti-PP1α antibodies (Amador et al., 2004), rabbit anti-Nek2 
(2 g/ml; Invitrogen) and mouse antiphospho- H3 (1:400; Cell Signaling Technology) and 
mouse anti-nucleophosmin (1:500; (Shu et al., 2005)). Secondary antibodies were Alexa 
488-conjugated goat anti-rabbit and Alexa 594-conjugated goat anti-mouse secondary 
antibodies (1 g/ml; Invitrogen). DNA was stained with 1 μg/ml DAPI (4,6-diamidino-2-
phenylindole) or 0.2 μg/ml Hoechst 33258 dye (Calbiochem, San Diego, Calif.), incubated 
together with the secondary antibody. Coverslips were mounted on slides in a drop of 
FluoroGuard anti-fade reagent (Bio-Rad, Hemel Hempstead, U.K.). Images were captured 
on Nikon TE300 or Olympus IX81 fluorescence microscopes. To score whether 
transfected cells had predominantly nuclear accumulation of recombinant protein, 
cytoplasmic accumulation or relatively equal distribution, pixel levels were measured in 
representative areas of the nucleus and cytoplasm using analySIS software. If these values 
were >10% different, then the cell was judged to have the protein predominantly in one 
compartment or the other. 
 
IV.2.9 NUCLEAR-CYTOPLASMIC FRACTIONATION   
 
Nuclear and cytoplasmic fractions of HeLa cells transfected with myc-tagged Nek2 
constructs was performed using the Nuclear/Cytosol Fractionation Kit (Cambridge 
BioScience Ltd., Cambridge, U.K.) according to manufacturer’s instructions. Western 
blots were performed as described (Faragher and Fry, 2003) using anti-myc (1:1,000; Cell 
Signaling Technology), anti-Lamin A/C (1:30; Chemicon, Chandlers Ford, U.K.) and anti-
γ-tubulin (1:3,000; Sigma) antibodies. 
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IV.2.10 KINASE SUBSTRATE TRACKING AND ELUCIDATION 
(KESTREL) ANALYSIS   
  
 HEK 293 cells were lysed in extraction buffer (EB; 50 mM Tris.HCl, pH 7.5, 5% 
glycerol, 1% Tritin X-100, 14 mM β-mercaptoethanol, 1 mM EDTA, 1 mM EGTA, 10 
g/ml leupeptin, 1 mM Pefabloc) and the nuclear fraction sedimented by centrifugation for 
20 min at 15,000×g. The nuclear pellet was incubated for 20 min with EB + 0.5 M NaCl 
and protein extracted by sedimenting insoluble material by centrifugation for 20 min at 
28,000×g. The supernatant was filtered, desalted on Sephadex G25 fine and 
chromatographed on heparin sepharose. Aliquots of the desalted extracts and eluted 
fractions were diluted 10-fold in 50 mM Tris.HCl, pH 7.5, 7.5 mM β-mercaptoethanol, 1 
mM EGTA, 10 g/ml leupeptin, 1 mM Pefabloc). These aliquots were incubated for 5 mins 
with 3 mM MnCl2, 2 KBq/ml [γ-32P]-ATP in the absence or presence of Nek2, Nek6, Nek7 
or Nek9 recombinant kinases (Invitrogen) and then separated by SDS-PAGE, transferred to 
polyvinylidene difluoride membrane and autoradiographed. 
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IV.3 RESULTS 
 
IV.3.1 EXPRESSION OF NEK2C IN HUMAN CELL LINES   
 
Three splice variants of the cell cycle-regulated Nek2 protein kinase have been 
described, Nek2A, Nek2B and Nek2C (originally called Nek2A-T; Fig. IV.1A). To 
confirm the expression of Nek2C, primers were designed for use in RT-PCR analysis that 
spanned the splice site and, when used on plasmids containing Nek2A and Nek2C cDNAs, 
amplified distinct bands of 153 bp and 129 bp, respectively (Fig. IV.1B). Using these 
primers, a major band of 153 bp, representing Nek2A, was amplified using mRNA isolated 
from HeLa, U2OS and HEK 293 human cell lines. However, a 129 bp band, at the 
expected size of Nek2C, was also reproducibly detected, although this was ~10-fold less 
abundant (Fig. IV.1B & C). To confirm the identity of this band, it was excised from the 
gel, re-amplified using the same primers, purified and subcloned into a pBlueScript vector. 
DNA sequencing confirmed that the 129 bp product contains the predicted sequence of 
Nek2C and lacks the 24 nucleotides present in Nek2A (Fig IV.1D). Hence, Nek2C is a 
bona fide splice variant whose expression can be detected, albeit consistently more weakly 
than Nek2A, in different human cell lines.  
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Figure IV.1. Expression of Nek2C in human cell lines  A. Schematic representation of the 
Nek2A, Nek2B and Nek2C proteins highlighting the positions of the catalytic domain (Kinase), leucine 
zipper motif (LZ), PP1 binding site, KEN-box and MR-tail. Amino acids numbers are indicated underneath. 
B. Agarose gel analysis of RT-PCR reactions performed on RNA extracted from cell lines or Nek2-
containing plasmids. No RNA (lane 1), HeLa mRNA (lane 2), U2OS mRNA (lane 3), pCMV-mycNek2A 
plasmid (lane 4) and pCMV-myc-Nek2C plasmid (lane 5). Position of the Nek2A (153 bp) and Nek2C (129 
bp) products are indicated. C. The 129 bp band from the HeLa RT-PCR reaction was excised and re-
amplified using the same primers (lane 1). RT-PCR reaction products from mRNA extracted from HEK 293 
cells were separated alongside for comparison (lane 2). D. Following subcloning into pBlueScript, the 129 bp 
product from HeLa cells was sequenced. The resulting chromatogram confirms the expected sequence for 
Nek2C. Nek2A has an additional 24 nucleotides inserted at the position indicated (arrow).  
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IV.3.2 NEK2C IS AN ACTIVE KINASE THAT BINDS PP1Α AND 
UNDERGOES DIMERIZATION   
 
Nek2C contains the complete catalytic kinase domain (Fig. 1A). It also contains the 
leucine zipper motif that is required for dimerization, and autophosphorylation, and the 
PP1 binding site (Fry et al., 1999; Helps et al., 2000). However, the 8 amino acid deletion 
removes two serine residues (S377 and S378) present in Nek2A that could act as sites for 
regulation (Fardilha et al., 2004b). First, to compare Nek2A and Nek2C kinase activity, 
full-length myc-tagged Nek2C, Nek2A and Nek2A-K37R (catalytically inactive mutant) 
proteins were either translated in vitro (data not shown) or expressed in HEK 293 cells by 
transient transfection (Fig. IV.2A). Nek2 proteins were then immunoprecipitated with anti-
myc antibodies and equal protein recovery confirmed by Western blotting with an anti-
Nek2 antibody. Kinase assays performed on the immune complexes revealed that 
Nek2AK37R was inactive as expected, whereas Nek2A and Nek2C were both capable of 
phosphorylating the control substrate β-casein to a similar extent (Fig. IV.2A, and data not 
shown). Equivalent levels of autophosphorylation of Nek2A and Nek2C were also detected.  
Second, to test PP1 binding, a GST-PP1α fusion protein was expressed in E. coli 
and used to pull-down in vitro translated proteins (Fig. IV.2B). Both Nek2A and Nek2C 
proteins bound GST-PP1α but not GST alone. In contrast, Nek2B, which lacks the PP1 
binding site, Nek2A-F386A, which has a mutation in the PP1 binding site, and Lamin A 
did not bind GST-PP1α. Third, to test dimerization, in vitro translated Nek2A, Nek2B, 
Nek2C and the control protein Rab4, were mixed with a His-tagged Nek2A C-terminal 
domain fusion protein that contains the entire non-catalytic domain including the leucine 
zipper motif. As predicted, all Nek isoforms, but not Rab4, were pulled down by nickel-
affinity chromatography (Fig. IV.2C). Hence, the 8 amino acid deletion in the non-catalytic 
domain does not interfere with the kinase activity, PP1 binding or dimerization of the 
Nek2C protein. 
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Figure IV.2. Nek2C is an active protein kinase that binds PP1α and undergoes 
dimerization  A. Myc-tagged Nek2A, Nek2C and Nek2A-K37R proteins were expressed in HEK 293 
cells. Following immunoprecipitation with an anti-myc antibody, an in vitro kinase assay was performed 
using 32P-γ-ATP and β-casein as substrates. Phosphorylated products were detected by SDS-PAGE and 
autoradiography (upper panel, 32P); the positions of β-casein and autophosphorylated Nek2 proteins are 
indicated. Equal levels of immunoprecipitated proteins were confirmed by Western blotting with an anti-
Nek2 antibody (lower panel, WB). B. 35S-labeled Nek2A, Nek2B, Nek2C, Nek2A-F386A and lamin A 
proteins were generated by in vitro translation (top panel) before binding with either GST-PP1α (middle 
panel) or GST alone (bottom panel). Proteins were analysed by SDS-PAGE and autoradiography. The 
position of the 45 kDa M.wt marker is indicated. C. 35S-labeled Nek2A, Nek2B, Nek2C and Rab4 proteins 
were  generated by in vitro translation (top panel) before binding to His-Nek2A-CTD (bottom panel). 
Proteins were analysed by SDS-PAGE and autoradiography. 
 
 
 
IV.3.3 NEK2C IS DEGRADED IN MITOTIC EGG EXTRACTS AND 
PROMETAPHASE-ARRESTED CELLS  
  
Total Nek2 exhibits cell cycle-dependent mRNA and protein expression with low 
levels in G1 and increased expression in S and G2 (Fry et al., 1995; Hayward et al., 2004). 
Ne
k2
A
Ne
k2
C
K3
7R
No
 D
NA
Nek2
β-casein
WB
32P
Nek2A Nek2B Nek2C Rab4
Input IVT
His-Nek2A-CTD
Pull-down
Ne
k2
A
Ne
k2
B
Ne
k2C
La
min
A
GST-PP1α
Pull-down
Input IVT
GST
Pull-down
45
45
45
Ne
k2
A-
F3
86
A
Characterization of Two Novel PP1 Regulators: I2L and Nek2C                                                       Chapter IV 
_______________________________________________________________________________________ 
120                                                                                                                                   Centre for Cell Biology 
University of Aveiro 
 
After mitotic entry, Nek2A is specifically targeted for proteasomal degradation as a result 
of APC/C-mediated ubiquitylation, whereas Nek2B remains stable as it lacks the 
degradation motifs present in the C terminus of Nek2A (Hames et al., 2001; Hayes et al., 
2006). These degradation motifs, a KEN-box and the C-terminal MR dipeptide, are present 
in Nek2C and we predicted that this isoform would also be degraded in mitosis. To test this 
we first generated Nek2A and Nek2C proteins by IVT and added them to mitotic extracts 
prepared from cytostatic factor-arrested Xenopus eggs. These extracts contain all the 
necessary machinery for APC/C-mediated ubiquitylation and proteasomal degradation 
(Murray, 1991). In untreated extracts, which represent metaphase II of meiosis, both 
proteins were slowly degraded, whereas upon addition of calcium, which releases the 
extracts into anaphase, both proteins were rapidly degraded (Fig. IV.3A & B). This 
degradation was proteasome-dependent as it was inhibited by MG132 (Fig. IV.3C). 
Moreover, both Nek2A and Nek2C were degraded in U2OS cells arrested with nocodazole 
in prometaphase of mitosis but not in S-phase arrested cells (Fig. IV.3D). Hence, Nek2C 
shows identical degradation kinetics to Nek2A both in vitro and in vivo and is most likely 
also an APC/C target. 
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Figure IV.3. Nek2C is degraded in mitotic egg extracts and mitotic cells  A. 35S-labeled 
Nek2A and Nek2C proteins were generated by in vitro translation and degradation assays performed in 
Xenopus CSF-arrested egg extracts without (-Ca2+) or with (+Ca2+) calcium. Samples were taken at the times 
indicated (min), separated by SDS-PAGE and exposed to autoradiography. B. The Xray films were analysed 
by densitometry and the amount of protein remaining at each timepoint was plotted. Open triangles, Nek2A –
Ca2+; open squares, Nek2C –Ca2+; solid triangles, Nek2A +Ca2+; solid squares, Nek2C +Ca2+. C. 
Degradation assays were carried out in cytostatic factor extracts +Ca2+ as described above in the absence (-
MG132) or presence (+MG132) of the proteasome inhibitor, MG132. D. Myc-tagged Nek2A and Nek2C 
proteins were transfected into U2OS cells before arresting the cells either in S-phase with hydroxyurea (S) or 
in M-phase with nocodazole (M) for 16 h. Cell extracts were analysed by Western blotting with myc and α-
tubulin antibodies, as indicated. 
 
 
 
IV.3.4 NEK2C CAN BIND MICROTUBULES AND LOCALIZE TO 
CENTROSOMES   
 
The C-terminal domain of Nek2 and specifically the region encompassing amino 
acids 333-370 is essential for the protein to interact with microtubules and localize to the 
centrosome (Hames et al., 2005). This region is present in Nek2C as well as Nek2A and 
Nek2B. Microtubule sedimentation assays confirmed that Nek2C could indeed bind to 
microtubules in vitro (Fig. IV.4A), whereas transfection revealed colocalization of myc-
tagged Nek2C with γ-tubulin at the centrosome (Fig. IV.4B). As has been previously 
described, Nek2 associates with proteins at the proximal ends of centrioles, whereas γ-
tubulin is distributed throughout the pericentriolar material, thus explaining why the two 
signals only partially overlap at high resolution. Previous localization of PP1 isoforms had 
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shown that PP1α and PP1γ1 are present at the centrosome in mitotic cells (Andreassen et 
al., 1998). Because Nek2C had been isolated in a yeast two hybrid screen with PP1γ as bait 
and Nek2C retains the PP1 binding site (KVHF386), we stained cells transfected with 
Nek2C with antibodies against PP1α. Again, we observed colocalization of the signals at 
interphase centrosomes (Fig. IV.4C). These centrosome localizations patterns were 
identical to those of Nek2A (Figs. IV.4B & C). Thus, as predicted from the known motifs, 
Nek2C can associate with microtubules and localize to the centrosome probably in a 
complex with PP1 
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Figure IV.4. Nek2C binds microtubules in vitro and associates with centrosomes in 
cells  A. Nek2A and Nek2C proteins were produced by in vitro translation in the presence of 35S-
methionine and analysed by SDS-PAGE and autoradiography either before (Input) or after sedimenting at 
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35,000 rpm in the absence (-MT) or presence (+MT) of taxol-stabilized microtubules. Pellet (P) and 
supernatant (S) fractions were analysed. The Coomassie Blue-stained gel (CB) is also shown indicating the 
presence of tubulin in the pellet fraction in the presence of microtubules. B & C. Immunofluorescence 
microscopy of U2OS cells transfected with myc-tagged Nek2A or Nek2C and stained with anti-myc (red) 
and either anti-γ-tubulin (B) or anti-PP1α (C) antibodies (green). Merged images are shown and centrosomes 
indicated with arrowheads; enlargements of the centrosomes are also included. Scale bar, 5 μm. 
 
 
IV.3.5 NON-CENTROSOMAL NEK2C ACCUMULATES IN THE 
NUCLEUS   
 
While examining U2OS cells transfected with Nek2C, we noticed that in most cells 
(82%) the non-centrosomal protein was predominantly present in the nucleus (Fig. IV.5A 
& B). This was in contrast to U2OS cells transfected with Nek2A in which the protein 
showed a variable localization, sometimes mainly nuclear (35%), sometimes mainly 
cytoplasmic (29%) and sometimes distributed evenly throughout the cell (36%). Almost 
identical results were obtained in HeLa cells (Fig. IV.5A & B). For comparison, we 
decided to determine the cytoplasmic-nuclear distribution of the third splice variant, 
Nek2B. Strikingly, Nek2B was rarely detected predominantly in the nucleus (7%) with the 
majority of cells having the transfected protein predominantly in the cytoplasm (59%). To 
corroborate these microscopy experiments, transfected HeLa cells were also subject to 
subcellular fractionation and analysis by Western blotting (Fig. IV.5C). Again, Nek2C was 
predominantly found in the nuclear fraction (70%), whereas Nek2A was present in equal 
amounts in the nuclear (49%) and cytoplasmic (51%) fractions. Using this approach, 
Nek2B also appeared to be equally distributed between nuclear (48%) and cytoplasmic 
(52%) fractions. This discrepancy with the microscopy data for Nek2B is most likely due 
to the microscopy being a measure of individual cells, while the Western blot is a measure 
of total transfected protein. It was clear from the microscopy that the most strongly 
expressing cells were the ones that tended to show equal staining throughout the cell (i.e. 
N=C). However, counting individual cells, very few showed accumulation of NekB in the 
nucleus, but there were clearly cells with protein accumulated in the cytoplasm (see Fig. 
IV.5A). Hence, we conclude that there is a preferential uptake of Nek2C into the nucleus, 
whereas Nek2A tends to be more evenly distributed and Nek2B remains more in the 
cytoplasm, at least in the less strongly expressing cells. Thus, nuclear translocation of 
Nek2 is regulated by alternative splicing. 
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Figure IV.5. Recombinant Nek2C is predominantly nuclear  A. Immunofluorescence 
microscope images of U2OS (a-i) and HeLa (j-r) cells transfected with myctagged Nek2A, Nek2B or Nek2C 
as indicated and stained with anti-myc antibodies (red) and with DAPI to highlight the nucleus (blue). Merge 
images are shown. Scale bar, 20 μm. B. The subcellular distribution of transfected protein was scored as 
either predominantly nuclear (N>C), evenly distributed throughout the cell (N=C) or predominantly 
cytoplasmic (N<C) in 100 cells in three independent experiments. Errors bars, s.d. C. Cytoplasmic (C) and 
nuclear (N) fractions were prepared from HeLa cells transfected with myc-tagged Nek2A, Nek2B or Nek2C 
before analysis by SDS-PAGE and Western blotting with antibodies against myc to detect transfected Nek2 
proteins, Lamin A/C (alternatively spliced nuclear proteins) and α-tubulin (a cytoplasmic protein). The 
histogram shows the relative fraction of each myctagged protein in the cytoplasmic and nuclear fractions; 
mean and standard error from three independent experiments are shown. 
 
 
Nek2A 
Nek2B 
Nek2C 
20μm 
Myc MycDAPI DAPI Merge Merge 
U2OS cells HeLa cells 
a b c
d e f
g h i p q r 
j k l 
m n o 
Characterization of Two Novel PP1 Regulators: I2L and Nek2C                                                       Chapter IV 
_______________________________________________________________________________________ 
126                                                                                                                                   Centre for Cell Biology 
University of Aveiro 
 
IV.3.6 NUCLEAR TRANSLOCATION OF NEK2C DEPENDS UPON AN 
NLS THAT FLANKS THE SPLICE SITE  
 
To explain the unexpected nuclear accumulation of Nek2C, but not Nek2A or 
Nek2B, we scanned the Nek2 protein sequence for potential nuclear localization signals 
(NLSs) and nuclear export signals (NESs) (Gorlich and Kutay, 1999; Mattaj and 
Englmeier, 1998). We identified in Nek2A a putative bipartite NLS at residues 361-383 
and a weak NES at residues 372-375 (Fig. IV.6A). The NLS comprises two patches of 
basic residues, RK (361-362) and KKK (381-383). Intriguingly, these two patches span the 
eight amino acids missing from Nek2C, resulting in a linker of 18 amino acids in Nek2A 
but a linker of only 10 amino acids in Nek2C. Because most bipartite NLSs have a linker 
of 10-12 amino acids (Robbins et al., 1991), we hypothesized that, as a result of the eight 
amino acid deletion, the NLS may be better recognized by the nuclear transport machinery 
in Nek2C than in Nek2A. Nek2B lacks the second basic patch so does not contain a 
bipartite NLS. Meanwhile, the leucine rich NES sequence LLNL (372-375) falls within the 
eight amino acid stretch missing from Nek2C and so could act as a functional NES only in 
Nek2A.  
To test whether either of these signals was functional, we generated a series of 
mutants in the predicted NES and NLS (Fig. IV.6A). All mutants localized correctly at the 
centrosome, suggesting that protein folding in the C-terminal domain was largely 
unaffected (data not shown). Mutations to abolish the putative NES 
(L372A/L373A/L375A) in the Nek2A protein had no effect with the protein again showing 
a fairly even mix of distributions. In contrast, mutation in the Nek2C protein of either the 
first basic patch (R361A/K362A) or the second basic patch (K373A/K374A/K375A) led to 
proteins that were rarely predominantly nuclear (<18%) (Fig. 6B & C). A combined 
mutant with all five basic residues mutated was even more effective at keeping the protein 
from accumulating in the nucleus (<2%). Thus, mutation of the NES did not lead to an 
accumulation of Nek2A in the nucleus, but mutation of the NLS did substantially reduce 
uptake of Nek2C into the nucleus. We conclude that a functional bipartite NLS is present 
in Nek2C, is less effective in Nek2A, and is completely absent in Nek2B. Hence, as a 
result of the NLS spanning the splice site, the cell can regulate the overall abundance and 
the particular isoform distribution of Nek2 in the cytoplasm and nucleus. 
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Figure IV.6. Mutation of the bipartite NLS leads to loss of Nek2C from the nucleus  A. 
The amino acid sequences of Nek2A, Nek2B and Nek2C starting at K359 and encompassing the proposed 
NLS are indicated. The two basic patches of the bipartite NLS are in bold and the eight amino acid insertion 
is underlined. For comparison, the sequences within this region of the four mutants, Nek2AmNES and 
Nek2C-mNLS-2A, -3A and –5A, are shown with the mutated residues in lower case. B. Immunofluorescence 
microscope images of U2OS (a-l) and HeLa (m-x) cells transfected with the myctagged Nek2 mutants as 
indicated stained with anti-myc antibodies (red) and with DAPI to reveal the nucleus (blue). Merge images 
are shown. Scale bar, 20 μm. C. The subcellular distribution of mutant protein was scored as either 
predominantly nuclear (N>C), evenly distributed throughout the cell (N=C) or predominantly cytoplasmic 
(N<C) in 100 cells in three independent experiments. Errors bars, s.d. 
 
 
 
IV.3.7 DETECTION OF A NOVEL NEK2 NUCLEAR SUBSTRATE   
 
Aspergillus NIMA promotes chromatin condensation through phosphorylation of 
histone H3 (De Souza et al., 2000). We therefore tested whether nuclear accumulation of 
Nek2C might similarly promote this event. However, although untransfected prophase 
cells had clearly condensed chromatin that stained with phospho-H3 antibodies, interphase 
cells with strong nuclear accumulation of transfected Nek2C exhibited neither condensed 
chromatin nor phospho-H3 staining (Fig. IV.7A). Nek2A has also been reported to 
colocalize with Nek11 in nucleoli and to interact with the nucleolar protein, 
nucleophosmin (Noguchi et al., 2004; Yao et al., 2004). We therefore examined whether 
Nek2C was concentrated in nucleoli and colocalized with nucleophosmin. As expected, the 
bulk of transfected cells contained myc-Nek2C in the nucleus, but there was almost 
complete exclusion from the nucleoli and hence no colocalization with nucleophosmin (Fig. 
IV.7B). With a nuclear function for Nek2C still unclear, we therefore, decided to perform 
an unbiased search for nuclear substrates of Nek2 using the KESTREL approach for 
substrate detection (Cohen and Knebel, 2006). This method has been developed for 
identifying bona fide substrates of kinases by making use of short incubation times, high 
concentrations of added kinase, and high specificity of radioactivity combined with 
extracts that have been fractionated to separate endogenous kinases from their substrates 
and concentrate the substrates. Cytoplasmic and nuclear extracts were prepared from HEK 
293 cells and fractionated by heparin sepharose chromatography. These fractions were then 
incubated for 5 min with Mn-ATP, the preferred substrate of Nek2 (Fry et al., 1995), and 
either no kinase or recombinant Nek2A, Nek6, Nek7 or Nek9 before separation by SDS-
PAGE and autoradiography (Fig. IV.7B). A 28 kDa protein in Fraction 3 of the nuclear 
extract was specifically phosphorylated by the Nek2 kinase but not the closely related 
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Nek6, Nek7 and Nek9 kinases. This protein was not detected in Fraction 3 of the 
cytoplasmic extract. Although substantial further work will be required to validate this 
observation, the specificity of the phosphorylation and the stringent nature of the 
KESTREL approach leads us to propose that this 28 kDa protein is likely to represent a 
novel nuclear substrate of Nek2.  
 
 
A                                                                                      B  
 
C 
 
 
Figure IV.7. Detection of a 28 kDa Nek2 substrate in HEK 293 nuclear extracts  A. 
U2OS cells that were either untransfected (a-c) or transfected with mycNek2C for 24 hours (d-f) were 
processed for immunofluroescence microscopy with Nek2 (a,d) and phospho-H3 (b,e) antibodies and DNA 
stained with Hoechst 33258 (c,f). Scale bar, 5 μm. B. U2OS cells transfected for 24 hours with mycNek2C 
were stained with anti-Nek2 (a) and anti-nucleophosmin (b) antibodies and DNA stained with Hoechst 33258 
(c). A merged image is shown (d). C. Nuclear extracts from HEK 293 cells were desalted and 
chromatographed on heparin sepharose. Aliquots of the desalted extract (load) and the fractions (numbered) 
were incubated with Mn-ATP in the absence (-) or presence of Nek2, Nek6, Nek7 or Nek9 kinases as 
indicated. The reactions were separated by SDS-PAGE, transferred to PVDF and analysed by 
autoradiography. The positions of molecular weight markers (kDa) and autophosphorylated Nek kinases are 
indicated. The 28 kDa protein in fraction 3, phosphorylated only in the presence of Nek2, is indicated (*). 
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IV.4 DISCUSSION 
 
Nek2A was originally isolated in a degenerate PCR-based screen for human 
kinases related to Aspergillus NIMA (Schultz et al., 1994). The first alternative splice 
variant, Nek2B, was identified in Xenopus oocytes (Uto et al., 1999), and subsequently in 
cultured human cells (Hames and Fry, 2002). Most recently, Nek2C (originally called 
Nek2A-T) was described following a yeast two hybrid screen performed with a testis 
library and PP1γ1 and PP1γ2 as baits (Fardilha et al., 2004b). These three splice variants 
differ only in their non-catalytic C-terminal domains, and hence, not surprisingly, all 
encode active protein kinases. Indeed, Nek2C differs from Nek2A only in so much as it 
lacks eight amino acids (371-378) in the middle of the non-catalytic domain. Nevertheless, 
our results suggest that this small change has significant consequences on subcellular 
localization, which in turn may allow the different splice variants to undertake distinct 
functions during cell division. 
Although several independent clones representing Nek2C were identified in the 
two hybrid screen with a testis library, the majority of clones isolated in that study were 
Nek2A (Fardilha et al., 2004b). Likewise, Nek2A cDNAs were isolated from mouse testis 
libraries in three independent laboratories (Arama et al., 1998; Rhee and Wolgemuth, 1997; 
Tanaka et al., 1997). Hence, both Nek2A and Nek2C are present in testis, although they 
may have distinct functions to play during meiotic cell division. By using common primers 
that span the splice site and amplify products of distinct sizes, we were able to detect 
Nek2C mRNA in three different human cell lines (U2OS, HeLa and HEK 293), although at 
levels ~10-fold lower than Nek2A. Previous studies revealed elevated expression of Nek2 
in cancer cell lines and primary tumors without distinguishing between Nek2A and Nek2C 
(Hayward and Fry, 2006). It will be interesting to determine whether there is elevation of 
both splice variants.  
Clearly, at the sequence level, there is very little difference between Nek2A and 
Nek2C, and one would predict that they share many of the same properties. With respect to 
regulation of kinase activity, we confirmed that Nek2A and Nek2C phosphorylate the 
exogenous substrate β-casein equally, show similar levels of autophosphorylation, have the 
capacity to undergo dimerization, and can both bind PP1α. Moreover, the extreme C 
terminus, which contains two APC/C-dependent degradation motifs, is identical in the two 
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proteins, and we found no difference in their destruction in mitotic extracts or 
prometaphase-arrested cells. Finally, Nek2A and Nek2C both retain the region 
encompassing amino acids 333-370 required for microtubule binding and centrosome 
localization, and experimentally, we were able to confirm that Nek2C retains these 
properties. Thus, our data not only confirm that Nek2A and Nek2C are biological very 
similar but provide further evidence for the correct mapping of these different functional 
motifs.  
Despite the high degree of sequence identity, we were able to identify an important 
difference in the behavior of the two variants. After expression of recombinant proteins, it 
was clear that Nek2C was preferentially taken up into the nucleus, whereas Nek2A was 
more evenly distributed throughout the cell. Mechanistically, this can be explained by the 
loss of the eight amino acids from Nek2C that result from splicing. Nek2C contains an 
RKX10KKK sequence, where X is an uncharged linker, that conforms perfectly to the well 
defined bipartite NLS motif (Robbins et al., 1991). Mutation of the NLS led to loss of 
nuclear Nek2C, whereas mutation of a putative NES located within the eight amino acids 
missing from Nek2C had no effect. Furthermore, Nek2B, which only has the first basic 
patch and so lacks a functional NLS altogether, was present within the nucleus less than 
either Nek2A or Nek2C in single cell analysis. Because Nek2 proteins are generally around 
45 kDa, they are close to the cut-off for proteins that can diffuse passively into the nucleus. 
This would explain why proteins were sometimes found in both compartments, particularly 
in the most strongly expressing cells. Localization of the endogenous protein, which is 
present at much lower levels, is likely to be more discretely controlled.  
Structural analysis of NLS-containing peptides bound to the cargo binding domain 
of importin-α show that there is space to accommodate two lysine or arginine residues in 
the upstream basic patch and five lysine or arginines in the second basic patch; these are 
ideally separated by a linker of 10 residues (Conti and Kuriyan, 2000; Conti et al., 1998). 
Studies on the NLS sequence of nucleoplasmin revealed that linkers shorter than 10 amino 
acids are not tolerated, whereas longer linkers are tolerated but can have reduced activity 
(Robbins et al., 1991). In Nek2A, the linker is extended to 18 amino acids and includes 
additional hydrophobic and proline residues that could alter the conformation of the linker 
and interfere with its ability to function as a bipartite NLS. Indeed, there is support for 
interaction of the linker backbone with importin-α residues (Conti and Kuriyan, 2000). 
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However, there are cells in which Nek2A is concentrated in the nucleus, indicating that the 
longer linker does not completely abrogate NLS activity (Fry et al., 1998b). Indeed, there 
may be an additional level of regulation at which the distribution of Nek2A is controlled. It 
is intriguing that the second basic patch overlaps with the PP1 binding site (383-386) 
raising the possibility that nuclear uptake via importin-α interaction and PP1 binding are 
mutually exclusive. On the other hand, simultaneous binding to importin-α and PP1 would 
be possible for opposing polypeptides of dimeric Nek2.  
The function of Nek2 in the nucleus remains to be determined. Conflicting data 
exists on whether endogenous Nek2 is localized to condensed chromatin in early stage 
meiotic cells (Rhee and Wolgemuth, 1997; Tanaka et al., 1997). However, persuasive 
studies on mouse spermatocytes suggest that Nek2 plays an active role in chromatin 
condensation during the first meiotic division through phosphorylation of the chromatin-
associated protein, high mobility A2 (Di Agostino et al., 2004b; Di Agostino et al., 2002). 
Nuclear entry of Nek2C may be necessary for providing access not only to downstream 
substrates, such as high mobility protein A2, but also to upstream regulators, including 
activated extracellular signal-regulated kinase 1/p90Rsk2, before nuclear envelope 
breakdown. This, coupled with the fact that NIMA regulates chromatin condensation in 
Aspergillus (De Souza et al., 2000), seems the most promising explanation for nuclear 
Nek2. However, in contrast to NIMA, we found that nuclear accumulation of Nek2C did 
not promote phosphorylation of histone H3, indicating that, alone, it is not sufficient to 
trigger premature chromatin condensation. Interactions have been described for Nek2 with 
nuclear proteins, including nucleophosmin (also known as numatrin or NPM/B23) and, 
interestingly, another NIMA-related kinase, Nek11 (Noguchi et al., 2004; Yao et al., 2004). 
However, we found that nuclear Nek2C was excluded from nucleoli and did not co-
localize with nucleophosmin, raising questions over the significance of these reported 
interactions. Because the nuclear function of Nek2C remains obscure, we opted instead to 
initiate a search for novel nuclear substrates of Nek2 using the unbiased KESTREL 
chromatographic approach. This led to identification of a 28 kDa protein as a likely 
physiological substrate of Nek2. Future efforts will be required to scale up this process to 
identify this protein by mass spectrometry. In conclusion, besides providing support for a 
nuclear role of Nek2, this work neatly illustrates how alternative splicing can modulate the 
structure, and thereby functionality, of a bipartite NLS motif. 
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CHAPTER V 
DISCUSSION 
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V  DISCUSSION 
 
Infertility is a growing problem in the Western world, presently affecting around 
20% of couples. Growing evidence from clinical and epidemiological studies suggests that, 
at least in part, this is paralleled by the increasing incidence of male reproductive problems 
(Iammarrone et al., 2003). Although male infertility is complex and results from a variety 
of underlying causes, defects in sperm motility appear to be one of the main culprits. 
However, sperm biology is a complex process, as cells go from the male reproductive tract 
into the female reproductive tract and through processes of acquisition of progressive 
motility, capacitation, hyperactivation of motility, directed motility and induction of the 
acrosome reaction. In contrast, the worldwide market for male contraceptives is also worth 
billions of euros. The demand for a reliable non-hormonal oral male contraceptive is 
phenomenal, since male-directed options, in what concerns contraception, are almost 
solely limited to condoms and vasectomy. Due to various shortcomings of both methods, 
researchers have been looking for hormonal based contraceptives that also have their 
limitations (Amory et al., 2006). Both male infertility and contraception would benefit 
greatly from a more rational approach based on targeting sperm-specific processes. 
However, the underlying molecular mechanisms which regulate sperm motility are still not 
fully understood, though protein phosphorylation is an attractive model (Ren et al., 2001; 
Smith et al., 1996; Vijayaraghavan et al., 1996; Vijayaraghavan et al., 1997; Visconti and 
Kopf, 1998; Smith et al., 1999; Huang et al., 2002). The latter is the most common 
regulatory mechanism for triggering intracellular events, and abnormal protein 
phosphorylation profiles have been associated with various disease processes and 
dysfunctional states. Consequently, kinases and phosphatases represent attractive targets 
for novel approaches in drug design. 
Protein phosphorylation is the main post-translational modification in eukaryotic 
cells, regulating numerous physiological processes. The phosphorylation of target 
regulatory proteins, controlled by a variety of extra- and intra-cellular signals, is a dynamic 
and reversible process where the phosphate groups are incorporated into target proteins by 
the kinases and removed by the phosphatases. Several studies have demonstrated the 
involvement of cyclic nucleotides, bicarbonate, cholesterol and protein phosphorylation in 
the acquisition of progressive motility, capacitation, hyperactivation, directed motility and 
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the acrosome reaction (Cross, 1998; Garbers and Kopf, 1980; Huang et al., 2002; Mishra et 
al., 2003; Smith et al., 1996; Smith et al., 1999; Vijayaraghavan et al., 1996; 
Vijayaraghavan et al., 1997; Visconti and Kopf, 1998). Therefore, the main focus of this 
work concerned sperm protein phosphatases and their involvement in the control of sperm 
signal transduction mechanisms. 
Recent sequencing projects of entire genomes has revealed that protein kinases and 
protein phosphatases constitute approximately 3% of all eukaryotic genes (Plowman et al., 
1999). However, there are at least 2-5 times fewer phosphatases than kinases, and this 
imbalance is even more pronounced when one considers only the Ser/Thr-specific 
phosphatases and kinases. For example, the human genome encodes approximately 20x 
fewer Ser/Thr phosphatases than kinases. Thus, whereas the diversity of the Ser/Thr-
specific protein kinases has kept pace with the increasing complexity of evolving 
organisms, that of the Ser/Thr phosphatases has not. Over the past decade it has become 
apparent that phosphatase diversity has been achieved not only by the evolution of new 
catalytic subunits, but mainly by the ability of each single catalytic subunit to interact with 
multiple regulatory (R) subunits. Phosphatases may be fewer in number, but they are still 
capable of dephosphorylating thousands of proteins with a tight, specific and independent 
regulation. This is explained by the formation of complexes between the phosphatases (the 
catalytic subunit) and the regulatory protein subunits in a mutually exclusive manner 
(Ayllon et al., 2002). The occurrence of large multimeric complexes, sometimes containing 
both phosphatase and kinase activities has recently began to be appreciated. 
Germ cell-specific PP1γ2 phosphatase is the predominant Ser/Thr phosphatase in 
spermatozoa and its activity is inversely correlated with sperm motility (Smith et al., 1996; 
Vijayaraghavan et al., 1996). PP1 inhibition by okadaic acid or calyculin A induces 
motility initiation and stimulation. Indeed, inhibition of immotile caput sperm PP1 activity 
with specific inhibitors, results in them acquiring normal motility parameters. Intriguingly, 
these effects are completely independent of calcium. Sperm are terminally differentiated 
cells, constituting a relatively simple model system to study the regulation of PP1 in 
relation to motility and metabolism. The PP1 driven endogenous regulation of protein 
phosphorylation and sperm motility could represent an important mechanism for 
physiological regulation of a cell that encounters dramatically different environments as it 
journeys through the seminiferous tubules and the female reproductive tract. Previous 
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results (Smith et al., 1996; Vijayaraghavan et al., 1996) provide strong support for a novel 
unifying hypothesis based on the observation that PP1 is present in sperm and that 
pharmacological modulation of its activity profoundly affects sperm motility. In other cell 
types PP1 has been implicated in the control of different aspects of cell metabolism, 
muscle contraction, mitosis, neurotransmitter release, etc. This regulation is the result of 
complex intracellular pathways, initiated by activation of distinct receptors and second 
messenger systems. However, the precise role played by the phosphatases and their 
regulation have only recently started to be elucidated. 
It is now well established that in somatic cells PP1 activity relies on its binding to 
several phosphatase regulators to provide the necessary functional, subcellular and cell 
type-specific diversity (we now know that the same mechanism also operates in germ 
cells). With this in mind, we have previously undertaken an in-depth survey using the yeast 
two hybrid approach to identify proteins expressed in human testis capable of interacting 
specifically with the alternatively spliced isoforms of PP1γ. Around 120, 160 and 85 
positive clones were identified, purified, partially sequenced and compared to the Genbank 
database for PP1γ1, PP1γ2 and the unique PP1γ2 C-terminus, respectively. The PP1 
interactomes thus defined comprised 26, 29 and 42 different proteins from human testis 
capable of binding to PP1γ1 PP1γ2 and the PP1γ2 C-terminus (Fardilha, 2004). The 
validity of the results obtained was confirmed by a variety of criteria, including the 
isolation of bona fide PP1 regulators (Fardilha et al., 2004) and the presence of a consensus 
PP1 binding motif in the newly identified proteins. The most abundant interacting protein 
identified was Nek2A (Fry et al., 1998). Although it is already known that Nek2A interacts 
with PP1, which dephosphorylates Nek2A itself and other Nek2A substrates (Helps et al., 
2000), a new alternatively spliced isoform of Nek2A was identified, that we named Nek2C 
(Fardilha et al., 2004; Wu et al., 2007). The existence of testis-specific protein isoforms 
seems to be a recurrent event which can be used for specific targeting in relation to 
therapeutic interventions. 
The importance of PP1γ1 and PP1γ2 function has been addressed with the targeted 
disruption of the PP1γ gene. Knock out mice were viable and homozygous females were 
fertile. On the contrary, disruption of the PP1γ gene caused sterility in males due to arrest 
of spermatogenesis at the spermatid stage (Varmuza et al., 1999). Histological examination 
revealed severe impairment of spermiogenesis beginning at the round spermatid stage. 
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Histopathological evidence shows that meiosis may be disrupted: the presence of 
polyploidy spermatids suggests a failure of one of the reductional divisions. These 
observations show that other PP1 isoforms can compensate for the lack of PP1γ1 in 
somatic cells and for the lack of PP1γ2 in germ cells but only until the final stages of 
spermatogenesis, where PP1γ2 becomes indispensable (Varmuza et al., 1999). Furthermore, 
it was shown that PP1γ2 has a role in sperm morphogenesis, being required for normal 
flagellar integrity and structures (Chakrabarti et al., 2007). It is interesting to note that even 
though PP1α, PP1β, PP1γ1 and PP1γ2 are virtually identical, they can compensate for each 
others absence in relation to some functions but not in all. That is, there are some processes 
that are absolutely PP1 isoform specific. 
Besides the two splice variants, Nek2A and Nek2B, identified in primary blood 
lymphocytes and adult transformed cells (Hames and Fry, 2002) that differ in their non-
catalytic carboxyl-termini, we have now described a third Nek2 variant, Nek2C (Fig. 
IV.1A). Nek2C was first identified in a human testis library (Fardilha et al., 2004; Wu et 
al., 2007), where Nek2 is also known to be highly expressed in the adult. Nek2 is 
expressed in a stage specific pattern during spermatogenesis and intense signals were also 
observed in oocytes (Tanaka et al., 1997). Alternative splicing is an unusual mechanism for 
modulating Nek2 localization and it supports the hypothesis that Nek2 has both nuclear 
and cytoplasmic functions, and that it might bind different PP1 isoforms depending on its 
function. Although Nek2A, Nek2B and Nek2C are likely to exhibit distinct functional 
properties, it may be difficult to specifically target Nek2A and Nek2C for therapeutics, 
since the only difference is that Nek2C lacks 8 amino acids present in Nek2A.  However, 
the effectiveness of siRNA directed against each, needs to be fully explored to assess the 
feasibility of this approach. The kinase/phosphatase complex of Nek2-PP1 functions as a 
bistable switch (Sohaskey and Ferrell, 2002). The binding and regulation of the Nek2-PP1 
complex by I2 opens new avenues for PP1 regulation, showing the existence of PP1 
trimeric complexes. Indeed, further complexity is provided by the expression of both Nek2 
variants (Nek2A and Nek2C) and both I2 isoforms (I2 and I2L) in sperm. It is tempting to 
speculate that in vivo they may express some degree of functional specificity. Future work 
in the laboratory will attempt to address this important issue. 
One particularly interesting mechanism for controlling PP1 activity involves its 
inhibition by heat-stable inhibitors, particularly protein phosphatase inhibitors I1 and I2 
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(phosphoproteins whose state of phosphorylation dictates their PP1 inhibitory activity). I1 
is phosphorylated by cAMP-dependent protein kinase (PKA) and dephosphorylated by the 
calcium/calmodulin-dependent protein phosphatase calcineurin (PP2B). Thus, PP1 is 
involved in the cross-talk between the intracellular messengers calcium and cAMP. I2 is 
also capable of inhibiting the catalytic subunit of PP1 leading to the production of a stable 
PP1-I2 complex. GSK-3 kinase phosphorylates I2 in the PP1-I2 complex, relieving the 
inhibition and producing active PP1. This biochemical scheme is likely to be operative in 
mammalian sperm, since preliminary studies have identified an I2-like activity and also 
GSK-3 in mammalian sperm (Smith et al., 1996; Vijayaraghavan et al., 1996). Immotile 
bovine caput epididymal sperm contain two fold higher levels of protein phosphatase 
activity, identified as PP1γ2, and six fold higher GSK-3 activity, compared to mature 
motile caudal sperm. Thus, high GSK-3 activity keeps PP1γ2 active in immotile caput 
sperm, but the complex PP1γ2/I2 forms and remains largely inactive in motile caudal 
sperm (Smith et al., 1996; Vijayaraghavan et al., 1996). 
In this work, we have now identified a new I2 isoform, that we called I2L. The two 
are highly similar, except for some important substitutions in key regulatory amino acids 
(Fig. III.1C and Fig. V.1). The identified differences between I2 and I2L may be crucial for 
their inhibition of PP1γ2 and consequent regulation of human sperm motility (Fardilha et 
al., 2004). Indeed, I2L exhibits an amino acid substitution of the key threonine residue that 
is phosphorylated by GSK-3 and that relieves PP1 inhibition. Consequently, I2L is not 
subject to regulation by this kinase and therefore can be viewed as a constitutive inhibitor 
of PP1. The I2L gene is only present in the primate and human genomes, suggesting that it 
may represent an evolutionary important event. 
 
 
 
Figure V.1A. Diagramatic comparison of I2L and I2. Boxed areas represent identical residues. 
Different amino acids are shown. The main difference is the Thr for Pro substitution at position 73. Drawn to 
scale. 
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I2-L    1 MAASTASHRPIKGILKNKTSTTSSMVASAEQPRRSVDEELSKKSQKWDEINILATYHPAD 
I2      1 MAASTASHRPIKGILKNKTSTTSSMVASAEQPRGNVDEELSKKSQKWDEMNILATYHPAD 
          *********************************  ************** ********** 
 
I2-L   61 KGYGLMKIDEPSPPYHSMMGDDEDACRDTETTEAMAPDILAKKLAAAEGLEPKYRIQEQE 
I2     61 KDYGLMKIDEPSTPYHSMMGDDEDACSDTEATEAMAPDILARKLAAAEGLEPKYRIQEQE 
          * ********** ************* *** ********** ****************** 
 
I2-L  121 SSGEEDSDLSPEEREKKRQFEMRRKLHYNEGLNIKLARQLISKDLHDDDEDEEMLETADG 
I2    121 SSGEEDSDLSPEEREKKRQFEMKRKLHYNEGLNIKLARQLISKDLHDDDEDEEMLETADG 
          ********************** ************************************* 
 
I2-L  181 ESMNTEESNQGSTPSDQQQNKLRSS 
I2    181 ESMNTEESNQGSTPSDQQQNKLRSS 
          ************************* 
95.6% identity in 205 residues overlap; Score: 1006.0; Gap frequency:0.0% 
Figure V.1B: Alignment of amino acid sequences of I2L and I2. Highlighted residues 
represent important regulatory sites; the underlined region represents the most highly conserved region of the 
protein. Amino acid differences are shown in colour. 
 
 
 
I2L and I2 are both heat-stable protein inhibitors of PP1 that were shown to inhibit 
its activity with nanomolar affinity (see Chapter III). The inactive complex PP1-I2 can be 
reactivated by phosphorylation of Thr73 on I2 by GSK-3 (DePaoli-Roach, 1984). 
Phosphorylation at this site can be enhanced by CK2 phosphorylation of Ser87 (Fig. III.4; 
Park and DePaoli-Roach, 1994). PP1γ2 and GSK3 are both present in sperm and their 
activities are 2- and 6-fold higher, respectively, in immotile caput compared to motile 
caudal epididymal sperm (Smith et al., 1996; Vijayaraghavan et al., 1996). Given that I2 is 
also expressed in sperm, PP1γ2 activity is also probably regulated by its interaction with I2, 
in a manner analogous to that described for somatic cells. However, although the 
expression of I2L in sperm remains to be demonstrated experimentally, it provides an 
interesting and hitherto unknown mechanism for the irreversible and unidirectional 
inhibition of PP1 that might correlate with the development of sperm motility during 
epidydimal transit. The absence of the most important regulatory residue of I2 from I2L (it 
has a Thr for Pro substitution at position 73) must have consequences on the regulation of 
PP1 and ultimately on the acquisition of sperm motility. 
In general, since in vivo protein phosphatases possess exquisite specificities, both in 
terms of substrates and localization, the key control mechanism must reside in the nature of 
the proteins to which they bind. An increasing number of proteins are being identified in 
diverse cell types that are responsible for regulating their catalytic activity. Indeed, the 
diversity of such phosphatase regulatory subunits explains not only the need for few 
catalytic subunit types, but also make the former attractive targets for pharmacological 
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intervention. A major question remaining is how the regulators exert their discrimination 
between virtually identical mammalian PP1 isoforms. The regulatory subunits are usually 
unrelated, but most possess a consensus RVxF motif, a canonical PP1 binding domain. 
However, resolution of the crystal structure of the complex between PP1γ and a 34kDa N-
terminal domain of the myosin phosphatase targeting subunit MYPT1 (Hartshorne et al., 
1998) demonstrated the importance of other structural elements amino- and carboxy-
terminal to the RVxF motif of MYPT1 to the reshaping of the catalytic cleft of PP1 (Terrak 
et al., 2004). These interactions also contribute to the increased myosin specificity of the 
complex. Another interaction was also observed between MYPT1 and the C terminus of 
PP1γ, involving residues that are not present in the other PP1 isoforms, thus giving an 
indication of at least one mechanism by which isoform specificity can be achieved. 
The importance of PP1 and its binding proteins as potential targets for signal 
transduction therapeutics is further strengthened by the work of Greengard and co-workers 
demonstrating the central role played by DARPP-32 in mediating many of the most 
important neuronal signaling pathways (Greengard et al., 1999). To date more than twenty 
primary signaling cascades have been shown to be under the regulation of the 
PP1/DARPP-32 system in the striatum and the PP1/I1 system in other brain regions. PP1 
has also been suggested to play a central role in the molecular mechanisms of the actions 
of drugs of abuse.  Furthermore, several lines of evidence also link PP1 to the basic 
processes thought to underlie memory and learning, such as LTP (long term potenciation) 
and LTD (long term depression). In fact, the relevance of PP1 within the context of aging 
and memory loss was recently given a rather intriguing boost. PP1 has been linked to the 
efficacy of learning and memory by limiting the acquisition of new knowledge and 
favouring memory decline (Genoux et al., 2002). PP1 inhibition prolongs memory when 
induced after learning, suggesting that PP1 promotes forgetting. These findings may 
account for aging-related cognitive decline and emphasize the physiological importance of 
PP1 as a suppressor of learning and memory. Altered PP1 activity may therefore be 
associated not only with the normal cognitive decline during aging, but may also explain 
the accelerated decline observed in AD patients and in other neurodegenerative diseases. 
Since I1 and DARPP-32 are not expressed in mammalian sperm, it is interesting to 
speculate that the PP1/I2 and PP1/I2L systems may function to regulate the diversity of 
sperm signalling cascades. 
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In conclusion, we have demonstrated the occurrence of two hitherto unknown PP1 
holoenzymes in testis/sperm (PP1/I2L and PP1/Nek2C), that may constitute potential 
targets for pharmaceutical intervention (Fig. V.2). However, before interfering with these 
protein complexes, a better understanding is required of their involvement in sperm 
motility and other sperm functions.  Nevertheless, the newly identified PP1 regulators 
exhibit novel and unusual properties. I2L is missing critical amino acid residues required 
for GSK-3 regulation, converting it into an irreversible PP1 inhibitor, whereas Nek2C is 
likely to have important nuclear functions given the functional NLS created by the specific 
splicing out of 8 amino acids. Therefore, both proteins may represent interesting specific 
targets to treat infertility and to develop new non-hormonal contraceptives. The 
characterization of testis- and sperm-specific PP1 regulatory proteins should aid in the 
development of novel signal transduction therapeutic approaches to male infertility and 
male contraception. 
 
 
 
Figure V.2. Signal transduction therapeutics for specific cellular events based on 
targeting of different PP1 regulators. 
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